ICD-codes explAIned
We provide ~16 000 AI-explAInations of medical conditions, illnesses, and terms based on the ICD-11 codes
DISCLAIMER: Please note that all explAInations are generated by AI and are not fact checked by a medical professional. ICD ExplAIned do not assume liability for any injuries or harm based on the use of this medical information.
What are ICD-codes?
ICD codes are codes used to classify diseases, health conditions, and symptoms. The codes are used for medical diagnosis, hospital management, and health insurance purposes. The International Classification of Diseases (ICD) is the standard diagnostic tool for epidemiology, health management, and clinical purposes. ICD codes are maintained by the World Health Organization (WHO).
What can I search for?
IcdexplAIned contain explanations for all ICD-11 codes chapter 1 to 22 and corresponding ICD-10 codes. Chapters 23 to X of ICD-11 has been excluded as they define causes for injuries and codes for special causes that have been considered not applicable for the purpose of icdexplAIned.
All explAInations
All explAInations of medical conditions are found in alphabetical order below.
- 1A00/A00 Cholera
- 1A01/A04 Intestinal infection due to other Vibrio
- 1A02/A03 Intestinal infections due to Shigella
- 1A03.0/A04.0 Enteropathogenic Escherichia coli infection
- 1A03.1/A04.1 Enterotoxigenic Escherichia coli infection
- 1A03.2/A04.2 Enteroinvasive Escherichia coli infection
- 1A03.3/A04.3 Enterohaemorrhagic Escherichia coli infection
- 1A03/A04 Intestinal infections due to Escherichia coli
- 1A03.Y/A04.8 Intestinal infections due to other specified Escherichia coli
- 1A03.Z/A04 Intestinal infections due to Escherichia coli, unspecified
- 1A04/A04.7 Intestinal infections due to Clostridioides difficile
- 1A05/A04.6 Intestinal infections due to Yersinia enterocolitica
- 1A06/A04.5 Gastroenteritis due to Campylobacter
- 1A07.0/A01.0 Typhoid peritonitis
- 1A07/A01.0 Typhoid fever
- 1A07.Y/A01.0 Other specified typhoid fever
- 1A07.Z/A01.0 Typhoid fever, unspecified
- 1A08/A01 Paratyphoid fever
- 1A09.0/A02.0 Salmonella enteritis
- 1A09/A02 Infections due to other Salmonella
- 1A09.Y/A02.8 Infections due to other Salmonella in other organs
- 1A09.Z/A02 Salmonella infection, unspecified
- 1A0Y/A04.9 Other specified bacterial intestinal infections
- 1A0Z/A04.9 Bacterial intestinal infections, unspecified
- 1A10/A05.0 Foodborne staphylococcal intoxication
- 1A11.0/A05.1 Foodborne intoxication by botulinum toxin
- 1A11.1/A05.1 Other forms of botulism
- 1A11/A05.1 Botulism
- 1A11.Z/A05.1 Botulism, unspecified
- 1A12/A05.2 Foodborne Clostridium perfringens intoxication
- 1A13/A05.4 Foodborne Bacillus cereus intoxication
- 1A1Y/A05.9 Other specified bacterial foodborne intoxications
- 1A1Z/A05.9 Bacterial foodborne intoxications, unspecified
- 1A20/A08.2 Enteritis due to Adenovirus
- 1A21/A08.3 Gastroenteritis due to Astrovirus
- 1A22/A08.0 Gastroenteritis due to Rotavirus
- 1A23/A08.1 Enteritis due to Norovirus
- 1A24/A08.5 Intestinal infections due to Cytomegalovirus
- 1A2Y/A08 Other specified viral intestinal infections
- 1A2Z/A08 Viral intestinal infections, unspecified
- 1A30/A07.0 Infections due to Balantidium coli
- 1A31/A07.1 Giardiasis
- 1A32/A07.2 Cryptosporidiosis
- 1A33.0/A07.3 Cystoisosporiasis of small intestine
- 1A33.1/A07.3 Cystoisosporiasis of colon
- 1A33/A07.3 Cystoisosporiasis
- 1A33.Y/A07.3 Other specified cystoisosporiasis
- 1A33.Z/A07.3 Cystoisosporiasis, unspecified
- 1A34/A07.8 Sarcocystosis
- 1A35/A07.8 Blastocystosis
- 1A36.0/A07.8 Intestinal infections due to Entamoeba
- 1A36.00/A06.0 Acute amoebiasis
- 1A36.01/A06.3 Amoeboma of intestine
- 1A36.0Z/A07.8 Intestinal infections due to Entamoeba, unspecified
- 1A36.1/A06 Extraintestinal infections due to Entamoeba
- 1A36.10/A06.4 Amoebic liver abscess
- 1A36.11/A06.5 Amoebic lung abscess
- 1A36.12/A06.7 Cutaneous amoebiasis
- 1A36.1Y/A06 Amoebiasis of other specified sites
- 1A36/A06 Amoebiasis
- 1A36.Z/A06 Amoebiasis, unspecified
- 1A3Y/A08.5 Other specified protozoal intestinal infections
- 1A3Z/A08.5 Protozoal intestinal infections, unspecified
- 1A40.0/A09.9 Gastroenteritis or colitis without specification of origin
- 1A40/A09 Gastroenteritis or colitis without specification of infectious agent
- 1A40.Z/A09 Infectious gastroenteritis or colitis without specification of infectious agent
- 1A60.0/A50.0 Early congenital syphilis, symptomatic
- 1A60.1/A50.1 Early congenital syphilis, latent
- 1A60.2/A50.3 Late congenital syphilitic oculopathy
- 1A60.3/A50.4 Late congenital neurosyphilis
- 1A60.4/A50 Other late congenital syphilis, symptomatic
- 1A60.5/A50.6 Late congenital syphilis, latent
- 1A60/A50 Congenital syphilis
- 1A60.Z/A50 Congenital syphilis, unspecified
- 1A61.0/A51.0 Primary genital syphilis
- 1A61.1/A51.1 Primary anal syphilis
- 1A61.2/A51.2 Primary syphilis of other sites
- 1A61.3/A51.3 Secondary syphilis of skin or mucous membranes
- 1A61.4/A51.4 Secondary syphilis of other sites
- 1A61.5/A51.5 Latent early syphilis
- 1A61/A51 Early syphilis
- 1A61.Y/A51 Other specified early syphilis
- 1A61.Z/A51 Early syphilis, unspecified
- 1A62.0/A52 Neurosyphilis
- 1A62.00/A52.2 Asymptomatic neurosyphilis
- 1A62.01/A52.1 Symptomatic late neurosyphilis
- 1A62.0Z/A52 Neurosyphilis, unspecified
- 1A62.1/A52.0 Cardiovascular late syphilis
- 1A62.2/A52.7 Symptomatic late syphilis of other sites
- 1A62.20/A52.7 Ocular late syphilis
- 1A62.21/A52.7 Late syphilis involving the musculoskeletal system
- 1A62.22/A52.7 Late syphilis of skin or mucous membranes
- 1A62.2Y/A52.7 Symptomatic late syphilis of other specified sites
- 1A62.2Z/A52.7 Symptomatic late syphilis of unspecified site
- 1A62/A52 Late syphilis
- 1A62.Y/A52.8 Other specified late syphilis
- 1A62.Z/A52 Late syphilis, unspecified
- 1A63/A53.0 Latent syphilis, unspecified as early or late
- 1A6Z/A50-A64 Syphilis, unspecified
- 1A70.0/A54.0 Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess
- 1A70.00/A54.0 Gonorrhoea of penis
- 1A70.0Y/A54.0 Other specified gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess
- 1A70.0Z/A54.0 Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess, unspecified
- 1A70.1/A54.1 Gonococcal infection of lower genitourinary tract with periurethral or accessory gland abscess
- 1A70/A54 Gonococcal genitourinary infection
- 1A70.Y/A54 Gonococcal infection of other specified genitourinary organ
- 1A70.Z/A54 Gonococcal genitourinary infection, unspecified
- 1A71/A54 Gonococcal pelviperitonitis
- 1A72.0/A54.4 Gonococcal infection of musculoskeletal system
- 1A72.1/A54.6 Gonococcal infection of rectum
- 1A72.2/A54.6 Gonococcal infection of anus
- 1A72.3/A54.5 Gonococcal pharyngitis
- 1A72.4/A54.3 Gonococcal infection of eye
- 1A72/A54 Gonococcal infection of other sites
- 1A72.Y/A54 Gonococcal infection of other specified sites
- 1A73/A54 Disseminated gonococcal infection
- 1A7Z/A54 Gonococcal infection, unspecified
- 1A80/A55 Chlamydial lymphogranuloma
- 1A81.0/A56.0 Chlamydial infection of lower genitourinary tract
- 1A81.1/A56.1 Chlamydial infection of internal reproductive organs
- 1A81/A56 Non-ulcerative sexually transmitted chlamydial infection
- 1A81.Y/A56.8 Non-ulcerative sexually transmitted chlamydial infection of other specified site
- 1A81.Z/A56 Non-ulcerative sexually transmitted chlamydial infection of unspecified site
- 1A8Y/A50-A64 Other specified sexually transmissible infections due to chlamydia
- 1A8Z/A50-A64 Sexually transmissible infections due to chlamydia, unspecified
- 1A90/A57 Chancroid
- 1A91/A58 Granuloma inguinale
- 1A92/A59 Trichomoniasis
- 1A93/A63.8 Sexually transmissible infestations
- 1A94.0/A60.0 Herpes simplex infection of genitalia or urogenital tract
- 1A94.1/A60.1 Herpes simplex infection of perianal skin or rectum
- 1A94/A60 Anogenital herpes simplex infection
- 1A94.Z/A60 Anogenital herpes simplex infection without further specification
- 1A95.0/A63.0 Anal warts
- 1A95.1/A63.0 Genital warts
- 1A95.2/A63.0 Extragenital condylomata acuminata
- 1A95/A63.0 Anogenital warts
- 1A9Y/A50-A64 Other specified predominantly sexually transmitted infections
- 1A9Z/A50-A64 Predominantly sexually transmitted infections, unspecified
- 1B10.0/A15 Respiratory tuberculosis, confirmed
- 1B10.1/A16 Respiratory tuberculosis, not confirmed
- 1B10/A16 Tuberculosis of the respiratory system
- 1B10.Z/A16 Respiratory tuberculosis, without mention of bacteriological or histological confirmation
- 1B11.0/A17.0 Tuberculous meningitis
- 1B11.1/A17.8 Tuberculous meningoencephalitis
- 1B11.2/A17.1 Meningeal tuberculoma
- 1B11.3/A17 Tuberculous granuloma of brain
- 1B11.4/A17 Tuberculous granuloma of the meninges
- 1B11/A17 Tuberculosis of the nervous system
- 1B11.Y/A17.8 Tuberculosis of other specified part of nervous system
- 1B11.Z/A17 Tuberculosis of the nervous system, unspecified
- 1B12.0/A18 Tuberculosis of heart
- 1B12.1/A18.5 Tuberculosis of eye
- 1B12.2/A18.6 Tuberculosis of ear
- 1B12.3/A18 Tuberculosis of endocrine glands
- 1B12.4/A18 Tuberculosis of the musculoskeletal system
- 1B12.40/M90.0 Tuberculosis of bones or joints
- 1B12.41/A18 Tuberculous myositis
- 1B12.4Y/A18 Tuberculosis of other specified part of the musculoskeletal system
- 1B12.4Z/A18 Tuberculosis of the musculoskeletal system, unspecified
- 1B12.5/A18.1 Tuberculosis of the genitourinary system
- 1B12.6/A18.2 Tuberculous peripheral lymphadenopathy
- 1B12.7/K93.0 Tuberculosis of the digestive system
- 1B12.8/A18.4 Cutaneous tuberculosis
- 1B12/A18 Tuberculosis of other systems and organs
- 1B12.Y/A18.8 Tuberculosis of other specified organ or site
- 1B13.0/A19.0 Acute miliary tuberculosis of a single specified site
- 1B13.1/A19.1 Acute miliary tuberculosis of multiple sites
- 1B13.2/A19 Acute miliary tuberculosis, unspecified site
- 1B13/A19 Miliary tuberculosis
- 1B13.Y/A19.8 Other specified miliary tuberculosis
- 1B13.Z/A19 Miliary tuberculosis, unspecified
- 1B14/Z22.7 Latent tuberculosis
- 1B1Y/A15-A19 Other specified tuberculosis
- 1B1Z/A15-A19 Tuberculosis, unspecified
- 1B20.0/A30 Paucibacillary leprosy
- 1B20.1/A30 Multibacillary leprosy
- 1B20.2/A30 Leprosy reactions
- 1B20.20/A30 Type I leprosy reaction
- 1B20.21/A30 Type II leprosy reaction
- 1B20.3/A30 Complications of leprosy
- 1B20/A30 Leprosy
- 1B20.Z/A30 Leprosy, unspecified
- 1B21.0/A31.0 Pulmonary infection due to non-tuberculous mycobacterium
- 1B21.1/A31 Non-tuberculous mycobacterial lymphadenitis
- 1B21.2/A31 Cutaneous non-tuberculous mycobacterial infection
- 1B21.20/A31 Mycobacterium ulcerans infection
- 1B21.2Y/A31 Cutaneous infection due to other specified non-tuberculous mycobacteria
- 1B21.2Z/A31 Cutaneous infection due to unspecified non-tuberculous mycobacteria
- 1B21.3/A31 Disseminated non-tuberculous mycobacterial infection
- 1B21.4/A31 Gastrointestinal non-tuberculous mycobacterial infection
- 1B21/A31 Infections due to non-tuberculous mycobacteria
- 1B21.Y/A31.8 Non-tuberculous mycobacterial infection of other specified site
- 1B21.Z/A31 Non-tuberculous mycobacterial infection of unspecified site
- 1B2Y/I Other specified mycobacterial diseases
- 1B2Z/I Mycobacterial diseases, unspecified
- 1B40.0/I00 Rheumatic arthritis, acute or subacute
- 1B40/I00 Acute rheumatic fever without mention of heart involvement
- 1B40.Y/I00 Other specified acute rheumatic fever without mention of heart involvement
- 1B40.Z/I00 Acute rheumatic fever without mention of heart involvement, unspecified
- 1B41.0/I01.0 Acute rheumatic pericarditis
- 1B41.1/I01.1 Acute rheumatic endocarditis
- 1B41.10/I01.1 Rheumatic aortitis
- 1B41.1Y/I01.1 Other specified acute rheumatic endocarditis
- 1B41.1Z/I01.1 Acute rheumatic endocarditis, unspecified
- 1B41.2/I01.2 Acute rheumatic myocarditis
- 1B41/I01 Acute rheumatic fever with heart involvement
- 1B41.Y/I01.8 Other acute rheumatic heart disease
- 1B41.Z/I01 Acute rheumatic heart disease, unspecified
- 1B42/I02 Rheumatic chorea
- 1B50/A38 Scarlet fever
- 1B51/J02.0 Streptococcal pharyngitis
- 1B53/G00.2 Meningitis due to Streptococcus
- 1B54/G00.3 Meningitis due to Staphylococcus
- 1B5Y/I Other specified staphylococcal or streptococcal diseases
- 1B5Z/I Staphylococcal or streptococcal diseases, unspecified
- 1B70.0/A46 Erysipelas
- 1B70.00/A46 Erysipelas of face
- 1B70.01/A46 Erysipelas of external ear
- 1B70.02/A46 Erysipelas of lower limb
- 1B70.0Y/A46 Erysipelas of other specified site
- 1B70.1/L03 Streptococcal cellulitis of skin
- 1B70.2/L03 Staphylococcal cellulitis of skin
- 1B70.3/No Mapping Ascending bacterial lymphangitis
- 1B70/No Mapping Bacterial cellulitis, erysipelas or lymphangitis
- 1B70.Y/No Mapping Bacterial cellulitis or lymphangitis due to other specified bacterium
- 1B70.Z/No Mapping Bacterial cellulitis or lymphangitis due to unspecified bacterium
- 1B71.0/M72.6 Streptococcal necrotising fasciitis
- 1B71.1/M72.6 Polymicrobial necrotising fasciitis
- 1B71.2/M72.6 Neonatal necrotising fasciitis
- 1B71/M72.6 Necrotising fasciitis
- 1B71.Y/M72.6 Necrotising fasciitis due to other specified bacterial infection
- 1B71.Z/M72.6 Necrotising fasciitis, unspecified
- 1B72.0/L01 Bullous impetigo
- 1B72.1/L01 Non-bullous impetigo
- 1B72.2/L01.1 Secondary impetiginisation of the skin
- 1B72/L01 Impetigo
- 1B72.Y/L01 Other specified impetigo
- 1B72.Z/L01 Impetigo, unspecified
- 1B73.0/B08.0 Streptococcal ecthyma
- 1B73.1/B08.0 Staphylococcal ecthyma
- 1B73.2/B08.0 Ecthyma gangrenosum
- 1B73/B08.0 Ecthyma
- 1B73.Y/B08.0 Other specified ecthyma
- 1B73.Z/B08.0 Ecthyma, unspecified
- 1B74.0/No Mapping Staphylococcus aureus superficial folliculitis
- 1B74/No Mapping Superficial bacterial folliculitis
- 1B74.Y/No Mapping Superficial bacterial folliculitis due to other specified organism
- 1B74.Z/No Mapping Superficial bacterial folliculitis due to unspecified organism
- 1B75.0/L02 Furuncle
- 1B75.1/L02 Carbuncle
- 1B75.2/L02 Furunculosis
- 1B75.3/L02 Pyogenic abscess of the skin
- 1B75.4/No Mapping Chronic deep bacterial folliculitis
- 1B75/No Mapping Deep bacterial folliculitis or pyogenic abscess of the skin
- 1B7Y/No Mapping Other specified pyogenic bacterial infection of skin and subcutaneous tissue
- 1B90.0/A25.0 Spirillosis
- 1B90.1/A25.1 Streptobacillosis
- 1B90/A25 Rat-bite fevers
- 1B91/A27 Leptospirosis
- 1B92/A24.0 Glanders
- 1B93.0/A20.0 Bubonic plague
- 1B93.1/A20.1 Cellulocutaneous plague
- 1B93.2/A20.2 Pneumonic plague
- 1B93.3/A20.3 Plague meningitis
- 1B93/A20 Plague
- 1B93.Y/A20.8 Other specified plague
- 1B93.Z/A20 Plague, unspecified
- 1B94.0/A21.0 Ulceroglandular tularaemia
- 1B94/A21 Tularaemia
- 1B94.Y/A21.8 Other specified tularaemia
- 1B94.Z/A21 Tularaemia, unspecified
- 1B95/A23 Brucellosis
- 1B96/A26 Erysipeloid
- 1B97/A22 Anthrax
- 1B98/A28.1 Cat-scratch disease
- 1B99/A28.0 Pasteurellosis
- 1B9A/A28.2 Extraintestinal yersiniosis
- 1B9Z/A28.8 Unspecified zoonotic bacterial disease
- 1C10.0/A42.0 Pulmonary actinomycosis
- 1C10.1/A42.1 Abdominal actinomycosis
- 1C10.2/A42.2 Cervicofacial actinomycosis
- 1C10.3/A42 Primary cutaneous actinomycosis
- 1C10/A42 Actinomycosis
- 1C10.Y/A42.8 Other specified forms of actinomycosis
- 1C10.Z/A42 Actinomycosis, unspecified
- 1C11.0/A44 Carrion disease
- 1C11.00/A44.0 Oroya fever
- 1C11.01/A44.1 Verruga peruana
- 1C11.1/A79.0 Trench fever
- 1C11/A44 Bartonellosis
- 1C11.Y/A44.8 Other forms of bartonellosis
- 1C12.0/A37.0 Whooping cough due to Bordetella pertussis
- 1C12.1/A37.1 Whooping cough due to Bordetella parapertussis
- 1C12/A37 Whooping cough
- 1C12.Y/A37.8 Other specified whooping cough
- 1C12.Z/A37 Whooping cough, unspecified
- 1C13/A35 Tetanus
- 1C14/A34 Obstetrical tetanus
- 1C15/A33 Tetanus neonatorum
- 1C16/A48.0 Gas gangrene
- 1C17.0/A36.0 Pharyngeal or tonsillar diphtheria
- 1C17.00/A36.0 Postdiphtheritic paralysis of uvula
- 1C17.0Y/A36.0 Other specified pharyngeal or tonsillar diphtheria
- 1C17.0Z/A36.0 Pharyngeal or tonsillar diphtheria, unspecified
- 1C17.1/A36.1 Nasal diphtheria
- 1C17.2/A36.2 Laryngeal diphtheria
- 1C17.3/A36.3 Cutaneous diphtheria
- 1C17/A36 Diphtheria
- 1C17.Y/A36.8 Other specified diphtheria
- 1C17.Z/A36 Diphtheria, unspecified
- 1C18/A48.4 Brazilian purpuric fever
- 1C19.0/A48.2 Nonpneumonic Legionnaires’ disease
- 1C19.1/A48.1 Legionnaires disease
- 1C19/A48.1 Legionellosis
- 1C1A.0/A32.0 Cutaneous listeriosis
- 1C1A.1/A32.1 Listerial meningitis or meningoencephalitis
- 1C1A/A32 Listeriosis
- 1C1A.Y/A32.8 Other specified listeriosis
- 1C1A.Z/A32 Listeriosis, unspecified
- 1C1B.0/A43.0 Pulmonary nocardiosis
- 1C1B.1/A43.1 Cutaneous nocardiosis
- 1C1B/A43 Nocardiosis
- 1C1B.Y/A43.8 Other specified forms of nocardiosis
- 1C1B.Z/A43 Nocardiosis, unspecified
- 1C1C.0/A39.0 Meningococcal meningitis
- 1C1C.1/A39.1 Waterhouse-Friderichsen syndrome
- 1C1C.2/A39 Meningococcaemia
- 1C1C.20/A39.2 Acute meningococcaemia
- 1C1C.2Y/A39 Other specified meningococcaemia
- 1C1C.2Z/A39 Meningococcaemia, unspecified
- 1C1C/A39 Meningococcal disease
- 1C1C.Y/A39.8 Other specified meningococcal disease
- 1C1C.Z/A39 Meningococcal disease, unspecified
- 1C1D.0/A66.0 Primary yaws
- 1C1D.1/A66.7 Secondary yaws
- 1C1D.2/A66 Tertiary yaws
- 1C1D.3/A66.8 Latent yaws
- 1C1D/A66 Yaws
- 1C1E.0/A67.0 Primary lesions of pinta
- 1C1E.1/A67.1 Intermediate lesions of pinta
- 1C1E.2/A67.2 Late lesions of pinta
- 1C1E.3/A67.3 Mixed lesions of pinta
- 1C1E/A67 Pinta
- 1C1F/A65 Endemic non-venereal syphilis
- 1C1G.0/A69.2 Early cutaneous Lyme borreliosis
- 1C1G.1/A69.2 Disseminated Lyme borreliosis
- 1C1G.10/A69.2 Lyme neuroborreliosis
- 1C1G.11/A69.2 Lyme carditis
- 1C1G.12/A69.2 Ophthalmic Lyme borreliosis
- 1C1G.13/M01.2 Lyme arthritis
- 1C1G.14/A69.2 Late cutaneous Lyme borreliosis
- 1C1G.1Y/A69.2 Other specified disseminated Lyme borreliosis
- 1C1G.1Z/A69.2 Disseminated Lyme borreliosis, unspecified
- 1C1G/A69.2 Lyme borreliosis
- 1C1G.Y/A69.2 Other specified Lyme borreliosis
- 1C1H.0/A69.0 Other Vincent infections
- 1C1H/A69.0 Necrotising ulcerative gingivitis
- 1C1H.Y/A69.0 Other specified necrotising ulcerative gingivitis
- 1C1H.Z/A69.0 Necrotising ulcerative gingivitis, unspecified
- 1C1J.0/A68.1 Tick-borne relapsing fever
- 1C1J.1/A68.0 Louse-borne relapsing fever
- 1C1J/A68 Relapsing fever
- 1C20/A74.0 Chlamydial conjunctivitis
- 1C21/K67.0 Chlamydial peritonitis
- 1C22/A70 Infections due to Chlamydia psittaci
- 1C23.0/A71.0 Initial stage of trachoma
- 1C23.1/A71.1 Active stage of trachoma
- 1C23/A71 Trachoma
- 1C23.Y/A71 Other specified trachoma
- 1C23.Z/A71 Trachoma, unspecified
- 1C2Y/A74.9 Other specified diseases due to chlamydiae
- 1C2Z/A74.9 Diseases due to chlamydiae, unspecified
- 1C30.0/A75.0 Epidemic louse-borne typhus fever due to Rickettsia prowazekii
- 1C30.1/A75.1 Recrudescent typhus
- 1C30.2/A75.2 Typhus fever due to Rickettsia typhi
- 1C30.3/A75.3 Typhus fever due to Orientia tsutsugamushi
- 1C30/A75 Typhus fever
- 1C30.Y/A75 Other specified typhus fever
- 1C30.Z/A75 Typhus fever, unspecified
- 1C31.0/A77.0 Spotted fever due to Rickettsia rickettsii
- 1C31.1/A77.1 Spotted fever due to Rickettsia conorii
- 1C31.2/A77.2 Spotted fever due to Rickettsia sibirica
- 1C31.3/A77.3 Spotted fever due to Rickettsia australis
- 1C31/A77 Spotted fever
- 1C31.Y/A77.8 Other specified spotted fever
- 1C31.Z/A77 Spotted fever, unspecified
- 1C32/A79.1 Rickettsialpox
- 1C33/A78 Q fever
- 1C3Y/A79.8 Other specified rickettsioses
- 1C3Z/A79 Rickettsioses, unspecified
- 1C40/B96.8 Campylobacteriosis
- 1C41/A49 Bacterial infection of unspecified site
- 1C42/A24 Melioidosis
- 1C43/B47.1 Actinomycetoma
- 1C44/L08.8 Non-pyogenic bacterial infections of the skin
- 1C45.0/A48.3 Streptococcal toxic shock syndrome
- 1C45.1/A48.3 Staphylococcal toxic shock syndrome
- 1C45/A48.3 Toxic shock syndrome
- 1C45.Y/A48.3 Toxic shock syndrome due to other specified infectious agent
- 1C45.Z/A48.3 Toxic shock syndrome without specified infectious agent
- 1C4Y/B96.8 Other specified bacterial diseases
- 1C4Z/B96.8 Unspecified bacterial disease
- 1C60.0/B20-B24 HIV disease clinical stage 1 associated with tuberculosis
- 1C60.1/B20-B24 HIV disease clinical stage 2 associated with tuberculosis
- 1C60.2/B20-B24 HIV disease clinical stage 3 associated with tuberculosis
- 1C60.3/B22.7 HIV disease clinical stage 4 associated with tuberculosis
- 1C60.30/B22.7 Kaposi sarcoma associated with human immunodeficiency virus disease associated with tuberculosis
- 1C60.3Y/B22.7 Other specified HIV disease clinical stage 4 associated with tuberculosis
- 1C60.3Z/B22.7 HIV disease clinical stage 4 associated with tuberculosis, unspecified
- 1C60/B20-B24 Human immunodeficiency virus disease associated with tuberculosis
- 1C60.Z/B20-B24 Human immunodeficiency virus disease associated with tuberculosis, clinical stage unspecified
- 1C61.0/B20-B24 HIV disease clinical stage 1 associated with malaria
- 1C61.1/B20-B24 HIV disease clinical stage 2 associated with malaria
- 1C61.2/B20-B24 HIV disease clinical stage 3 associated with malaria
- 1C61.3/B22.7 HIV disease clinical stage 4 associated with malaria
- 1C61.30/B22.7 Kaposi sarcoma associated with human immunodeficiency virus disease associated with malaria
- 1C61.3Y/B22.7 Other specified HIV disease clinical stage 4 associated with malaria
- 1C61.3Z/B22.7 HIV disease clinical stage 4 associated with malaria, unspecified
- 1C61/B20-B24 Human immunodeficiency virus disease associated with malaria
- 1C61.Z/B20-B24 Human immunodeficiency virus disease associated with malaria, clinical stage unspecified
- 1C62.0/B20-B24 HIV disease clinical stage 1 without mention of tuberculosis or malaria
- 1C62.1/B20-B24 HIV disease clinical stage 2 without mention of tuberculosis or malaria
- 1C62.2/B20-B24 HIV disease clinical stage 3 without mention of tuberculosis or malaria
- 1C62.3/B22.7 HIV disease clinical stage 4 without mention of tuberculosis or malaria
- 1C62/B20-B24 Human immunodeficiency virus disease without mention of tuberculosis or malaria
- 1C62.Z/B20-B24 Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified
- 1C80/A80-A89 Viral encephalitis not elsewhere classified
- 1C81/A80 Acute poliomyelitis
- 1C82/A82 Rabies
- 1C83/A83.1 Western equine encephalitis
- 1C84/A83.2 Eastern equine encephalitis
- 1C85/A83.0 Japanese encephalitis
- 1C86/A83.3 St Louis encephalitis
- 1C87/A83.6 Rocio viral encephalitis
- 1C88/A83.4 Murray Valley encephalitis
- 1C89/A84.0 Far Eastern tick-borne encephalitis
- 1C8A/A84.1 Central European tick-borne encephalitis
- 1C8B/A83.5 California encephalitis
- 1C8C/A92.2 Venezuelan equine encephalitis
- 1C8D/A83.5 La Crosse encephalitis
- 1C8E.1/A87.0 Enteroviral meningitis
- 1C8E.2/A87.1 Meningitis due to adenovirus
- 1C8E/G02.0 Viral meningitis not elsewhere classified
- 1C8E.Y/G02.0 Other specified viral meningitis not elsewhere classified
- 1C8E.Z/G02.0 Viral meningitis not elsewhere classified, unspecified
- 1C8F/A87.2 Lymphocytic choriomeningitis
- 1C8Y/A80-A89 Other specified viral infections of the central nervous system
- 1C8Z/A80-A89 Viral infections of the central nervous system, unspecified
- 1D00.0/G04.2 Bacterial encephalitis
- 1D00.1/G04 Fungal encephalitis
- 1D00.2/G04 Parasitic or protozoal encephalitis
- 1D00/G04 Infectious encephalitis not elsewhere classified
- 1D00.Y/G04.8 Other specified infectious encephalitis not elsewhere classified
- 1D00.Z/G04 Infectious encephalitis not elsewhere classified, unspecified
- 1D01.0/G00 Bacterial meningitis
- 1D01.00/G00.0 Meningitis due to Haemophilus influenzae
- 1D01.0Y/G00.8 Other specified bacterial meningitis
- 1D01.0Z/G00 Bacterial meningitis, unspecified
- 1D01.1/G02.1 Fungal meningitis
- 1D01.10/G02.1 Meningitis due to Cryptococcus neoformans
- 1D01.1Y/G02.1 Other specified fungal meningitis
- 1D01.1Z/G02.1 Fungal meningitis, unspecified
- 1D01.2/G00-G09 Parasitic or protozoal meningitis
- 1D01.3/G03.2 Benign recurrent meningitis
- 1D01/G00-G09 Infectious meningitis not elsewhere classified
- 1D01.Y/G00-G09 Other specified infectious meningitis not elsewhere classified
- 1D01.Z/G00-G09 Infectious meningitis not elsewhere classified, unspecified
- 1D02.0/G04.2 Bacterial myelitis
- 1D02.1/G04 Viral myelitis
- 1D02.2/G04 Fungal myelitis
- 1D02.3/G04 Parasitic myelitis
- 1D02/G04 Infectious myelitis not elsewhere classified
- 1D02.Y/G04.8 Other specified infectious myelitis not elsewhere classified
- 1D02.Z/G04 Infectious myelitis not elsewhere classified, unspecified
- 1D03.0/G00-G09 Intraspinal intramedullary abscess
- 1D03.1/G00-G09 Intraspinal subdural abscess
- 1D03.2/G00-G09 Intraspinal extradural abscess
- 1D03.3/G06.0 Intracranial abscess
- 1D03.30/G06.0 Deep cerebral hemispheric abscess
- 1D03.31/G06.0 Abscess of the corpus callosum
- 1D03.32/G06.0 Pituitary abscess
- 1D03.33/G06.0 Multiple or widespread intracranial abscess
- 1D03.3Y/G06.0 Other specified intracranial abscess
- 1D03.3Z/G06.0 Intracranial abscess, unspecified
- 1D03.4/G00-G09 Intraspinal epidural abscess
- 1D03.5/G00-G09 Spinal cord abscess
- 1D03/G00-G09 Infectious abscess of the central nervous system
- 1D03.Y/G00-G09 Other specified site of infectious abscess of the central nervous system
- 1D03.Z/G00-G09 Infectious abscess of the central nervous system, site unspecified
- 1D04.0/G00-G09 Parasitic intracerebral granuloma
- 1D04.1/G06.0 Intracranial granuloma
- 1D04.10/G06.0 Fungal intracranial granuloma
- 1D04.1Y/G06.0 Other specified intracranial granuloma
- 1D04.1Z/G06.0 Intracranial granuloma, unspecified
- 1D04.2/G00-G09 Intraspinal intramedullary granuloma
- 1D04.3/G00-G09 Intraspinal subdural granuloma
- 1D04.4/G00-G09 Intraspinal extradural granuloma
- 1D04.5/G00-G09 Intraspinal epidural granuloma
- 1D04/G00-G09 Infectious granulomas of the central nervous system
- 1D04.Y/G00-G09 Other specified site of infectious granulomas of the central nervous system
- 1D04.Z/G00-G09 Infectious granulomas of the central nervous system, site unspecified
- 1D05.0/G00-G09 Epidural infectious cyst
- 1D05.1/G00-G09 Subdural infectious cyst
- 1D05/G00-G09 Infectious cysts of the central nervous system
- 1D05.Y/G00-G09 Other specified infectious cysts of the central nervous system
- 1D05.Z/G00-G09 Infectious cysts of the central nervous system, unspecified
- 1D0Y/G00-G09 Other specified non-viral and unspecified infections of the central nervous system
- 1D0Z/G00-G09 Non-viral and unspecified infections of the central nervous system, unspecified
- 1D20/A97.0 Dengue without warning signs
- 1D21/A97.1 Dengue with warning signs
- 1D22/A97.2 Severe dengue
- 1D2Z/A97 Dengue fever, unspecified
- 1D40/A92.0 Chikungunya virus disease
- 1D41/A93.2 Colorado tick fever
- 1D42/A92.1 O’nyong-nyong fever
- 1D43/A93.0 Oropouche virus disease
- 1D44/A92.4 Rift Valley fever
- 1D45/A93.1 Sandfly fever
- 1D46/A92.3 West Nile virus infection
- 1D47/A95 Yellow fever
- 1D48/A92.5 Zika virus disease
- 1D49/A98.0 Crimean-Congo haemorrhagic fever
- 1D4A/A98.1 Omsk haemorrhagic fever
- 1D4B/A98.2 Kyasanur Forest disease
- 1D4C/A92-A99 Alkhurma haemorrhagic fever
- 1D4D/B33.1 Ross River disease
- 1D4E/A92-A99 Severe fever with thrombocytopenia syndrome
- 1D4Y/A92-A99 Other specified arthropod-borne viral fevers
- 1D4Z/A92-A99 Arthropod-borne viral fever, virus unspecified
- 1D60.0/I Ebola disease
- 1D60.00/I Bundibugyo virus disease
- 1D60.01/A98.4 Ebola virus disease
- 1D60.02/I Sudan virus disease
- 1D60.03/I Atypical Ebola disease
- 1D60.0Y/I Other specified Ebola disease
- 1D60.0Z/I Ebola disease, virus unspecified
- 1D60.1/A98.3 Marburg disease
- 1D60.10/A98.3 Marburg virus disease
- 1D60.11/A98.3 Atypical Marburg disease
- 1D60.1Y/A98.3 Other specified Marburg disease
- 1D60.1Z/A98.3 Marburg disease, virus unspecified
- 1D60/I Filovirus disease
- 1D60.Y/I Other specified filovirus disease
- 1D60.Z/I Filovirus disease, virus unspecified
- 1D61.0/A96.0 Argentinian haemorrhagic fever
- 1D61.1/A96.1 Bolivian haemorrhagic fever
- 1D61.2/A96.2 Lassa fever
- 1D61.3/A96 Venezuelan haemorrhagic fever
- 1D61/I Arenavirus disease
- 1D61.Y/I Other specified arenavirus disease
- 1D61.Z/I Arenavirus disease, unspecified
- 1D62.0/A98.5 Haemorrhagic fever with renal syndrome
- 1D62.1/B33.4 Hantavirus pulmonary syndrome
- 1D62.2/I Atypical hantavirus disease
- 1D62/I Hantavirus disease
- 1D62.Y/I Other specified hantavirus disease
- 1D62.Z/I Hantavirus disease, unspecified
- 1D63/I Henipavirus encephalitis
- 1D64/J12.9 Middle East respiratory syndrome
- 1D65/U04 Severe acute respiratory syndrome
- 1D6Y/I Other specified zoonotic viral diseases
- 1D6Z/I Zoonotic viral disease, virus unspecified
- 1D80.0/B26.9 Mumps without complication
- 1D80.1/B26.0 Orchitis due to mumps virus
- 1D80.2/B26.1 Meningitis due to mumps virus
- 1D80.3/B26.2 Encephalitis due to mumps virus
- 1D80.4/B26.3 Pancreatitis due to mumps virus
- 1D80/B26 Mumps
- 1D80.Y/B26.8 Other specified mumps
- 1D81.0/B27 Mononucleosis due to Epstein-Barr virus
- 1D81.1/B27.1 Mononucleosis due to cytomegalovirus
- 1D81/B27 Infectious mononucleosis
- 1D81.Y/B27.8 Other specified infectious mononucleosis
- 1D81.Z/B27 Infectious mononucleosis, unspecified
- 1D82.0/B25.1 Cytomegaloviral hepatitis
- 1D82.1/B25.2 Cytomegaloviral pancreatitis
- 1D82/B25 Cytomegaloviral disease
- 1D82.Y/B25.8 Other specified cytomegaloviral disease
- 1D82.Z/B25 Cytomegaloviral disease, unspecified
- 1D83/B33.0 Epidemic myalgia
- 1D84.0/B30.1 Conjunctivitis due to adenovirus
- 1D84.1/B30.3 Acute epidemic haemorrhagic conjunctivitis
- 1D84/B30.9 Viral conjunctivitis
- 1D84.Y/B30.9 Other specified viral conjunctivitis
- 1D84.Z/B30.9 Viral conjunctivitis, unspecified
- 1D85.0/B33.2 Dilated cardiomyopathy secondary to viral myocarditis
- 1D85.1/B33.2 Acute viral carditis
- 1D85.2/B33.2 Chronic viral carditis
- 1D85.3/B33.2 Aseptic myocarditis of newborn
- 1D85.4/B33.2 Coxsackie carditis
- 1D85/B33.2 Viral carditis
- 1D85.Y/B33.2 Other specified viral carditis
- 1D85.Z/B33.2 Viral carditis, unspecified
- 1D86/B33 Viral haemorrhagic fever, not elsewhere classified
- 1D90/B34.0 Adenovirus infection of unspecified site
- 1D91/B34.1 Enterovirus infection of unspecified site
- 1D92/B34.2 Coronavirus infection, unspecified site
- 1D93/B34.3 Parvovirus infection of unspecified site
- 1D9Y/B34.8 Other viral infections of unspecified site
- 1D9Z/B34 Unspecified viral infection of unspecified site
- 1E1Y/B33.8 Other specified viral diseases
- 1E1Z/B33 Unspecified viral disease
- 1E30/J10 Influenza due to identified seasonal influenza virus
- 1E31/J09 Influenza due to identified zoonotic or pandemic influenza virus
- 1E32/J11 Influenza, virus not identified
- 1E50.0/B15 Acute hepatitis A
- 1E50.1/B16 Acute hepatitis B
- 1E50.2/B17.1 Acute hepatitis C
- 1E50.3/B17.0 Acute hepatitis D
- 1E50.4/B17.2 Acute hepatitis E
- 1E50/B15-B19 Acute viral hepatitis
- 1E50.Y/B15-B19 Other specified acute viral hepatitis
- 1E50.Z/B15-B19 Acute viral hepatitis, unspecified
- 1E51.0/B18 Chronic hepatitis B
- 1E51.00/B18 Chronic hepatitis B with human immunodeficiency virus co-infection
- 1E51.0Y/B18 Other specified chronic hepatitis B
- 1E51.0Z/B18 Chronic hepatitis B, unspecified
- 1E51.1/B18.2 Chronic hepatitis C
- 1E51.2/B18 Chronic hepatitis D
- 1E51.3/B18 Chronic hepatitis E
- 1E51/B18 Chronic viral hepatitis
- 1E51.Y/B18.8 Other specified chronic viral hepatitis
- 1E51.Z/B18 Chronic viral hepatitis, unspecified
- 1E5Z/B15-B19 Viral hepatitis, unspecified
- 1E70/B03 Smallpox
- 1E71/B04 Monkeypox
- 1E72/B08.0 Cowpox
- 1E73/B08.0 Vaccinia
- 1E74/B08.0 Buffalopox
- 1E75/B08.0 Orf
- 1E76/B08.1 Molluscum contagiosum
- 1E7Y/B08.8 Other specified infections due to poxvirus
- 1E7Z/B08.8 Infections due to poxvirus, unspecified
- 1E80.0/B07 Digital or periungual warts
- 1E80.1/B07 Plantar warts
- 1E80/B07 Common warts
- 1E80.Y/B07 Other specified common warts
- 1E81/B07 Plane warts
- 1E82.0/B00-B09 Focal epithelial hyperplasia of oral mucous membranes
- 1E82/B00-B09 Warts of lips or oral cavity
- 1E83/B07 Wart virus proliferation in immune-deficient states
- 1E8Z/B00-B09 Viral warts, not elsewhere classified
- 1E90.0/B01.9 Varicella without complication
- 1E90.1/B01.0 Varicella meningitis
- 1E90.2/B01.1 Varicella encephalitis
- 1E90/B01 Varicella
- 1E90.Y/B01.8 Varicella with other specified complication
- 1E91.0/B02 Zoster without complications
- 1E91.1/B02.3 Ophthalmic zoster
- 1E91.2/B02.7 Disseminated zoster
- 1E91.3/B02.2 Zoster with central nervous system involvement
- 1E91.4/B02.2 Acute neuropathy of cranial nerve due to zoster
- 1E91.40/B02.2 Acute trigeminal zoster neuropathy
- 1E91.41/B02.2 Acute herpetic geniculate ganglionitis
- 1E91.4Y/B02.2 Other specified acute neuropathy of cranial nerve due to zoster
- 1E91.5/B02 Postherpetic polyneuropathy
- 1E91/B02 Zoster
- 1E91.Y/B02.8 Zoster with other specified complications
- 1E91.Z/B02 Zoster, unspecified
- 1F00.0/B00 Herpes simplex infection of skin or mucous membrane
- 1F00.00/B00.9 Herpes simplex infection of skin
- 1F00.01/B00.8 Herpes simplex labialis
- 1F00.02/B00.2 Herpes simplex gingivostomatitis
- 1F00.03/B00.7 Disseminated cutaneous herpes simplex infection complicating other skin diseases
- 1F00.0Y/B00 Other specified herpes simplex infection of skin or mucous membrane
- 1F00.1/B00.5 Herpes simplex infection of the eye
- 1F00.10/B00.5 Herpes simplex keratitis
- 1F00.11/B00.5 Herpes simplex infection of eyelid
- 1F00.1Y/B00.5 Other specified herpes simplex infection of the eye
- 1F00.1Z/B00.5 Herpes simplex infection of the eye, unspecified
- 1F00.2/B00 Herpes simplex infection of central nervous system
- 1F00.20/B00.3 Herpes simplex meningitis
- 1F00.21/B00.4 Encephalitis due to herpes simplex virus
- 1F00.3/B00.7 Disseminated herpes simplex infection
- 1F00/B00 Herpes simplex infections
- 1F00.Y/B00.8 Other specified herpes simplex infections
- 1F00.Z/B00 Herpes simplex infections, unspecified
- 1F01/B08.2 Roseola infantum
- 1F02.0/B06 Rubella with neurological complications
- 1F02.1/M01.4 Rubella arthritis
- 1F02.2/B06.9 Rubella without complication
- 1F02/B06 Rubella
- 1F02.Y/B06.8 Rubella with other specified complication
- 1F03.0/B05.9 Measles without complication
- 1F03.1/B05.0 Measles complicated by encephalitis
- 1F03.2/B05.1 Measles complicated by meningitis
- 1F03/B05 Measles
- 1F03.Y/B05.8 Measles with other complications
- 1F04/B08.3 Erythema infectiosum
- 1F05.0/B08.4 Enteroviral vesicular stomatitis
- 1F05.1/B08.5 Enteroviral vesicular pharyngitis
- 1F05.2/A88.0 Enteroviral exanthematous fever
- 1F05.3/B08.8 Foot and mouth disease
- 1F05/B00-B09 Picornavirus infections presenting in the skin or mucous membranes
- 1F05.Y/B00-B09 Other specified picornavirus infections presenting in the skin or mucous membranes
- 1F0Y/B00-B09 Other specified viral infections characterised by skin or mucous membrane lesions
- 1F0Z/B00-B09 Viral infections characterised by skin or mucous membrane lesions, unspecified
- 1F20.0/B44 Invasive aspergillosis
- 1F20.00/B44.8 Invasive aspergillosis of the digestive tract
- 1F20.01/B44.8 Invasive cerebral aspergillosis
- 1F20.02/B44.7 Disseminated aspergillosis
- 1F20.0Y/B44 Invasive aspergillosis of other specified site
- 1F20.1/B44 Non-invasive aspergillosis
- 1F20.10/B44.8 Aspergillus otomycosis
- 1F20.11/B44.8 Chronic aspergillosis of the paranasal sinuses
- 1F20.12/B44.1 Chronic pulmonary aspergillosis
- 1F20.13/B44.2 Tonsillar aspergillosis
- 1F20.14/B44 Aspergillus bronchitis
- 1F20.15/B44 Obstructing aspergillus tracheobronchitis
- 1F20.1Y/B44 Other specified non-invasive aspergillosis
- 1F20/B44 Aspergillosis
- 1F20.Z/B44 Aspergillosis, unspecified
- 1F21/B46.8 Basidiobolomycosis
- 1F22/B40 Blastomycosis
- 1F23.0/B37.0 Candidosis of lips or oral mucous membranes
- 1F23.1/B37 Candidosis of skin or mucous membranes
- 1F23.10/B37.3 Vulvovaginal candidosis
- 1F23.11/B37.4 Candida balanoposthitis
- 1F23.12/B37 Flexural or intertriginous candidosis
- 1F23.13/B37 Candidosis of nail or paronychium
- 1F23.14/B37 Chronic mucocutaneous candidosis
- 1F23.15/B37 Disseminated cutaneous candidosis
- 1F23.16/B37 Candida otomycosis
- 1F23.1Y/B37 Candidosis of skin or mucous membrane of other specified site
- 1F23.1Z/B37 Candidosis of skin or mucous membranes, unspecified
- 1F23.2/B37 Candidosis of gastrointestinal tract
- 1F23.3/B37 Systemic or invasive candidosis
- 1F23.30/B37.5 Candida meningitis
- 1F23.31/B37.1 Pulmonary candidosis
- 1F23.3Y/B37 Other specified systemic or invasive candidosis
- 1F23.3Z/B37 Systemic or invasive candidosis, unspecified
- 1F23/B37 Candidosis
- 1F23.Y/B37.8 Other specified candidosis
- 1F23.Z/B37 Candidosis, unspecified
- 1F24/B43 Chromoblastomycosis
- 1F25.0/B38 Pulmonary coccidioidomycosis
- 1F25.00/B38 Acute pulmonary coccidioidomycosis
- 1F25.01/B38 Chronic pulmonary coccidioidomycosis
- 1F25.1/B38 Extrathoracic coccidioidomycosis
- 1F25.10/B38.7 Disseminated coccidioidomycosis
- 1F25.11/B38.3 Primary cutaneous coccidioidomycosis
- 1F25.12/B38.4 Coccidioides meningitis
- 1F25.1Y/B38 Other specified extrathoracic coccidioidomycosis
- 1F25/B38 Coccidioidomycosis
- 1F25.Z/B38 Coccidioidomycosis, unspecified
- 1F26/B46.8 Conidiobolomycosis
- 1F27.0/B45.0 Pulmonary cryptococcosis
- 1F27.1/B45.1 Cerebral cryptococcosis
- 1F27.2/B45.7 Disseminated cryptococcosis
- 1F27/B45 Cryptococcosis
- 1F27.Y/B45.8 Other specified cryptococcosis
- 1F27.Z/B45 Cryptococcosis, unspecified
- 1F28.0/B35 Dermatophytosis of scalp
- 1F28.1/B35.1 Dermatophytosis of nail
- 1F28.2/B35.3 Dermatophytosis of foot
- 1F28.3/B35.6 Genitocrural dermatophytosis
- 1F28.4/B35.8 Kerion
- 1F28.5/B35.8 Disseminated dermatophytosis
- 1F28/B35 Dermatophytosis
- 1F28.Y/B35.8 Other specified dermatophytosis
- 1F28.Z/B35 Dermatophytosis, unspecified
- 1F29/B47.0 Eumycetoma
- 1F2A.0/B39.2 Pulmonary histoplasmosis capsulati
- 1F2A.1/B39.5 Histoplasmosis due to Histoplasma duboisii
- 1F2A/B39 Histoplasmosis
- 1F2A.Y/B39 Other specified histoplasmosis
- 1F2A.Z/B39 Histoplasmosis, unspecified
- 1F2B/B48.0 Lobomycosis
- 1F2C/B46 Mucormycosis
- 1F2D.0/B36.0 Pityriasis versicolor
- 1F2D.1/B36 Malassezia folliculitis
- 1F2D.2/B36.2 White piedra
- 1F2D.3/B36.3 Black piedra
- 1F2D.4/B36.1 Tinea nigra
- 1F2D.5/B36 Onychomycosis due to non-dermatophyte mould
- 1F2D/B36 Non-dermatophyte superficial dermatomycoses
- 1F2D.Y/B36.8 Other specified non-dermatophyte superficial dermatomycoses
- 1F2E.0/B41.0 Pulmonary paracoccidioidomycosis
- 1F2E.1/B41.7 Disseminated paracoccidioidomycosis
- 1F2E/B41 Paracoccidioidomycosis
- 1F2E.Y/B41.8 Other specified paracoccidioidomycosis
- 1F2E.Z/B41 Paracoccidioidomycosis, unspecified
- 1F2F/B48.8 Phaeohyphomycosis
- 1F2G.0/B48.5 Pulmonary pneumocystosis
- 1F2G/B48.5 Pneumocystosis
- 1F2G.Z/B48.5 Pneumocystosis, unspecified
- 1F2H/B48.2 Scedosporiosis
- 1F2J.0/B42.1 Lymphocutaneous sporotrichosis
- 1F2J.1/B42.8 Fixed cutaneous sporotrichosis
- 1F2J.2/B42.0 Pulmonary sporotrichosis
- 1F2J.3/B42.7 Disseminated sporotrichosis
- 1F2J/B42 Sporotrichosis
- 1F2J.Y/B42.8 Other specified sporotrichosis
- 1F2J.Z/B42 Sporotrichosis, unspecified
- 1F2K/B48.4 Talaromycosis
- 1F2L.0/B35-B49 Disseminated adiaspiromycosis
- 1F2L.1/B35-B49 Pulmonary adiaspiromycosis
- 1F2L/B35-B49 Emmonsiosis
- 1F2L.Y/B35-B49 Other specified emmonsiosis
- 1F2L.Z/B35-B49 Emmonsiosis, unspecified
- 1F2Y/B35-B49 Other specified mycoses
- 1F2Z/B35-B49 Mycoses, unspecified
- 1F40.0/B50.0 Plasmodium falciparum malaria with cerebral complications
- 1F40/B50 Malaria due to Plasmodium falciparum
- 1F40.Y/B50.8 Other severe and complicated Plasmodium falciparum malaria
- 1F40.Z/B50 Malaria due to Plasmodium falciparum, unspecified
- 1F41.0/B51.0 Plasmodium vivax malaria with rupture of spleen
- 1F41/B51 Malaria due to Plasmodium vivax
- 1F41.Y/B51.8 Malaria due to Plasmodium vivax with other complications
- 1F41.Z/B51 Plasmodium vivax malaria without complication
- 1F42.0/B52.0 Plasmodium malariae malaria with nephropathy
- 1F42/B52.9 Malaria due to Plasmodium malariae
- 1F42.Y/B52.9 Malaria due to Plasmodium malariae with other complications
- 1F42.Z/B52.9 Plasmodium malariae malaria without complication
- 1F43/B53.0 Malaria due to Plasmodium ovale
- 1F44/B53 Other parasitologically confirmed malaria
- 1F45/B54 Malaria without parasitological confirmation
- 1F4Z/B50-B64 Malaria, unspecified
- 1F50/B60.1 Acanthamoebiasis
- 1F51.0/B56.0 Gambiense trypanosomiasis
- 1F51.00/B56.0 Meningitis in Gambiense trypanosomiasis
- 1F51.0Y/B56.0 Other specified gambiense trypanosomiasis
- 1F51.0Z/B56.0 Gambiense trypanosomiasis, unspecified
- 1F51.1/B56.1 Rhodesiense trypanosomiasis
- 1F51.10/B56.1 Meningitis in Rhodesiense trypanosomiasis
- 1F51.1Y/B56.1 Other specified rhodesiense trypanosomiasis
- 1F51.1Z/B56.1 Rhodesiense trypanosomiasis, unspecified
- 1F51/B56 African trypanosomiasis
- 1F51.Y/B56 Other specified african trypanosomiasis
- 1F51.Z/B56 African trypanosomiasis, unspecified
- 1F52/B60.0 Babesiosis
- 1F53.1/B57.1 Acute Chagas disease without heart involvement
- 1F53.2/B57.2 Chronic Chagas disease with heart involvement
- 1F53.3/B57.3 Chagas disease with digestive system involvement
- 1F53.4/B57.4 Meningitis in Chagas disease
- 1F53/B57 Chagas disease
- 1F53.Y/B57 Other specified Chagas disease
- 1F53.Z/B57 Chagas disease, unspecified
- 1F54.0/B55.0 Visceral leishmaniasis
- 1F54.1/B55.1 Cutaneous leishmaniasis
- 1F54.2/B55.2 Mucocutaneous leishmaniasis
- 1F54/B55 Leishmaniasis
- 1F54.Z/B55 Leishmaniasis, unspecified
- 1F55/B60.2 Naegleriasis
- 1F56/B48.1 Rhinosporidiosis
- 1F57.0/B58.1 Hepatitis due to Toxoplasma gondii
- 1F57.1/B58.2 Meningoencephalitis due to Toxoplasma gondii
- 1F57.2/B58.3 Pulmonary toxoplasmosis due to Toxoplasma gondii
- 1F57.3/B58.0 Eye disease due to Toxoplasma gondii
- 1F57/B58 Toxoplasmosis
- 1F57.Y/B58.8 Other specified toxoplasmosis
- 1F57.Z/B58 Toxoplasmosis, unspecified
- 1F58/B60.8 Microsporidiosis
- 1F5Z/B60.8 Unspecified protozoal disease
- 1F60.0/B65-B83 Eosinophilic meningitis due to Angiostrongylus cantonensis
- 1F60.1/B81.3 Intestinal angiostrongyliasis
- 1F60/B65-B83 Angiostrongyliasis
- 1F60.Y/B65-B83 Other specified angiostrongyliasis
- 1F60.Z/B65-B83 Angiostrongyliasis, unspecified
- 1F61/B81.0 Anisakiasis
- 1F62/B77 Ascariasis
- 1F63.0/B81.1 Capillariasis of the intestine
- 1F63/B65-B83 Capillariasis
- 1F63.Y/B65-B83 Other specified capillariasis
- 1F63.Z/B65-B83 Capillariasis, unspecified
- 1F64/B72 Dracunculiasis
- 1F65/B80 Enterobiasis
- 1F66.0/B74.3 Loiasis
- 1F66.1/B74.4 Mansonelliasis
- 1F66.2/B74 Filariasis due to Brugia species
- 1F66.3/B74 Lymphatic filariasis
- 1F66.30/B74.0 Filariasis due to Wuchereria bancrofti
- 1F66.31/B74.1 Filariasis due to Brugia malayi
- 1F66.32/B74.2 Filariasis due to Brugia timori
- 1F66.3Z/B74 Lymphatic filariasis, unspecified
- 1F66.4/B74.8 Subcutaneous dirofilariasis
- 1F66/B74 Filariasis
- 1F66.Y/B74.8 Other specified filariasis
- 1F66.Z/B74 Filariasis, unspecified
- 1F67/B83.1 Gnathostomiasis
- 1F68.0/B76 Ancylostomiasis
- 1F68.1/B76.1 Necatoriasis
- 1F68.2/B76 Cutaneous larva migrans
- 1F68/B76 Hookworm diseases
- 1F69/B81.8 Oesophagostomiasis
- 1F6A.0/B73 Onchocerciasis of the eye
- 1F6A.1/B73 Onchocerciasis of the skin
- 1F6A/B73 Onchocerciasis
- 1F6A.Y/B73 Other specified onchocerciasis
- 1F6B/B78 Strongyloidiasis
- 1F6C/B83.3 Syngamosis
- 1F6D/B83.0 Toxocariasis
- 1F6E/B75 Trichinosis
- 1F6F/B81.2 Trichostrongyliasis
- 1F6G/B79 Trichuriasis
- 1F6H/B65-B83 Uncinariosis
- 1F6Y/B65-B83 Other specified diseases due to nematodes
- 1F6Z/B65-B83 Diseases due to nematodes, unspecified
- 1F70.0/B69.0 Cysticercosis of central nervous system
- 1F70.00/B69.0 Meningitis due to Cysticercosis
- 1F70.1/B69.1 Cysticercosis of eye
- 1F70/B69 Cysticercosis
- 1F70.Y/B69.8 Other specified cysticercosis
- 1F70.Z/B69 Cysticercosis, unspecified
- 1F71/B70.0 Diphyllobothriasis
- 1F72/B71.1 Dipylidiasis
- 1F73.0/B67.8 Echinococcus infection of liver
- 1F73.1/B67.7 Echinococcus infection of lung
- 1F73.2/B67.7 Echinococcus infection of bone
- 1F73.3/B67.7 Echinococcus infection of central nervous system
- 1F73/B67.7 Echinococcosis
- 1F73.Y/B67.7 Other specified echinococcosis
- 1F73.Z/B67.7 Echinococcosis, unspecified
- 1F74/B71.0 Hymenolepiasis
- 1F75/B70.1 Sparganosis
- 1F76.0/B68.0 Taeniasis due to Taenia solium
- 1F76.1/B68.1 Taeniasis due to Taenia saginata
- 1F76/B68 Taeniasis
- 1F76.Y/B68 Other specified taeniasis
- 1F76.Z/B68 Taeniasis, unspecified
- 1F7Y/B71.8 Other specified diseases due to cestodes
- 1F7Z/B71 Diseases due to cestodes, unspecified
- 1F80/B66.1 Clonorchiasis
- 1F81/B66.2 Dicrocoeliasis
- 1F82/B66.3 Fascioliasis
- 1F83/B66.5 Fasciolopsiasis
- 1F84/B66.0 Opisthorchiasis
- 1F85/B66.4 Paragonimiasis
- 1F86.0/B65.0 Schistosomiasis due to Schistosoma haematobium
- 1F86.1/B65.1 Schistosomiasis due to Schistosoma mansoni
- 1F86.2/B65.2 Schistosomiasis due to Schistosoma japonicum
- 1F86.3/B65 Other schistosomiases
- 1F86.4/B65.3 Cercarial dermatitis
- 1F86.5/B65 Schistosomal pneumonitis
- 1F86/B65 Schistosomiasis
- 1F86.Z/B65 Schistosomiasis due to unspecified or unknown Schistosoma species
- 1F8Y/B66.8 Other specified diseases due to trematodes
- 1F8Z/B66 Diseases due to trematodes, unspecified
- 1F90.0/B82.9 Mixed intestinal helminthiases
- 1F90.1/B82.9 Intestinal parasitic infestation not otherwise specified
- 1F90.2/B82.0 Intestinal helminthiasis, unspecified
- 1F90/B82.9 Other and unspecified infestation by parasitic worms
- 1F90.Y/B82.9 Other specified other and unspecified infestation by parasitic worms
- 1F90.Z/B82.9 Other and unspecified infestation by parasitic worms, unspecified
- 1F91/B65-B83 Diphyllobothriasis and sparganosis
- 1F9Z/B65-B83 Helminthiases, unspecified
- 1G00.0/B85.0 Pediculosis capitis
- 1G00.1/B85.1 Pediculosis corporis
- 1G00/B85.2 Pediculosis
- 1G00.Z/B85.2 Pediculosis of unspecified site or type
- 1G01.0/B87.2 Ocular myiasis
- 1G01.1/B87.3 Nasopharyngeal myiasis
- 1G01.2/B87 Laryngeal myiasis
- 1G01.3/B87.0 Cutaneous myiasis
- 1G01/B87 Myiasis
- 1G01.Y/B87.8 Other specified myiasis
- 1G01.Z/B87 Myiasis, unspecified
- 1G02/B88.3 External hirudiniasis
- 1G03/B85.3 Pthiriasis
- 1G04.0/B86 Classical scabies
- 1G04.1/B86 Crusted scabies
- 1G04/B86 Scabies
- 1G04.Y/B86 Other and unspecified scabies
- 1G05/B88.1 Tungiasis
- 1G06/B88.8 Cimicosis
- 1G07.0/B88.0 Infestation by Demodex
- 1G07/B88.9 Infestation by mites
- 1G07.Y/B88.9 Infestation of the skin by other specified parasitic mites
- 1G0Y/B85-B89 Infestation by other specified ectoparasite
- 1G0Z/B85-B89 Infestation by unknown or unspecified ectoparasite
- 1G2Y/I Other specified parasitic diseases
- 1G2Z/I Unspecified parasitic diseases
- 1G40/A30-A49 Sepsis without septic shock
- 1G41/R57.2 Sepsis with septic shock
- 1G60.0/B47 Mycetoma of unknown or unspecified type
- 1G60.1/I Pythiosis
- 1G60.2/I Protothecosis
- 1G60/I Certain other disorders of infectious origin
- 1G60.Y/I Other specified disorders of infectious origin not elsewhere classified
- 1G80/B90 Sequelae of tuberculosis
- 1G81/I Sequelae of trachoma
- 1G82/B92 Sequelae of leprosy
- 1G83/B91 Sequelae of poliomyelitis
- 1G84/I Sequelae of viral encephalitis
- 1G85/I Sequelae of diphtheria
- 1G8Y/I Sequelae of other specified infectious diseases
- 1H0Z/I Infection, unspecified
- 2A00.0/C69-C72 Gliomas of brain
- 2A00.00/C71 Glioblastoma of brain
- 2A00.0Y/C69-C72 Other specified gliomas of brain
- 2A00.0Z/C69-C72 Gliomas of brain, unspecified
- 2A00.1/C69-C72 Embryonal tumours of brain
- 2A00.10/C71.6 Medulloblastoma of brain
- 2A00.11/C71 Central primitive neuroectodermal tumour
- 2A00.1Y/C69-C72 Other specified embryonal tumours of brain
- 2A00.1Z/C69-C72 Embryonal tumours of brain, unspecified
- 2A00.2/C69-C72 Tumours of neuroepithelial tissue of brain
- 2A00.20/C69-C72 Tumours of the pineal gland or pineal region
- 2A00.21/D33.2 Mixed neuronal-glial tumours
- 2A00.22/D33 Choroid plexus tumours
- 2A00.2Y/C69-C72 Other specified tumours of neuroepithelial tissue of brain
- 2A00.2Z/C69-C72 Tumours of neuroepithelial tissue of brain, unspecified
- 2A00.3/C71.6 Central neurocytoma of brain
- 2A00.4/C69-C72 Astroblastoma of the brain
- 2A00.5/C69-C72 Primary neoplasm of brain of unknown or unspecified type
- 2A00/C69-C72 Primary neoplasms of brain
- 2A01.0/C69-C72 Meningiomas
- 2A01.00/C70 Primary malignant meningioma
- 2A01.0Y/C69-C72 Other specified meningiomas
- 2A01.0Z/C69-C72 Meningiomas, unspecified
- 2A01.1/C70 Mesenchymal tumours of meninges
- 2A01.2/C70.0 Primary neoplasm of meninges of unknown or unspecified type
- 2A01/C69-C72 Primary neoplasms of meninges
- 2A02.0/C72 Gliomas of spinal cord, cranial nerves or other parts of the central nervous system
- 2A02.00/C72 Glioblastoma of spinal cord, cranial nerves or other parts of central nervous system
- 2A02.0Y/C72 Other specified gliomas of spinal cord, cranial nerves or other parts of the central nervous system
- 2A02.0Z/C72 Gliomas of spinal cord, cranial nerves or other parts of the central nervous system, unspecified
- 2A02.1/C72 Tumours of cranial or paraspinal nerves
- 2A02.10/C47.9 Malignant peripheral nerve sheath tumour of cranial or paraspinal nerves
- 2A02.11/C72 Paraspinal neuroblastoma
- 2A02.12/C72.3 Malignant neoplasm of the optic nerve
- 2A02.1Y/C72 Other specified tumours of cranial or paraspinal nerves
- 2A02.1Z/C72 Tumours of cranial or paraspinal nerves, unspecified
- 2A02.2/C72 Primary neoplasm of spinal cord of unknown or unspecified type
- 2A02.3/D33.3 Benign neoplasm of cranial nerves
- 2A02.4/D33.4 Benign neoplasm of spinal cord
- 2A02/C72 Primary neoplasm of spinal cord, cranial nerves or remaining parts of central nervous system
- 2A0Z/C69-C72 Other and unspecified neoplasms of brain or central nervous system
- 2A20.0/C92.1 Chronic myelogenous leukaemia, BCR-ABL1-positive
- 2A20.00/C92.1 Chronic myelogenous leukaemia with blast crisis
- 2A20.01/C92.1 Chronic myelogenous leukaemia, Philadelphia chromosome (Ph1) positive
- 2A20.02/C92.1 Chronic myelogenous leukaemia, t(9:22)(q34; q11)
- 2A20.03/C92.1 Naegeli-type monocytic leukaemia
- 2A20.0Y/C92.1 Other specified chronic myelogenous leukaemia, BCR-ABL1-positive
- 2A20.0Z/C92.1 Chronic myelogenous leukaemia, BCR-ABL1-positive, unspecified
- 2A20.1/D47.1 Chronic neutrophilic leukaemia
- 2A20.2/D47.4 Primary myelofibrosis
- 2A20.3/D47.5 Chronic eosinophilic leukaemia, not elsewhere classified
- 2A20.4/D45 Polycythaemia vera
- 2A20.5/D47.7 Non mast cell myeloproliferative neoplasm, unclassifiable
- 2A20/D47.7 Non mast cell myeloproliferative neoplasms
- 2A20.Y/D47.7 Other specified non mast cell myeloproliferative neoplasms
- 2A20.Z/D47.7 Non mast cell myeloproliferative neoplasms, unspecified
- 2A21.0/C96.2 Systemic mastocytosis
- 2A21.00/C94.3 Mast cell leukaemia
- 2A21.0Y/C96.2 Other specified systemic mastocytosis
- 2A21.0Z/C96.2 Systemic mastocytosis, unspecified
- 2A21.1/C96.2 Cutaneous mastocytosis
- 2A21.10/C96.2 Urticaria pigmentosa
- 2A21.1Y/C96.2 Other specified cutaneous mastocytosis
- 2A21.2/C96.2 Mast cell sarcoma
- 2A21.3/C96.2 Extracutaneous mastocytoma
- 2A21/C96.2 Mastocytosis
- 2A21.Y/C96.2 Other specified mastocytosis
- 2A21.Z/C96.2 Mastocytosis, unspecified
- 2A22/D47.1 Other and unspecified myeloproliferative neoplasms
- 2A30/D46 Refractory anaemia
- 2A31/D46 Refractory neutropaenia
- 2A32/D46 Refractory thrombocytopenia
- 2A33/D46.1 Refractory anaemia with ring sideroblasts
- 2A34/D46.5 Refractory cytopenia with multi-lineage dysplasia
- 2A35/D46.2 Refractory anaemia with excess of blasts
- 2A36/D46.6 Myelodysplastic syndrome with isolated del(5q)
- 2A37/D46 Myelodysplastic syndrome, unclassifiable
- 2A38/D46 Refractory cytopenia of childhood
- 2A3Y/D46 Other specified myelodysplastic syndromes
- 2A3Z/D46 Myelodysplastic syndromes, unspecified
- 2A40/C93.1 Chronic myelomonocytic leukaemia
- 2A41/C92.2 Atypical chronic myeloid leukaemia, BCR-ABL1- negative
- 2A42.0/C93.3 Juvenile myelomonocytic leukaemia in complete remission
- 2A42/C93.3 Juvenile myelomonocytic leukaemia
- 2A42.Y/C93.3 Other specified juvenile myelomonocytic leukaemia
- 2A42.Z/C93.3 Juvenile myelomonocytic leukaemia, unspecified
- 2A43/D37-D48 Refractory anaemia with ring sideroblasts associated with marked thrombocytosis
- 2A44/C94.6 Myeloproliferative and myelodysplastic disease, unclassifiable
- 2A4Y/C81-C96 Other specified myelodysplastic and myeloproliferative neoplasms
- 2A4Z/C81-C96 Myelodysplastic and myeloproliferative neoplasms, unspecified
- 2A50/C92.7 Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement
- 2A51/C92.7 Myeloid neoplasm associated with PDGFRB rearrangement
- 2A52/C92.7 Myeloid or lymphoid neoplasms with FGFR1 abnormalities
- 2A5Z/C94.7 Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1, unspecified
- 2A60.0/C92.9 Acute myeloid leukaemia with recurrent genetic abnormalities
- 2A60.1/C92.7 Acute myeloid leukaemia with myelodysplasia-related changes
- 2A60.2/D47.1 Therapy-related myeloid neoplasms
- 2A60.20/C92.7 Therapy related acute myeloid leukaemia or myelodysplastic syndrome
- 2A60.2Y/D47.1 Other specified therapy-related myeloid neoplasms
- 2A60.2Z/D47.1 Therapy-related myeloid neoplasms, unspecified
- 2A60.3/C92.0 Acute myeloid leukaemia, not elsewhere classified by criteria of other types
- 2A60.30/C92.0 Acute myeloid leukaemia with minimal differentiation
- 2A60.31/C92.0 Acute myeloid leukaemia without maturation
- 2A60.32/C92.0 Acute myeloid leukaemia with maturation
- 2A60.33/C92.5 Acute myelomonocytic leukaemia
- 2A60.34/C93.0 Acute monoblastic or monocytic leukaemia
- 2A60.35/C94.0 Acute erythroid leukaemia
- 2A60.36/C94.2 Acute megakaryoblastic leukaemia
- 2A60.37/C92.0 Acute basophilic leukaemia
- 2A60.38/C94.4 Acute panmyelosis with myelofibrosis
- 2A60.39/C92.3 Myeloid sarcoma
- 2A60.3Y/C92.0 Other specified acute myeloid leukaemia, not elsewhere classified by criteria of other types
- 2A60.3Z/C92.0 Acute myeloid leukaemia, unspecified
- 2A60.4/C92.7 Myeloid proliferation associated with Down syndrome
- 2A60.40/D61.9 Transient abnormal myelopoiesis
- 2A60.41/C92.7 Myeloid leukaemia associated with Down syndrome
- 2A60.4Y/C92.7 Other specified myeloid proliferation associated with Down syndrome
- 2A60.4Z/C92.7 Myeloid proliferation associated with Down syndrome, unspecified
- 2A60.5/C86.4 Blastic plasmacytoid dendritic cell neoplasm
- 2A60/C81-C96 Acute myeloid leukaemias and related precursor neoplasms
- 2A60.Y/C81-C96 Other specified acute myeloid leukaemias and related precursor neoplasms
- 2A60.Z/C81-C96 Acute myeloid leukaemias and related precursor neoplasms, unspecified
- 2A61/C94 Acute leukaemias of ambiguous lineage
- 2A70.0/C81-C96 B Lymphoblastic leukaemia or lymphoma, not elsewhere classified
- 2A70.1/C81-C96 B lymphoblastic leukaemia or lymphoma with t(9:22) (q34;q11.2); BCR-ABL1
- 2A70/C81-C96 Precursor B-lymphoblastic neoplasms
- 2A70.Y/C81-C96 Other B-lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities
- 2A71/C81-C96 Precursor T-lymphoblastic neoplasms
- 2A7Z/C81-C96 Precursor lymphoid neoplasms, unspecified
- 2A80.0/C82.0 Follicular lymphoma grade 1
- 2A80.1/C82.1 Follicular lymphoma grade 2
- 2A80.2/C82.2 Follicular lymphoma grade 3
- 2A80.3/C82.6 Primary cutaneous follicle centre lymphoma
- 2A80.4/C82.9 Paediatric type follicular lymphoma
- 2A80.5/C82.9 Follicular lymphoma in situ
- 2A80.6/C82.9 Follicular lymphoma of small intestine
- 2A80/C82.9 Follicular lymphoma
- 2A80.Y/C82.9 Other specified follicular lymphoma
- 2A80.Z/C82.9 Follicular lymphoma, unspecified
- 2A81.0/C85.2 Primary mediastinal large B-cell lymphoma
- 2A81.1/C83.3 Intravascular large B-cell lymphoma
- 2A81.2/C83.3 Plasmablastic lymphoma
- 2A81.3/C83.3 Lymphomatoid granulomatosis
- 2A81.4/C83.3 T-cell/histiocyte rich large B-cell lymphoma
- 2A81.5/C83.3 Primary diffuse large B-cell lymphoma of central nervous system
- 2A81.6/C83.3 Epstein-Barr Virus-positive diffuse large B cell lymphoma of the elderly
- 2A81.7/C83.3 Diffuse large B-cell lymphoma associated with chronic inflammation
- 2A81.8/C83.3 ALK-positive large B-cell lymphoma
- 2A81.9/C83.3 Primary effusion lymphoma
- 2A81.A/C83.3 Primary cutaneous diffuse large B-cell lymphoma, leg type
- 2A81/C83.3 Diffuse large B-cell lymphomas
- 2A81.Y/C83.3 Other specified diffuse large B-cell lymphomas
- 2A81.Z/C83.3 Diffuse large B-cell lymphoma, not otherwise specified
- 2A82.0/C91.7 Chronic lymphocytic leukaemia or small lymphocytic lymphoma
- 2A82.00/C91.1 Chronic lymphocytic leukaemia of B-cell type
- 2A82.0Y/C91.7 Other specified chronic lymphocytic leukaemia or small lymphocytic lymphoma
- 2A82.0Z/C91.7 Chronic lymphocytic leukaemia or small lymphocytic lymphoma, unspecified
- 2A82.1/C91.3 B-cell prolymphocytic leukaemia
- 2A82.10/C91.3 B-cell prolymphocytic leukaemia in complete remission
- 2A82.1Y/C91.3 Other specified b-cell prolymphocytic leukaemia
- 2A82.1Z/C91.3 B-cell prolymphocytic leukaemia, unspecified
- 2A82.2/C91.4 Hairy-cell leukaemia
- 2A82.3/C91.7 Splenic B-cell lymphoma or leukaemia, unclassifiable
- 2A82/C91.7 Mature B-cell neoplasm with leukaemic behaviour
- 2A82.Y/C91.7 Other specified mature B-cell neoplasm with leukaemic behaviour
- 2A82.Z/C91.7 Mature B-cell neoplasm with leukaemic behaviour, unspecified
- 2A83.0/D47.2 Monoclonal gammopathy of undetermined significance
- 2A83.1/C90.0 Plasma cell myeloma
- 2A83.2/C90.3 Solitary plasmacytoma
- 2A83.3/C90 Extraosseous plasmacytoma
- 2A83.4/C90.1 Plasma cell leukaemia
- 2A83.5/C90 Monoclonal immunoglobulin deposition disease
- 2A83.50/D47.7 Heavy chain deposition disease
- 2A83.51/D47.7 Light and heavy chain deposition disease
- 2A83.52/D47.7 Light chain deposition disease
- 2A83/C90 Plasma cell neoplasms
- 2A83.Y/C90 Other specified multiple myeloma and plasma cell neoplasms
- 2A83.Z/C90 Plasma cell neoplasm, unspecified
- 2A84.0/C88 Alpha heavy chain disease
- 2A84.1/C88 Gamma heavy chain disease
- 2A84.2/C88 Mu heavy chain disease
- 2A84/C88 Heavy chain diseases or malignant immunoproliferative diseases
- 2A84.Y/C88 Other specified malignant immunoproliferative diseases
- 2A84.Z/C88 Heavy chain diseases, unspecified
- 2A85.0/C88.7 Nodal marginal zone lymphoma
- 2A85.1/C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of stomach
- 2A85.2/C88.7 Extranodal marginal zone B-cell lymphoma, primary site skin
- 2A85.3/C85.7 Extranodal marginal zone B-cell lymphoma, primary site excluding stomach or skin
- 2A85.4/C88.0 Lymphoplasmacytic lymphoma
- 2A85.5/C83.1 Mantle cell lymphoma
- 2A85.6/C83.7 Burkitt lymphoma including Burkitt leukaemia
- 2A85/C85.1 Other specified mature B-cell neoplasms or lymphoma
- 2A85.Y/C85.1 Further specified mature B-cell neoplasms or lymphoma
- 2A86.0/C85.1 Malignant lymphoma of B cell type, not elsewhere classified
- 2A86.1/C85.1 B-cell lymphoma unclassifiable with features intermediate between Burkitt lymphoma and diffuse large B-cell lymphoma
- 2A86.2/C85.1 B-cell lymphoma unclassifiable with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma
- 2A86/C81-C96 B-cell lymphoma, mixed features
- 2A86.Y/C81-C96 Other specified B-cell lymphoma, mixed features
- 2A86.Z/C81-C96 B-cell lymphoma, mixed features, unspecified
- 2A8Z/C81-C96 Mature B-cell neoplasms, unspecified
- 2A90.0/C91.6 T-cell prolymphocytic leukaemia
- 2A90.1/C86 T-cell large granular lymphocytic leukaemia
- 2A90.2/C86 Chronic lymphoproliferative disorders of NK-cells
- 2A90.3/C86 Aggressive NK cell leukaemia
- 2A90.4/C86 Systemic Epstein-Barr Virus-positive T-cell lymphoma of childhood
- 2A90.5/C91.5 Adult T-cell lymphoma or leukaemia, human T-cell lymphotropic virus type 1-associated
- 2A90.6/C86.0 Extranodal NK/T-cell lymphoma, nasal type
- 2A90.7/C86.2 Enteropathy associated T-cell lymphoma
- 2A90.8/C86.1 Hepatosplenic T-cell lymphoma
- 2A90.9/C86.5 Angioimmunoblastic T-cell lymphoma
- 2A90.A/C84.6 Anaplastic large cell lymphoma, ALK-positive
- 2A90.B/C84.7 Anaplastic large cell lymphoma, ALK-negative
- 2A90.C/C84.4 Peripheral T-cell lymphoma, not otherwise specified
- 2A90/C86 Mature T-cell lymphoma, specified types, nodal or systemic
- 2B00/C86.3 Subcutaneous panniculitis-like T-cell lymphoma
- 2B01/C84.0 Mycosis fungoides
- 2B02/C84.1 Sézary syndrome
- 2B03.0/C86.6 Primary cutaneous CD30 positive anaplastic large cell lymphoma
- 2B03.1/C84 Lymphomatoid papulosis
- 2B03/C84 Primary cutaneous CD-30 positive T-cell lymphoproliferative disorders
- 2B0Y/C84 Other specified primary cutaneous mature T-cell or NK-cell lymphomas and lymphoproliferative disorders
- 2B0Z/C84 Primary cutaneous T-cell lymphoma of undetermined or unspecified type
- 2B2Y/C84.8 Other specified mature T-cell or NK-cell neoplasms
- 2B2Z/C84 Mature T-cell or NK-cell neoplasms, unspecified
- 2B30.0/C81.0 Nodular lymphocyte predominant Hodgkin lymphoma
- 2B30.1/C81.7 Classical Hodgkin lymphoma
- 2B30.10/C81.1 Nodular sclerosis classical Hodgkin lymphoma
- 2B30.11/C81.4 Lymphocyte-rich classical Hodgkin lymphoma
- 2B30.12/C81.2 Mixed cellularity classical Hodgkin lymphoma
- 2B30.13/C81.3 Lymphocyte depleted classical Hodgkin lymphoma
- 2B30.1Z/C81.7 Classical Hodgkin lymphoma, unspecified
- 2B30/C81 Hodgkin lymphoma
- 2B30.Z/C81 Hodgkin lymphoma, unspecified
- 2B31.0/D76.3 Juvenile xanthogranuloma
- 2B31.1/C96.8 Histiocytic sarcoma
- 2B31.2/C81-C96 Langerhans cell histiocytosis
- 2B31.20/C96.6 Langerhans cell histiocytosis involving the skin
- 2B31.2Y/C81-C96 Other specified Langerhans cell histiocytosis
- 2B31.3/C96.4 Langerhans cell sarcoma
- 2B31.4/C96.4 Interdigitating dendritic cell sarcoma
- 2B31.5/C96.4 Follicular dendritic cell sarcoma
- 2B31.6/C96.4 Indeterminate cell histiocytosis
- 2B31.7/C96.4 Fibroblastic reticular cell tumour
- 2B31/C81-C96 Histiocytic or dendritic cell neoplasms
- 2B31.Y/C81-C96 Other specified histiocytic or dendritic cell neoplasms
- 2B31.Z/C81-C96 Histiocytic or dendritic cell neoplasms, unspecified
- 2B32.0/D47.7 Post-transplant lymphoproliferative disorder, early lesion
- 2B32.1/D75.8 Reactive plasmacytic hyperplasia
- 2B32.2/D47.7 Post-transplant lymphoproliferative disorder, Infectious mononucleosis-like
- 2B32.3/D47.7 Polymorphic post-transplant lymphoproliferative disorder
- 2B32/D47.9 Immunodeficiency-associated lymphoproliferative disorders
- 2B32.Y/D47.9 Other specified immunodeficiency-associated lymphoproliferative disorders
- 2B32.Z/D47.9 Immunodeficiency-associated lymphoproliferative disorders, unspecified
- 2B33.0/C95.0 Acute leukaemia, not elsewhere classified
- 2B33.1/C92 Myeloid leukaemia
- 2B33.2/C96.9 Chronic myeloid leukaemia, not elsewhere classified
- 2B33.3/C91.0 Lymphoid leukaemia, not elsewhere classified
- 2B33.4/C95.9 Leukaemia, unspecified
- 2B33.5/C85.9 Malignant lymphoma, not elsewhere classified
- 2B33/C96.9 Malignant haematopoietic neoplasms without further specification
- 2B33.Y/C96.9 Other malignant haematopoietic neoplasms without further specification
- 2B3Z/C81-C96 Neoplasms of haematopoietic or lymphoid tissues, unspecified
- 2B50.0/C40 Chondrosarcoma of bone or articular cartilage of limbs
- 2B50.1/C41.9 Chondrosarcoma of bone or articular cartilage of pelvis
- 2B50.2/C41.3 Chondrosarcoma of bone or articular cartilage of ribs, sternum or clavicle
- 2B50/C41.9 Chondrosarcoma, primary site
- 2B50.Y/C41.9 Chondrosarcoma of bone or articular cartilage of other specified sites
- 2B50.Z/C41.9 Chondrosarcoma of bone or articular cartilage of unspecified sites
- 2B51.0/C41.1 Osteosarcoma of bone or articular cartilage of jaw
- 2B51.1/C40 Osteosarcoma of bone or articular cartilage of limbs
- 2B51.2/C41.4 Osteosarcoma of bone or articular cartilage of pelvis
- 2B51/C41.9 Osteosarcoma, primary site
- 2B51.Y/C41.9 Osteosarcoma of bone and articular cartilage of other specified sites
- 2B51.Z/C41.9 Osteosarcoma of bone and articular cartilage of unspecified sites
- 2B52.0/C40 Ewing sarcoma of bone or articular cartilage of limbs
- 2B52.1/C41.4 Ewing sarcoma of bone or articular cartilage of pelvis
- 2B52.2/C41.3 Ewing sarcoma of bone or articular cartilage of ribs
- 2B52.3/C41.9 Ewing sarcoma of soft tissue
- 2B52/C41.9 Ewing sarcoma, primary site
- 2B52.Y/C41.9 Ewing sarcoma of bone and articular cartilage of other specified sites
- 2B52.Z/C41.9 Ewing sarcoma of bone and articular cartilage of unspecified sites
- 2B53.0/C41.9 Myxofibrosarcoma, primary site
- 2B53.1/C41.9 Fibroblastic or myofibroblastic tumour of skin
- 2B53/C41.9 Fibroblastic or myofibroblastic tumour, primary site
- 2B53.Y/C41.9 Other specified fibroblastic or myofibroblastic tumour, primary site
- 2B53.Z/C41.9 Fibroblastic or myofibroblastic tumour, primary site, unspecified
- 2B54.0/C41.9 Unclassified pleomorphic sarcoma of skin
- 2B54.1/C41.9 Unclassified pleomorphic sarcoma of retroperitoneum or peritoneum
- 2B54/C41.9 Unclassified pleomorphic sarcoma, primary site
- 2B54.Y/C41.9 Unclassified pleomorphic sarcoma, primary site, other specified site
- 2B54.Z/C41.9 Unclassified pleomorphic sarcoma, primary site, unspecified site
- 2B55.0/C41.9 Rhabdomyosarcoma of the oral cavity or pharynx
- 2B55.1/C41.9 Rhabdomyosarcoma of respiratory or intrathoracic organs
- 2B55.2/C41.9 Rhabdomyosarcoma of male genital organs
- 2B55/C41.9 Rhabdomyosarcoma, primary site
- 2B55.Y/C41.9 Rhabdomyosarcoma, other specified primary site
- 2B55.Z/C41.9 Rhabdomyosarcoma, unspecified primary site
- 2B56.0/C41.9 Angiosarcoma of heart
- 2B56.1/C41.9 Angiosarcoma of skin
- 2B56.2/C41.9 Angiosarcoma of breast
- 2B56.3/C22.3 Angiosarcoma of liver
- 2B56/C41.9 Angiosarcoma, primary site
- 2B56.Y/C41.9 Angiosarcoma, other specified primary site
- 2B56.Z/C41.9 Angiosarcoma, unspecified primary site
- 2B57.0/C46 Kaposi sarcoma of lung
- 2B57.1/C46.0 Kaposi sarcoma of skin
- 2B57.2/C46 Kaposi sarcoma of gastrointestinal sites
- 2B57/C46 Kaposi sarcoma, primary site
- 2B57.Y/C46.8 Kaposi sarcoma of other specified primary sites
- 2B57.Z/C46 Kaposi sarcoma of unspecified primary site
- 2B58.0/C41.9 Leiomyosarcoma of retroperitoneum or peritoneum
- 2B58.1/C41.9 Leiomyosarcoma of uterus
- 2B58.2/C41.9 Leiomyosarcoma of stomach
- 2B58/C41.9 Leiomyosarcoma, primary site
- 2B58.Y/C41.9 Leiomyosarcoma, other specified primary site
- 2B58.Z/C41.9 Leiomyosarcoma, unspecified primary site
- 2B59.0/C41.9 Liposarcoma of soft tissue of limb
- 2B59.1/C41.9 Liposarcoma of retroperitoneum or peritoneum
- 2B59.2/C41.9 Liposarcoma of male genital organs
- 2B59/C41.9 Liposarcoma, primary site
- 2B59.Y/C41.9 Liposarcoma, other specified primary site
- 2B59.Z/C41.9 Liposarcoma, unspecified primary site
- 2B5A.0/C41.9 Synovial sarcoma of soft tissues of limb
- 2B5A.1/C41.9 Synovial sarcoma of respiratory or intra-thoracic organs
- 2B5A/C41.9 Synovial sarcoma, primary site
- 2B5A.Y/C41.9 Synovial sarcoma, other specified primary site
- 2B5A.Z/C41.9 Synovial sarcoma, unspecified primary site
- 2B5B.0/C41.9 Gastrointestinal stromal tumour of stomach
- 2B5B.1/C41.9 Gastrointestinal stromal tumour of small intestine
- 2B5B/C41.9 Gastrointestinal stromal tumour, primary site
- 2B5B.Y/C41.9 Gastrointestinal stromal tumour of other gastrointestinal sites
- 2B5B.Z/C41.9 Gastrointestinal stromal tumour of unspecified gastrointestinal sites
- 2B5C/C41.9 Endometrial stromal sarcoma, primary site
- 2B5D.0/C41.9 Malignant mixed epithelial mesenchymal tumour of ovary
- 2B5D.1/C41.9 Malignant mixed epithelial and mesenchymal tumour of corpus uteri
- 2B5D/C41.9 Malignant mixed epithelial mesenchymal tumour, primary site
- 2B5D.Y/C41.9 Malignant mixed epithelial mesenchymal tumour, other specified primary site
- 2B5D.Z/C41.9 Malignant mixed epithelial mesenchymal tumour, unspecified primary site
- 2B5E/C41.9 Malignant nerve sheath tumour of peripheral nerves or autonomic nervous system, primary site
- 2B5F.0/C41.9 Sarcoma, not elsewhere classified of uterus
- 2B5F.1/C41.9 Sarcoma, not elsewhere classified of retroperitoneum or peritoneum
- 2B5F.10/C48.1 Myosarcomas of omentum
- 2B5F.1Y/C41.9 Other specified sarcoma, not elsewhere classified of retroperitoneum or peritoneum
- 2B5F.1Z/C41.9 Sarcoma, not elsewhere classified of retroperitoneum or peritoneum, unspecified
- 2B5F.2/C41.9 Sarcoma, not elsewhere classified of other specified sites
- 2B5F.3/C41.9 Sarcoma, not elsewhere classified, primary site unknown
- 2B5F/C41.9 Sarcoma, not elsewhere classified, primary site
- 2B5G/C41.9 Myosarcoma of uterus, part not specified
- 2B5H/C41.9 Well differentiated lipomatous tumour, primary site
- 2B5J/C41.9 Malignant miscellaneous tumours of bone or articular cartilage of other or unspecified sites
- 2B5K/C49 Unspecified malignant soft tissue tumours or sarcomas of bone or articular cartilage of other or unspecified sites
- 2B5Y/C41.9 Other specified malignant mesenchymal neoplasms
- 2B5Z/C41.9 Malignant mesenchymal neoplasm of unspecified type
- 2B60.0/C00 Basal cell carcinoma of lip
- 2B60.1/C00 Squamous cell carcinoma of lip
- 2B60/C00 Malignant neoplasms of lip
- 2B60.Y/C00.8 Other specified malignant neoplasms of lip
- 2B60.Z/C00 Malignant neoplasms of lip, unspecified
- 2B61.0/C01 Squamous cell carcinoma of the base of the tongue
- 2B61/C01 Malignant neoplasms of base of tongue
- 2B61.Y/C01 Other specified malignant neoplasms of base of tongue
- 2B61.Z/C01 Malignant neoplasms of base of tongue, unspecified
- 2B62.0/C02 Squamous cell carcinoma of other or unspecified parts of tongue
- 2B62.1/C02.4 Malignant neoplasms of lingual tonsil
- 2B62.10/C02.4 Squamous cell carcinoma of lingual tonsil
- 2B62/C02 Malignant neoplasms of other or unspecified parts of tongue
- 2B62.Y/C02.8 Other specified malignant neoplasms of other and unspecified parts of tongue
- 2B62.Z/C02 Malignant neoplasms of other or unspecified parts of tongue, unspecified
- 2B63.0/C03 Squamous cell carcinoma of gum
- 2B63/C03 Malignant neoplasms of gum
- 2B63.Y/C03 Other specified malignant neoplasm of gum
- 2B63.Z/C03 Malignant neoplasms of gum, unspecified
- 2B64.0/C04 Squamous cell carcinoma of floor of mouth
- 2B64/C04 Malignant neoplasms of floor of mouth
- 2B64.Y/C04.8 Other specified malignant neoplasm of floor of mouth
- 2B64.Z/C04 Malignant neoplasms of floor of mouth, unspecified
- 2B65.0/C05 Adenocarcinoma of palate
- 2B65.1/C05 Squamous cell carcinoma of palate
- 2B65/C05 Malignant neoplasms of palate
- 2B65.Y/C05.8 Other specified malignant neoplasm of palate
- 2B65.Z/C05 Malignant neoplasms of palate, unspecified
- 2B66.0/C06 Squamous cell carcinoma of other or unspecified parts of mouth
- 2B66/C06 Malignant neoplasms of other or unspecified parts of mouth
- 2B66.Y/C06.8 Other specified malignant neoplasms of other and unspecified parts of mouth
- 2B66.Z/C06 Malignant neoplasms of other or unspecified parts of mouth, unspecified
- 2B67.0/C07 Adenocarcinoma of parotid gland
- 2B67.1/C07 Squamous cell carcinoma of parotid gland
- 2B67/C07 Malignant neoplasms of parotid gland
- 2B67.Y/C07 Other specified malignant neoplasms of parotid gland
- 2B67.Z/C07 Malignant neoplasms of parotid gland, unspecified
- 2B68.0/C08 Adenocarcinoma of submandibular or sublingual glands
- 2B68.1/C08 Squamous cell carcinoma of submandibular or sublingual glands
- 2B68.2/C08 Other specified malignant neoplasms of submandibular or sublingual glands
- 2B68/C08 Malignant neoplasms of submandibular or sublingual glands
- 2B68.Z/C08 Malignant neoplasms of submandibular or sublingual glands, unspecified
- 2B69.0/C09 Squamous cell carcinoma of tonsil
- 2B69.1/C09 Other specified malignant neoplasms of tonsil
- 2B69/C09 Malignant neoplasms of tonsil
- 2B69.Z/C09 Malignant neoplasms of tonsil, unspecified
- 2B6A.0/C10 Squamous cell carcinoma of oropharynx
- 2B6A/C10 Malignant neoplasms of oropharynx
- 2B6A.Y/C10.8 Other specified malignant neoplasms of oropharynx
- 2B6A.Z/C10 Malignant neoplasms of oropharynx, unspecified
- 2B6B.0/C11 Squamous cell carcinoma of nasopharynx
- 2B6B.1/C11 Malignant epithelial neoplasms of nasopharynx, unspecified type
- 2B6B.2/C11 Malignant neoplasms of pharyngeal tonsil
- 2B6B.20/C11 Squamous cell carcinoma of pharyngeal tonsil
- 2B6B.21/C11 Other or unspecified malignant epithelial neoplasm of pharyngeal tonsil
- 2B6B.2Y/C11 Other specified malignant neoplasms of pharyngeal tonsil
- 2B6B.2Z/C11 Malignant neoplasm of pharyngeal tonsil without mention of type
- 2B6B/C11 Malignant neoplasms of nasopharynx
- 2B6B.Y/C11.8 Other specified malignant neoplasms of nasopharynx
- 2B6B.Z/C11 Malignant neoplasms of nasopharynx, unspecified
- 2B6C.0/C12 Squamous cell carcinoma of piriform sinus
- 2B6C/C12 Malignant neoplasms of piriform sinus
- 2B6C.Y/C12 Other specified malignant neoplasms of piriform sinus
- 2B6C.Z/C12 Malignant neoplasms of piriform sinus, unspecified
- 2B6D.0/C13 Squamous cell carcinoma of hypopharynx and variants
- 2B6D/C13 Malignant neoplasms of hypopharynx
- 2B6D.Y/C13.8 Other specified malignant neoplasms of hypopharynx
- 2B6D.Z/C13 Malignant neoplasms of hypopharynx, unspecified
- 2B6E.0/C14 Squamous cell carcinoma of other or ill-defined sites in the lip, oral cavity or pharynx
- 2B6E/C14 Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx
- 2B6E.Y/C14.8 Other specified malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx
- 2B6E.Z/C14 Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx, unspecified
- 2B6Y/C00-C14 Other specified malignant neoplasms of lip, oral cavity or pharynx
- 2B6Z/C00-C14 Malignant neoplasms of lip, oral cavity or pharynx, unspecified
- 2B70.0/C15 Adenocarcinoma of oesophagus
- 2B70.00/C15 Barrett adenocarcinoma
- 2B70.0Y/C15 Other specified adenocarcinoma of oesophagus
- 2B70.0Z/C15 Adenocarcinoma of oesophagus, unspecified
- 2B70.1/C15 Squamous cell carcinoma of oesophagus
- 2B70/C15 Malignant neoplasms of oesophagus
- 2B70.Y/C15.8 Other specified malignant neoplasms of oesophagus
- 2B70.Z/C15 Malignant neoplasms of oesophagus, unspecified
- 2B71.0/C15-C26 Adenocarcinoma of oesophagogastric junction
- 2B71/C15-C26 Malignant neoplasms of oesophagogastric junction
- 2B71.Y/C15-C26 Other specified malignant neoplasm of oesophagogastric junction
- 2B71.Z/C15-C26 Malignant neoplasms of oesophagogastric junction, unspecified
- 2B72.0/C16 Adenocarcinoma of stomach
- 2B72.1/C16 Malignant neuroendocrine neoplasm of stomach
- 2B72/C16 Malignant neoplasms of stomach
- 2B72.Y/C16.8 Other specified malignant neoplasms of stomach
- 2B72.Z/C16 Malignant neoplasms of stomach, unspecified
- 2B80.0/C17.0 Malignant neoplasms of duodenum
- 2B80.00/C17.0 Adenocarcinoma of duodenum
- 2B80.01/C17.0 Neuroendocrine neoplasm of duodenum
- 2B80.0Y/C17.0 Other specified malignant neoplasms of the duodenum
- 2B80.0Z/C17.0 Malignant neoplasms of duodenum, unspecified
- 2B80.1/C17 Malignant neoplasms of jejunum or ileum
- 2B80.10/C17 Adenocarcinoma of jejunum or ileum
- 2B80.11/C17 Neuroendocrine neoplasms of jejunum or ileum
- 2B80.1Y/C17 Other specified malignant neoplasms of jejunum or ileum
- 2B80.1Z/C17 Malignant neoplasms of jejunum or ileum, unspecified
- 2B80.2/C17 Malignant neoplasms of small intestine, site unspecified
- 2B80.20/C17 Adenocarcinoma of small intestine, site unspecified
- 2B80.21/C17 Neuroendocrine neoplasms of small intestine, site unspecified
- 2B80.2Y/C17 Other specified malignant neoplasms of small intestine, site unspecified
- 2B80/C17 Malignant neoplasms of small intestine
- 2B80.Y/C17.8 Other specified malignant neoplasms of small intestine
- 2B80.Z/C17 Malignant neoplasms of small intestine, unspecified
- 2B81.0/C18.1 Adenocarcinoma of appendix
- 2B81.1/C18.1 Mucinous adenocarcinoma of appendix
- 2B81.2/C18.1 Neuroendocrine neoplasms of appendix
- 2B81/C18.1 Malignant neoplasms of appendix
- 2B81.Y/C18.1 Other specified malignant neoplasms of appendix
- 2B81.Z/C18.1 Malignant neoplasms of appendix, unspecified
- 2B90.0/C18 Malignant neoplasm of ascending colon and right flexure of colon
- 2B90.00/C18 Adenocarcinoma of ascending colon or right flexure of colon
- 2B90.0Y/C18 Other specified malignant neoplasm of ascending colon and right flexure of colon
- 2B90.0Z/C18 Malignant neoplasm of ascending colon and right flexure of colon, unspecified
- 2B90.1/C18 Malignant neoplasm of descending colon and splenic flexure of colon
- 2B90.10/C18 Adenocarcinoma of descending colon or splenic flexure of colon
- 2B90.1Y/C18 Other specified malignant neoplasm of descending colon and splenic flexure of colon
- 2B90.1Z/C18 Malignant neoplasm of descending colon and splenic flexure of colon, unspecified
- 2B90.2/C18.4 Malignant neoplasm of transverse colon
- 2B90.20/C18.4 Adenocarcinoma of transverse colon
- 2B90.2Y/C18.4 Other specified malignant neoplasm of transverse colon
- 2B90.2Z/C18.4 Malignant neoplasm of transverse colon, unspecified
- 2B90.3/C18.7 Malignant neoplasm of sigmoid colon
- 2B90.30/C18.7 Adenocarcinoma of sigmoid colon
- 2B90.3Y/C18.7 Other specified malignant neoplasm of sigmoid colon
- 2B90.3Z/C18.7 Malignant neoplasm of sigmoid colon, unspecified
- 2B90/C18 Malignant neoplasms of colon
- 2B90.Y/C18.8 Other specified malignant neoplasms of colon
- 2B90.Z/C18 Malignant neoplasms of colon, unspecified
- 2B91.0/C19 Adenocarcinoma of rectosigmoid junction
- 2B91/C19 Malignant neoplasms of rectosigmoid junction
- 2B91.Y/C19 Other specified malignant neoplasms of rectosigmoid junction
- 2B91.Z/C19 Malignant neoplasms of rectosigmoid junction, unspecified
- 2B92.0/C20 Adenocarcinomas of rectum
- 2B92.1/C20 Neuroendocrine neoplasms of rectum
- 2B92/C20 Malignant neoplasms of rectum
- 2B92.Y/C20 Other specified malignant neoplasms of rectum
- 2B92.Z/C20 Malignant neoplasms of rectum, unspecified
- 2B93.0/C15-C26 Adenocarcinoma of large intestine, site unspecified
- 2B93/C15-C26 Malignant neoplasms of large intestine, site unspecified
- 2B93.Y/C15-C26 Other specified malignant neoplasms of large intestine, site unspecified
- 2B93.Z/C15-C26 Malignant neoplasms of large intestine, site and type unspecified
- 2B9Y/C15-C26 Other specified malignant neoplasms of large intestine
- 2C00.0/C21 Adenocarcinoma of anus or anal canal
- 2C00.1/C21 Melanoma of anus or anal canal
- 2C00.2/C21 Neuroendocrine neoplasm of anus or anal canal
- 2C00.3/C21 Squamous cell carcinoma of anus or anal canal
- 2C00/C21 Malignant neoplasms of anus or anal canal
- 2C00.Y/C21.8 Other specified malignant neoplasms of anus and anal canal
- 2C00.Z/C21 Malignant neoplasms of anus or anal canal, unspecified
- 2C0Y/C15-C26 Other specified malignant neoplasms of intestine
- 2C0Z/C15-C26 Malignant neoplasms of intestine, unspecified
- 2C10.0/C25 Adenocarcinoma of pancreas
- 2C10.1/C25.4 Neuroendocrine neoplasms of pancreas
- 2C10/C25 Malignant neoplasm of pancreas
- 2C10.Y/C25.8 Other specified malignant neoplasms of pancreas
- 2C10.Z/C25 Malignant neoplasm of pancreas, unspecified
- 2C11.0/C26 Adenocarcinoma of other or ill-defined digestive organs
- 2C11.1/C26 Mucinous carcinoma of other or ill-defined digestive organs
- 2C11.2/C26 Other specified malignant neoplasms of other or ill-defined digestive organs
- 2C11/C26 Malignant neoplasms of other or ill-defined digestive organs
- 2C11.Z/C26 Malignant neoplasms of other or ill-defined digestive organs, unspecified
- 2C12.0/C22 Malignant neoplasm of liver
- 2C12.00/C22 Combined hepatocellular-cholangiocarcinoma
- 2C12.01/C22.2 Hepatoblastoma
- 2C12.02/C22.0 Hepatocellular carcinoma of liver
- 2C12.03/C22 Mesothelial carcinoma of liver
- 2C12.0Y/C22 Other specified malignant neoplasm of liver
- 2C12.1/C22 Malignant neoplasm of intrahepatic bile ducts
- 2C12.10/C22.1 Intrahepatic cholangiocarcinoma
- 2C12.1Y/C22 Other specified malignant neoplasms of intrahepatic bile ducts
- 2C12/C22 Malignant neoplasms of liver or intrahepatic bile ducts
- 2C12.Z/C22 Malignant neoplasms of liver or intrahepatic bile ducts, unspecified
- 2C13.0/C23 Adenocarcinoma of the gallbladder
- 2C13/C23 Malignant neoplasms of gallbladder
- 2C13.Y/C23 Other specified malignant neoplasm of gallbladder
- 2C13.Z/C23 Malignant neoplasms of gallbladder, unspecified
- 2C14.0/C24.0 Adenocarcinoma of proximal biliary tract, cystic duct
- 2C14.1/C24.0 Mucinous cystic neoplasm with associated invasive carcinoma of cystic duct
- 2C14.2/C24.0 Neuroendocrine neoplasms of cystic duct
- 2C14/C24.0 Malignant neoplasms of proximal biliary tract, cystic duct
- 2C14.Y/C24.0 Other specified malignant neoplasms of biliary tract, cystic duct
- 2C14.Z/C24.0 Malignant neoplasms of proximal biliary tract, cystic duct, unspecified
- 2C15.0/C24.0 Adenocarcinoma of biliary tract, distal bile duct
- 2C15.1/C24.0 Mucinous cystic neoplasm with associated invasive carcinoma of distal bile duct
- 2C15.2/C24.0 Neuroendocrine neoplasms of distal bile duct
- 2C15/C24.0 Malignant neoplasms of biliary tract, distal bile duct
- 2C15.Y/C24.0 Other specified malignant neoplasms of biliary tract, distal bile duct
- 2C15.Z/C24.0 Malignant neoplasms of biliary tract, distal bile duct, unspecified
- 2C16.0/C24.1 Adenocarcinoma of ampulla of Vater
- 2C16.1/C24.1 Neuroendocrine neoplasms of ampulla of Vater
- 2C16/C24.1 Malignant neoplasms of ampulla of Vater
- 2C16.Y/C24.1 Other specified malignant neoplasms of ampulla of Vater
- 2C16.Z/C24.1 Malignant neoplasms of ampulla of Vater, unspecified
- 2C17.0/C24 Adenocarcinoma of other or unspecified parts of biliary tract
- 2C17.1/C24 Mucinous cystic neoplasm with associated invasive carcinoma of other or unspecified parts of biliary tract
- 2C17.2/C24 Neuroendocrine neoplasms of other or unspecified parts of biliary tract
- 2C17/C24 Malignant neoplasms of other or unspecified parts of biliary tract
- 2C17.Y/C24.8 Other specified malignant neoplasms of overlapping lesion of biliary tract
- 2C17.Z/C24 Malignant neoplasms of other or unspecified parts of biliary tract, unspecified
- 2C18.0/C15-C26 Hilar cholangiocarcinoma
- 2C18.1/C15-C26 Mucinous cystic neoplasm with associated invasive carcinoma of perihilar bile duct
- 2C18.2/C15-C26 Neuroendocrine neoplasm of perihilar bile duct
- 2C18/C15-C26 Malignant neoplasms of perihilar bile duct
- 2C18.Y/C15-C26 Other specified malignant neoplasms of perihilar bile duct
- 2C18.Z/C15-C26 Malignant neoplasms of perihilar bile duct, unspecified
- 2C1Z/C15-C26 Malignant neoplasms of digestive organs, unspecified
- 2C20.0/C30.0 Adenocarcinoma of nasal cavity
- 2C20.1/C30.0 Malignant neuroepitheliomatous neoplasm of nasal cavity
- 2C20.2/C30.0 Melanoma of nasal cavity
- 2C20.3/C30.0 Olfactory neuroblastoma
- 2C20.4/C30.0 Squamous cell carcinoma of nasal cavity
- 2C20/C30.0 Malignant neoplasms of nasal cavity
- 2C20.Y/C30.0 Other specified malignant neoplasm of nasal cavity
- 2C20.Z/C30.0 Malignant neoplasms of nasal cavity, unspecified
- 2C21.0/C30.1 Adenocarcinoma of middle ear
- 2C21.1/C30.1 Squamous cell carcinoma of middle ear
- 2C21.2/C30.1 Unspecified malignant epithelial neoplasm of middle ear
- 2C21/C30.1 Malignant neoplasms of middle ear
- 2C21.Y/C30.1 Other specified malignant neoplasm of middle ear
- 2C21.Z/C30.1 Malignant neoplasms of middle ear, unspecified
- 2C22.0/C31 Adenocarcinoma of accessory sinuses
- 2C22.1/C31 Squamous cell carcinoma of accessory sinuses
- 2C22.10/C31 Squamous cell carcinoma of sphenoidal sinus
- 2C22.1Y/C31 Squamous cell carcinoma of other specified accessory sinuses
- 2C22.2/C31 Malignant epithelial neoplasms of accessory sinuses, unspecified type
- 2C22.3/C31 Melanomas of accessory sinuses
- 2C22/C31 Malignant neoplasms of accessory sinuses
- 2C22.Y/C31.8 Other specified malignant neoplasms of accessory sinuses
- 2C22.Z/C31 Malignant neoplasms of accessory sinuses, unspecified
- 2C23.1/C32.0 Malignant neoplasms of glottis of larynx
- 2C23.10/C32.0 Squamous cell carcinoma of larynx, glottis
- 2C23.1Y/C32.0 Other specified malignant neoplasms of larynx, glottis
- 2C23.2/C32.1 Malignant neoplasms of supraglottis of larynx
- 2C23.20/C32.1 Squamous cell carcinoma of larynx, supraglottis
- 2C23.2Y/C32.1 Other specified malignant neoplasms of larynx, supraglottis
- 2C23.3/C32.2 Malignant neoplasms of subglottis of larynx
- 2C23.30/C32.2 Squamous cell carcinoma of larynx, subglottis
- 2C23.31/C32.2 Adenocarcinoma of larynx, subglottis
- 2C23.3Y/C32.2 Other specified malignant neoplasms of larynx, subglottis
- 2C23.4/C32 Malignant neoplasm of laryngeal cartilage
- 2C23.5/C32 Malignant neoplasm of overlapping lesion of larynx
- 2C23/C32 Malignant neoplasms of larynx
- 2C23.Z/C32 Malignant neoplasms of larynx, unspecified
- 2C24.0/C33 Adenocarcinoma of trachea
- 2C24.1/C33 Squamous cell carcinoma of trachea
- 2C24.2/C33 Malignant epithelial neoplasms of trachea, unspecified type
- 2C24/C33 Malignant neoplasms of trachea
- 2C24.Y/C33 Other specified malignant neoplasms of trachea
- 2C24.Z/C33 Malignant neoplasms of trachea, unspecified
- 2C25.0/C34 Adenocarcinoma of bronchus or lung
- 2C25.1/C34 Small cell carcinoma of bronchus or lung
- 2C25.2/C34 Squamous cell carcinoma of bronchus or lung
- 2C25.3/C34 Large cell carcinoma of bronchus or lung
- 2C25.4/C34 Carcinoid or other malignant neuroendocrine neoplasms of bronchus or lung
- 2C25.5/C34 Unspecified malignant epithelial neoplasm of bronchus or lung
- 2C25/C34 Malignant neoplasms of bronchus or lung
- 2C25.Y/C34.8 Other specified malignant neoplasms of bronchus or lung
- 2C25.Z/C34 Malignant neoplasms of bronchus or lung, unspecified
- 2C26.0/C45.0 Mesothelioma of pleura
- 2C26/C38.4 Malignant neoplasms of the pleura
- 2C26.Y/C38.4 Other specified malignant neoplasms of the pleura
- 2C26.Z/C38.4 Malignant neoplasms of the pleura, unspecified
- 2C27.0/C37 Carcinoma of thymus
- 2C27.1/C37 Carcinoid tumour or other neuroendocrine neoplasms of thymus
- 2C27.2/C37 Malignant thymoma
- 2C27/C37 Malignant neoplasms of thymus
- 2C27.Y/C37 Other specified malignant neoplasms of thymus
- 2C27.Z/C37 Malignant neoplasms of thymus, unspecified
- 2C28.0/C38 Malignant germ cell neoplasms of heart, mediastinum or non-mesothelioma of pleura
- 2C28.1/C38 Other specified malignant neoplasms of heart, mediastinum or non-mesothelioma of pleura
- 2C28/C38 Malignant neoplasms of heart, mediastinum or non-mesothelioma of pleura
- 2C28.Z/C38 Malignant neoplasms of heart, mediastinum or non-mesothelioma of pleura, unspecified
- 2C29.0/C39 Squamous cell carcinomas of other and ill-defined sites in the respiratory system and intrathoracic organs
- 2C29.1/C39 Other specified malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs
- 2C29/C39 Malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs
- 2C29.Z/C39 Malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs, unspecified
- 2C2Y/C00-C75 Other specified malignant neoplasms of middle ear, respiratory or intrathoracic organs
- 2C2Z/C00-C75 Malignant neoplasms of middle ear, respiratory or intrathoracic organs, unspecified
- 2C30.0/C43.9 Superficial spreading melanoma, primary
- 2C30.1/C43.9 Nodular melanoma, primary
- 2C30.2/C43.9 Lentigo maligna melanoma, primary
- 2C30.3/C43.9 Acral lentiginous melanoma, primary
- 2C30/C43.9 Melanoma of skin
- 2C30.Y/C43.9 Other specified melanoma of skin
- 2C30.Z/C43.9 Melanoma of skin, unspecified
- 2C31.0/C44 Verrucous squamous cell carcinoma of skin
- 2C31.1/C44 Keratoacanthoma
- 2C31/C44 Squamous cell carcinoma of skin
- 2C31.Z/C44 Cutaneous squamous cell carcinoma
- 2C32.0/C44 Nodular basal cell carcinoma of skin
- 2C32.1/C44 Sclerosing basal cell carcinoma of skin
- 2C32.2/C44 Superficial basal cell carcinoma of skin
- 2C32/C44 Basal cell carcinoma of skin
- 2C32.Y/C44.8 Other specified basal cell carcinoma of skin
- 2C32.Z/C44 Basal cell carcinoma of skin, unspecified
- 2C33/C44 Adnexal carcinoma of skin
- 2C34/C43-C44 Cutaneous neuroendocrine carcinoma
- 2C35/C44 Cutaneous sarcoma
- 2C3Y/C43-C44 Other specified malignant neoplasms of skin
- 2C3Z/C43-C44 Malignant neoplasm of skin of unknown or unspecified type
- 2C40/C47 Malignant neuroepitheliomatous neoplasms of peripheral nerves or autonomic nervous system
- 2C41/C47 Malignant perineurioma
- 2C4Y/C47.8 Other specified malignant neoplasms of peripheral nerves and autonomic nervous system
- 2C4Z/C47 Malignant neoplasms of peripheral nerves or autonomic nervous system, unspecified
- 2C50.0/C48.0 Cystic, mucinous or serous carcinoma of retroperitoneum
- 2C50/C48.0 Malignant neoplasms of retroperitoneum
- 2C50.Y/C48.0 Other specified malignant neoplasms of retroperitoneum
- 2C50.Z/C48.0 Malignant neoplasms of retroperitoneum, unspecified
- 2C51.0/C48.2 Adenocarcinomas of peritoneum
- 2C51.1/C48.2 Cystic, mucinous or serous carcinoma of peritoneum
- 2C51.2/C45.1 Mesotheliomas of peritoneum
- 2C51.20/C45.1 Mesothelioma of mesocolon
- 2C51.21/C45.1 Mesothelioma of mesentery
- 2C51.2Y/C45.1 Mesotheliomas of other specified sites of peritoneum
- 2C51.2Z/C45.1 Mesotheliomas of peritoneum, site unspecified
- 2C51/C48.2 Malignant neoplasms of peritoneum
- 2C51.Y/C48.2 Other specified malignant neoplasms of peritoneum
- 2C51.Z/C48.2 Malignant neoplasms of peritoneum, unspecified
- 2C52.0/C48.1 Cystic, mucinous or serous carcinoma of omentum
- 2C52/C45-C49 Malignant neoplasms of omentum
- 2C52.Y/C45-C49 Other specified malignant neoplasms of omentum
- 2C52.Z/C45-C49 Malignant neoplasms of omentum, unspecified
- 2C53.0/C48.8 Adenocarcinoma involving overlapping sites of retroperitoneum, peritoneum or omentum
- 2C53.1/C45 Mesothelioma involving overlapping sites of retroperitoneum, peritoneum or omentum
- 2C53/C45-C49 Malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum
- 2C53.Y/C45-C49 Other specified malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum
- 2C53.Z/C45-C49 Malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum, unspecified
- 2C5Y/C45-C49 Other specified malignant neoplasms of retroperitoneum, peritoneum or omentum
- 2C5Z/C45-C49 Malignant neoplasms of retroperitoneum, peritoneum or omentum, unspecified
- 2C60/C50-C50 Carcinoma of breast, specialised type
- 2C61.0/C50-C50 Invasive ductal carcinoma of breast
- 2C61.1/C50-C50 Invasive lobular carcinoma of breast
- 2C61.2/C50-C50 Invasive pleomorphic lobular carcinoma of breast
- 2C61.3/C50-C50 Invasive carcinoma of breast with mixed ductal and lobular features
- 2C61.4/C50-C50 Invasive carcinoma of breast, unidentifiable type
- 2C61/C50-C50 Invasive carcinoma of breast
- 2C62/C50-C50 Inflammatory carcinoma of breast
- 2C63/C50-C50 Malignant phyllodes tumour of breast
- 2C64/C50-C50 Solid papillary carcinoma of breast with evidence of invasion
- 2C65/C50 Hereditary breast and ovarian cancer syndrome
- 2C6Y/C50-C50 Other specified malignant neoplasms of breast
- 2C6Z/C50-C50 Malignant neoplasms of breast, unspecified
- 2C70.0/C51 Basal cell carcinoma of vulva
- 2C70.1/C51 Melanoma of vulva
- 2C70.2/C51 Squamous cell carcinoma of vulva
- 2C70/C51 Malignant neoplasms of vulva
- 2C70.Y/C51.8 Other specified malignant neoplasms of vulva
- 2C70.Z/C51 Malignant neoplasms of vulva, unspecified
- 2C71.0/C52 Adenocarcinoma of vagina
- 2C71.1/C52 Melanoma of vagina
- 2C71.2/C52 Squamous cell carcinoma of vagina
- 2C71/C52 Malignant neoplasms of vagina
- 2C71.Y/C52 Other specified malignant neoplasms of vagina
- 2C71.Z/C52 Malignant neoplasms of vagina, unspecified
- 2C72.0/C51-C58 Adenocarcinoma of uterine ligament, parametrium, or uterine adnexa
- 2C72.1/C51-C58 Mucinous or serous carcinoma of uterine ligament, parametrium, or uterine adnexa
- 2C72.3/C51-C58 Carcinosarcomas of uterine ligament, parametrium, or uterine adnexa
- 2C72/C51-C58 Malignant neoplasms of uterine ligament, parametrium, or uterine adnexa
- 2C72.Y/C51-C58 Other specified malignant neoplasms of uterine ligament, parametrium, and uterine adnexa
- 2C72.Z/C51-C58 Malignant neoplasms of uterine ligament, parametrium, or uterine adnexa, unspecified
- 2C73.0/C56 Carcinomas of ovary
- 2C73.00/C56 Clear cell adenocarcinoma of ovary
- 2C73.01/C56 Endometrioid adenocarcinoma of ovary
- 2C73.02/C56 Low grade serous adenocarcinoma of ovary
- 2C73.03/C56 High grade serous adenocarcinoma of ovary
- 2C73.04/C56 Mucinous adenocarcinoma of ovary
- 2C73.0Y/C56 Other specified carcinomas of ovary
- 2C73.0Z/C56 Carcinomas of ovary, unspecified
- 2C73.1/C56 Dysgerminoma of ovary
- 2C73.2/C56 Granulosa cell malignant tumour of ovary
- 2C73.3/C56 Malignant teratoma of ovary
- 2C73.4/C56 Serous cystadenoma, borderline malignancy of ovary
- 2C73.5/C56 Endodermal sinus tumour, unspecified site, female
- 2C73/C56 Malignant neoplasms of ovary
- 2C73.Y/C56 Other specified malignant neoplasms of the ovary
- 2C73.Z/C56 Malignant neoplasms of ovary, unspecified
- 2C74.0/C57.0 Adenocarcinoma of fallopian tube
- 2C74/C57.0 Malignant neoplasms of fallopian tube
- 2C74.Y/C57.0 Other specified malignant neoplasms of fallopian tube
- 2C74.Z/C57.0 Malignant neoplasms of fallopian tube, unspecified
- 2C75.0/C58 Malignant trophoblastic neoplasms of placenta
- 2C75/C58 Malignant neoplasms of placenta
- 2C75.Y/C58 Other specified malignant neoplasms of placenta
- 2C75.Z/C58 Malignant neoplasms of placenta, unspecified
- 2C76.0/C54 Endometrial endometrioid adenocarcinoma
- 2C76.1/C54 Endometrial mucinous adenocarcinoma
- 2C76.2/C54 Endometrial clear cell adenocarcinoma
- 2C76.3/C54 Endometrial serous adenocarcinoma
- 2C76.4/C54 Endometrial mixed adenocarcinoma
- 2C76.40/C54 Endometrial squamous cell carcinoma
- 2C76.41/C54 Endometrial small cell carcinoma
- 2C76.42/C54 Endometrial undifferentiated carcinoma
- 2C76.43/C54 Carcinosarcoma of uterus
- 2C76/C54 Malignant neoplasms of corpus uteri
- 2C76.Y/C54.8 Other specified malignant neoplasms of corpus uteri
- 2C76.Z/C54 Malignant neoplasms of corpus uteri, unspecified
- 2C77.0/C53.9 Squamous cell carcinoma of cervix uteri
- 2C77.1/C53.9 Adenocarcinoma of cervix uteri
- 2C77.2/C53.9 Adenosquamous carcinoma of cervix uteri
- 2C77.3/C53.9 Neuroendocrine carcinoma of cervix uteri
- 2C77/C53.9 Malignant neoplasms of cervix uteri
- 2C77.Y/C53.9 Other specified malignant neoplasms of cervix uteri
- 2C77.Z/C53.9 Malignant neoplasms of cervix uteri, unspecified
- 2C78/C55 Malignant neoplasms of uterus, part not specified
- 2C79/C57.8 Malignant neoplasm involving overlapping sites of female genital organs
- 2C7Y/C51-C58 Other specified malignant neoplasms of female genital organs
- 2C7Z/C51-C58 Malignant neoplasms of female genital organs, unspecified
- 2C80.2/C62.9 Germ cell tumour of testis
- 2C80/C62.9 Malignant neoplasms of testis
- 2C80.Y/C62.9 Other specified malignant neoplasms of testis
- 2C80.Z/C62.9 Malignant neoplasms of testis, unspecified
- 2C81.0/C60 Squamous cell carcinoma of penis
- 2C81.1/C60 Melanoma of penis
- 2C81/C60 Malignant neoplasms of penis
- 2C81.Y/C60.8 Other specified malignant neoplasm of penis
- 2C81.Z/C60 Malignant neoplasms of penis, unspecified
- 2C82.0/C61 Adenocarcinoma of prostate
- 2C82/C61 Malignant neoplasms of prostate
- 2C82.Y/C61 Other specified malignant neoplasms of prostate
- 2C82.Z/C61 Malignant neoplasms of prostate, unspecified
- 2C83.0/C63.2 Squamous cell carcinoma of scrotum
- 2C83/C63.2 Malignant neoplasms of scrotum
- 2C83.Y/C63.2 Other specified malignant neoplasms of scrotum
- 2C83.Z/C63.2 Malignant neoplasms of scrotum, unspecified
- 2C84/C63 Malignant neoplasms of other specified male genital organs
- 2C8Z/C60-C63 Malignant neoplasms of male genital organs, unspecified
- 2C90.0/C64 Renal cell carcinoma of kidney, except renal pelvis
- 2C90/C64 Malignant neoplasms of kidney, except renal pelvis
- 2C90.Y/C64 Other specified malignant neoplasms of kidney, except renal pelvis
- 2C90.Z/C64 Malignant neoplasms of kidney, except renal pelvis, unspecified
- 2C91.0/C65 Urothelial carcinoma of renal pelvis
- 2C91/C65 Malignant neoplasms of renal pelvis
- 2C91.Y/C65 Other specified malignant neoplasms of renal pelvis
- 2C91.Z/C65 Malignant neoplasms of renal pelvis, unspecified
- 2C92.0/C66 Urothelial carcinoma of ureter
- 2C92/C66 Malignant neoplasms of ureter
- 2C92.Y/C66 Other specified malignant neoplasms of ureter
- 2C92.Z/C66 Malignant neoplasms of ureter, unspecified
- 2C93.0/C68 Adenocarcinoma of urethra or paraurethral gland
- 2C93.1/C68 Squamous cell carcinoma of urethra or paraurethral gland
- 2C93.2/C68 Urothelial carcinoma of urethra or paraurethral gland
- 2C93/C68 Malignant neoplasms of urethra or paraurethral gland
- 2C93.Y/C68.8 Other specified malignant neoplasms of urethra and paraurethral gland
- 2C93.Z/C68 Malignant neoplasms of urethra or paraurethral gland, unspecified
- 2C94.0/C67 Adenocarcinoma of bladder
- 2C94.1/C67 Squamous cell carcinoma of bladder
- 2C94.2/C67 Urothelial carcinoma of bladder
- 2C94/C67 Malignant neoplasms of bladder
- 2C94.Y/C67.8 Other specified malignant neoplasms of bladder
- 2C94.Z/C67 Malignant neoplasms of bladder, unspecified
- 2C95.0/C68.8 Adenocarcinoma involving overlapping sites of urinary organs
- 2C95.1/C68.8 Squamous cell carcinomas involving overlapping sites of urinary organs
- 2C95.2/C68.8 Urothelial carcinoma involving overlapping sites of urinary organs
- 2C95/C68.8 Malignant neoplasm involving overlapping sites of urinary organs
- 2C95.Y/C68.8 Other specified malignant neoplasms of overlapping lesion of urinary organs
- 2C95.Z/C68.8 Malignant neoplasm involving overlapping sites of urinary organs, unspecified
- 2C9Y/C64-C68 Other specified malignant neoplasms of urinary tract
- 2C9Z/C64-C68 Malignant neoplasms of urinary tract, unspecified
- 2D00.0/C69.0 Melanoma of conjunctiva
- 2D00.1/C69.0 Malignant neoplasm of caruncle
- 2D00.2/C69.0 Squamous cell carcinoma of conjunctiva
- 2D00/C69.0 Malignant neoplasm of conjunctiva
- 2D00.Y/C69.0 Other specified malignant neoplasm of conjunctiva
- 2D00.Z/C69.0 Malignant neoplasm of conjunctiva, unspecified
- 2D01.0/C69.1 Melanoma of cornea
- 2D01.1/C69.1 Squamous cell carcinoma of cornea
- 2D01/C69.1 Malignant neoplasm of cornea
- 2D01.Y/C69.1 Other specified malignant neoplasms of cornea
- 2D01.Z/C69.1 Malignant neoplasm of cornea, unspecified
- 2D02.0/C69.2 Adenocarcinoma of retinal pigment epithelium
- 2D02.1/C69.2 Malignant neuroepithelial tumours of retina
- 2D02.2/C69.2 Retinoblastoma
- 2D02/C69.2 Malignant neoplasm of retina
- 2D02.Y/C69.2 Other specified malignant neoplasm of retina
- 2D02.Z/C69.2 Malignant neoplasm of retina, unspecified
- 2D03.0/C69.5 Adenocarcinoma of the lacrimal apparatus
- 2D03.1/C69.5 Mucoepidermoid carcinoma of lacrimal apparatus
- 2D03.2/C69.5 Squamous cell carcinoma of the lacrimal apparatus
- 2D03/C69.5 Malignant neoplasm of lacrimal apparatus
- 2D03.Y/C69.5 Other specified malignant neoplasm of lacrimal apparatus
- 2D03.Z/C69.5 Malignant neoplasm of lacrimal apparatus, unspecified
- 2D04/C69.6 Malignant neoplasm of orbit
- 2D05.0/C69.3 Melanoma of choroid
- 2D05/C69.3 Malignant neoplasm of choroid
- 2D05.Y/C69.3 Other specified malignant neoplasm of choroid
- 2D05.Z/C69.3 Malignant neoplasm of choroid, unspecified
- 2D06.0/C69.4 Adenocarcinoma of ciliary epithelium
- 2D06.1/C69.4 Malignant medulloepithelioma of ciliary body
- 2D06.3/C69.4 Malignant neuroepithelial tumours of ciliary body
- 2D06.4/C69.4 Melanoma of ciliary body
- 2D06/C69.4 Malignant neoplasm of ciliary body
- 2D06.Y/C69.4 Other specified malignant neoplasm of ciliary body
- 2D06.Z/C69.4 Malignant neoplasm of ciliary body, unspecified
- 2D07.0/C69 Adenocarcinoma of iris epithelium
- 2D07.1/C69 Malignant neuroepithelial tumours of iris
- 2D07.2/C69 Melanoma of iris
- 2D07/C69 Malignant neoplasm of iris
- 2D07.Y/C69 Other specified malignant neoplasm of iris
- 2D07.Z/C69 Malignant neoplasm of iris, unspecified
- 2D0Y/C69.8 Other specified malignant neoplasms of eye and ocular adnexa
- 2D0Z/C69 Malignant neoplasms of eye or ocular adnexa, unspecified
- 2D10.0/C73 Follicular carcinoma of thyroid gland
- 2D10.1/C73 Papillary carcinoma of thyroid gland
- 2D10.2/C73 Poorly differentiated carcinoma of thyroid gland
- 2D10.3/C73 Undifferentiated carcinoma of thyroid gland
- 2D10.4/C73 Medullary carcinoma of thyroid gland
- 2D10/C73 Malignant neoplasms of thyroid gland
- 2D10.Y/C73 Other specified malignant neoplasms of thyroid gland
- 2D10.Z/C73 Malignant neoplasms of thyroid gland, unspecified
- 2D11.0/C74 Adenocarcinoma of adrenal gland
- 2D11.1/C74 Malignant phaeochromocytoma of adrenal gland
- 2D11.2/C74 Neuroblastoma of adrenal gland
- 2D11/C74 Malignant neoplasms of adrenal gland
- 2D11.Y/C74 Other specified malignant neoplasms of adrenal gland
- 2D11.Z/C74 Malignant neoplasms of adrenal gland, unspecified
- 2D12.0/C75 Malignant epithelial neoplasms of other endocrine glands or related structures, unspecified type
- 2D12.1/C75 Adenocarcinoma of other endocrine glands or related structures
- 2D12/C75 Malignant neoplasms of other endocrine glands or related structures
- 2D12.Y/C75.8 Other specified malignant neoplasms of other endocrine glands or related structures
- 2D12.Z/C75 Malignant neoplasms of other endocrine glands or related structures, unspecified
- 2D1Z/C73-C75 Malignant neoplasms of endocrine glands, unspecified
- 2D3Y/C00-C75 Other specified malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues
- 2D3Z/C00-C75 Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues, unspecified
- 2D40/C80.9 Adenocarcinoma of unspecified site
- 2D41/C80.9 Unspecified carcinoma of unspecified site
- 2D42/C76.7 Malignant neoplasms of ill-defined sites
- 2D43/C97-C97 Malignant neoplasms of independent, multiple primary sites
- 2D4Y/C80.9 Other specified malignant neoplasms of ill-defined or unspecified primary sites
- 2D4Z/C80.9 Unspecified malignant neoplasms of ill-defined or unspecified sites
- 2D50/C79.3 Malignant neoplasm metastasis in brain
- 2D51/C79.3 Malignant neoplasm metastasis in meninges
- 2D52/C79.4 Malignant neoplasm metastasis in spinal cord, cranial nerves or remaining parts of central nervous system
- 2D60.0/C77.0 Malignant neoplasm metastasis in lymph nodes of head, face or neck
- 2D60.1/C77.1 Malignant neoplasm metastasis in intrathoracic lymph nodes
- 2D60.2/C77.2 Malignant neoplasm metastasis in intra-abdominal lymph nodes
- 2D60.3/C77.3 Malignant neoplasm metastasis in axillary lymph nodes
- 2D60.4/C77.4 Malignant neoplasm metastasis in inguinal lymph nodes
- 2D60.5/C77.5 Malignant neoplasm metastasis in intrapelvic lymph nodes
- 2D60/C77 Malignant neoplasm metastasis in lymph node of a single region
- 2D60.Y/C77 Other specified malignant neoplasm metastasis in lymph node of a single region
- 2D60.Z/C77 Malignant neoplasm metastasis in lymph node of a single region, unspecified
- 2D61/C77.8 Malignant neoplasm metastases in lymph nodes of multiple regions
- 2D6Z/C77 Metastatic malignant neoplasm to unspecified lymph node
- 2D70/C78.0 Malignant neoplasm metastasis in lung
- 2D71/C78.1 Malignant neoplasm metastasis in mediastinum
- 2D72/C78.2 Malignant neoplasm metastasis in pleura
- 2D73/C78.3 Malignant neoplasm metastasis in upper respiratory tract organs
- 2D7Y/C78.8 Malignant neoplasm metastasis in other specified thoracic organs
- 2D7Z/C78 Malignant neoplasm metastasis in thoracic or respiratory organs, unspecified
- 2D80.0/C78.7 Malignant neoplasm metastasis in liver
- 2D80.1/C78.7 Malignant neoplasm metastasis in intrahepatic bile duct
- 2D80/C78.7 Malignant neoplasm metastasis in liver or intrahepatic bile duct
- 2D80.Y/C78.7 Malignant neoplasm metastasis in liver or intrahepatic bile duct, other specified site
- 2D80.Z/C78.7 Malignant neoplasm metastasis in liver or intrahepatic bile duct, unspecified site
- 2D81/C76-C80 Malignant neoplasm metastasis in pancreas
- 2D82/C76-C80 Malignant neoplasm metastasis in extrahepatic bile ducts
- 2D83/C76-C80 Malignant neoplasm metastasis in ampulla of Vater
- 2D84/C78.4 Malignant neoplasm metastasis in the small intestine
- 2D85/C78.5 Malignant neoplasm metastasis in large intestine
- 2D86/C76-C80 Malignant neoplasm metastasis in anus
- 2D8Y/C76-C80 Malignant neoplasm metastasis in other specified digestive system organ
- 2D8Z/C76-C80 Malignant neoplasm metastasis in unspecified digestive system organ
- 2D90/C78.6 Malignant neoplasm metastasis in retroperitoneum
- 2D91/C78.6 Malignant neoplasm metastasis in peritoneum
- 2E00/C79.0 Malignant neoplasm metastasis in kidney or renal pelvis
- 2E01/C79.1 Malignant neoplasm metastasis in bladder
- 2E02/C76-C80 Malignant neoplasm metastasis in other or unspecified urinary system organs
- 2E03/C79.5 Malignant neoplasm metastasis in bone or bone marrow
- 2E04/C76-C80 Malignant neoplasm metastasis in soft tissue
- 2E05.0/C79.6 Malignant neoplasm metastasis in ovary
- 2E05/C76-C80 Malignant neoplasm metastasis in female reproductive system
- 2E05.Y/C76-C80 Malignant neoplasm metastasis in other female reproductive system organs
- 2E05.Z/C76-C80 Malignant neoplasm metastasis in female reproductive system, unspecified
- 2E06/C76-C80 Malignant neoplasm metastasis in male genital organs
- 2E07/C79.7 Malignant neoplasm metastasis in adrenal gland
- 2E08/C79.2 Metastatic malignant neoplasm involving skin
- 2E09/C79.4 Malignant neoplasm metastasis in peripheral nervous system
- 2E0Y/C76-C80 Malignant neoplasm metastasis in other specified sites
- 2E2Z/C76-C80 Malignant neoplasm metastasis, unspecified
- 2E60.0/D00.0 Carcinoma in situ of lip, oral cavity or pharynx
- 2E60.1/D00.1 Carcinoma in situ of oesophagus
- 2E60.2/D00.2 Carcinoma in situ of stomach
- 2E60/D00 Carcinoma in situ of oral cavity, oesophagus or stomach
- 2E61.0/D01.0 Carcinoma in situ of colon
- 2E61.1/D01.2 Carcinoma in situ of rectum
- 2E61.2/D01.3 Carcinoma in situ of anal canal
- 2E61.3/D01.5 Carcinoma in situ of gallbladder, biliary tract or ampulla of Vater
- 2E61/D01 Carcinoma in situ of other or unspecified digestive organs
- 2E61.Y/D01 Carcinoma in situ of other specified digestive organs
- 2E61.Z/D01 Carcinoma in situ of unspecified digestive organs
- 2E62.0/D02.0 Carcinoma in situ of larynx
- 2E62.1/D02.1 Carcinoma in situ of trachea
- 2E62.2/D02.2 Carcinoma in situ of bronchus or lung
- 2E62/D02 Carcinoma in situ of middle ear or respiratory system
- 2E62.Y/D02 Carcinoma in situ of other specified sites of middle ear and respiratory system
- 2E62.Z/D02 Carcinoma in situ of unspecified sites of middle ear and respiratory system
- 2E63.0/D03.9 Melanoma in situ of skin
- 2E63.00/D03.9 Lentigo maligna
- 2E63.0Z/D03.9 Melanoma in situ of skin, unspecified
- 2E63.1/D03.9 Melanoma in situ of conjunctiva
- 2E63/D03.9 Melanoma in situ neoplasms
- 2E63.Y/D03.9 Melanoma in situ neoplasms, other specified site
- 2E63.Z/D03.9 Melanoma in situ neoplasms, unspecified site
- 2E64.0/D04.9 Intraepidermal squamous cell carcinoma
- 2E64.00/D04.9 Bowen disease of skin
- 2E64.01/D04.9 Actinic intraepidermal squamous cell carcinoma
- 2E64.0Y/D04.9 Other specified intraepidermal squamous cell carcinoma
- 2E64.0Z/D04.9 Intraepidermal squamous cell carcinoma, unspecified
- 2E64.1/D04.9 Extramammary Paget disease of skin
- 2E64.2/D04.9 Carcinoma in situ of anal margin or perianal skin
- 2E64/D04.9 Carcinoma in situ of skin
- 2E64.Y/D04.9 Other specified carcinoma in situ of skin
- 2E64.Z/D04.9 Carcinoma in situ of skin, unspecified
- 2E65.0/D05.0 Lobular carcinoma in situ of breast
- 2E65.1/D05 Lobular carcinoma in situ of breast, pleomorphic subtype
- 2E65.2/D05.1 Ductal carcinoma in situ of breast
- 2E65.3/D05 Ductal carcinoma in situ of breast, comedo subtype
- 2E65.4/D05 Mixed ductal and lobular carcinoma in situ of breast
- 2E65.5/D05 Paget disease of nipple
- 2E65/D05 Carcinoma in situ of breast
- 2E65.Y/D05 Other specified carcinoma in situ of breast
- 2E65.Z/D05 Carcinoma in situ of breast, unspecified
- 2E66.2/D06 High grade squamous intraepithelial lesion of cervix uteri
- 2E66/D06 Carcinoma in situ of cervix uteri
- 2E66.Y/D06 Other specified carcinoma in situ of cervix uteri
- 2E66.Z/D06 Carcinoma in situ of cervix uteri, unspecified
- 2E67.0/D07.0 Carcinoma in situ of endometrium
- 2E67.1/D07.1 Carcinoma in situ of vulva
- 2E67.11/D07.1 Vulvar Paget disease
- 2E67.12/D07.1 Vulvar intraepithelial neoplasia, HPV-independent
- 2E67.13/D07.1 High grade squamous intraepithelial lesion of vulva , HPV-associated
- 2E67.2/D07.2 Carcinoma in situ of vagina
- 2E67.22/D07.2 High grade squamous intraepithelial lesion of vagina
- 2E67.2Y/D07.2 Other specified carcinoma in situ of vagina
- 2E67.2Z/D07.2 Carcinoma in situ of vagina, unspecified
- 2E67.3/D07.3 Carcinoma in situ of other or unspecified female genital organs
- 2E67.4/D07.4 Carcinoma in situ of penis
- 2E67.40/D07.4 Squamous cell carcinoma in situ of skin of penis
- 2E67.41/D07.4 Squamous cell carcinoma in situ of mucocutaneous epithelium of penis
- 2E67.5/D07.5 High grade intraepithelial lesion of prostate
- 2E67.6/D07.6 Carcinoma in situ of other or unspecified male genital organs
- 2E67/D07 Carcinoma in situ of other or unspecified genital organs
- 2E68/D09.0 Carcinoma in situ of bladder
- 2E69/D09.1 Carcinoma in situ of other or unspecified urinary organs
- 2E6A.0/D09.9 Carcinoma in situ of the conjunctiva
- 2E6A.1/D09.9 Carcinoma in situ of the cornea
- 2E6A/D09.9 Carcinoma in situ of the eye or ocular adnexa
- 2E6A.Y/D09.9 Carcinoma in situ of other and unspecified part of the eye and adnexa
- 2E6B/D09.3 Carcinoma in situ of thyroid and other endocrine glands
- 2E6Y/D09.9 Carcinoma in situ of other specified site
- 2E6Z/D09.9 Carcinoma in situ of unspecified site
- 2E80.0/D17 Lipoma
- 2E80.00/D17 Superficial subcutaneous lipoma
- 2E80.01/D17 Deep subfascial lipoma
- 2E80.02/D17 Deep internal or visceral lipoma
- 2E80.0Y/D17 Lipoma, other specified site
- 2E80.0Z/D17 Lipoma, unspecified site
- 2E80.1/D17 Lipoblastoma
- 2E80/D17 Benign lipomatous neoplasm
- 2E80.Y/D17 Other specified benign lipomatous neoplasm
- 2E80.Z/D17 Benign lipomatous neoplasm, unspecified
- 2E81.0/D18.0 Neoplastic haemangioma
- 2E81.00/D18.0 Umbilical cord haemangioma
- 2E81.01/D18.0 Conjunctival haemangioma or haemolymphangioma
- 2E81.0Y/D18.0 Neoplastic haemangioma of other specified site
- 2E81.0Z/D18.0 Neoplastic haemangioma, unspecified site
- 2E81.1/D18.1 Benign lymphatic neoplasms
- 2E81.10/D18.1 Disseminated lymphangiomatosis
- 2E81.11/D18.1 Acquired progressive lymphangioma
- 2E81.1Y/D18.1 Other specified benign lymphatic neoplasms
- 2E81.1Z/D18.1 Benign lymphatic neoplasms, unspecified
- 2E81.2/D18 Benign vascular neoplasms of infancy and childhood
- 2E81.20/D18 Focal infantile haemangioma
- 2E81.21/D18 Multifocal infantile haemangioma
- 2E81.2Y/D18 Other specified benign vascular neoplasms of infancy and childhood
- 2E81.2Z/D18 Benign vascular neoplasms of infancy and childhood, unspecified
- 2E81/D18 Benign vascular neoplasms
- 2E81.Y/D18 Other specified benign vascular neoplasms
- 2E81.Z/D18 Benign vascular neoplasms, unspecified
- 2E82.0/D10-D36 Benign chondrogenic tumours of bone or articular cartilage of limbs
- 2E82.1/D10-D36 Benign chondrogenic tumours of bone or articular cartilage of other specified sites
- 2E82/D10-D36 Benign chondrogenic tumours
- 2E82.Z/D10-D36 Benign chondrogenic tumours, site unspecified
- 2E83.0/D16.4 Benign osteogenic tumours of bone or articular cartilage of skull or face
- 2E83.1/D16.5 Benign osteogenic tumours of bone or articular cartilage of lower jaw
- 2E83.2/D16.6 Benign osteogenic tumours of bone or articular cartilage of vertebral column
- 2E83.3/D16.7 Benign osteogenic tumours of bone or articular cartilage of ribs, sternum or clavicle
- 2E83.4/D16.8 Benign osteogenic tumours of bone or articular cartilage of pelvic bones, sacrum or coccyx
- 2E83.5/D16 Benign osteogenic tumours of bone or articular cartilage of limbs
- 2E83/D16 Benign osteogenic tumours
- 2E83.Y/D16.8 Benign osteogenic tumour of other specified site
- 2E83.Z/D16 Benign osteogenic tumour of unspecified site
- 2E84.0/D10-D36 Benign fibrogenic or myofibrogenic tumour of skin
- 2E84/D10-D36 Benign fibrogenic or myofibrogenic tumour
- 2E84.Y/D10-D36 Benign fibrogenic or myofibrogenic tumour of other specified sites
- 2E84.Z/D10-D36 Benign fibrogenic or myofibrogenic tumour, site unknown
- 2E85.0/D21 Benign fibrohistiocytic tumour of soft tissues of limbs
- 2E85.1/D20 Benign fibrohistiocytic tumour of retroperitoneum or peritoneum
- 2E85.2/D10-D36 Benign fibrohistiocytic tumour of skin
- 2E85/D10-D36 Benign fibrohistiocytic tumour
- 2E85.Y/D10-D36 Benign fibrohistiocytic tumour of other specified sites
- 2E85.Z/D10-D36 Benign fibrohistiocytic tumour, site unspecified
- 2E86.0/D25.9 Leiomyoma of uterus
- 2E86.1/D21.9 Leiomyoma of other or unspecified sites
- 2E86.2/D21.9 Rhabdomyoma
- 2E86/D10-D36 Benign smooth muscle or skeletal muscle tumour
- 2E86.Y/D10-D36 Other specified benign smooth muscle or skeletal muscle tumour
- 2E86.Z/D10-D36 Benign smooth muscle or skeletal muscle tumour, unspecified
- 2E87/D10-D36 Benign gastrointestinal stromal tumour
- 2E88/D10-D36 Benign endometrial stromal nodule
- 2E89.0/D16 Benign tumours of uncertain differentiation, bone or cartilage
- 2E89.1/D21.9 Benign tumours of uncertain differentiation, soft tissue
- 2E89/D10-D36 Benign mesenchymal tumours of uncertain differentiation
- 2E89.Y/D10-D36 Benign mesenchymal tumours of uncertain differentiation of other specified site
- 2E89.Z/D10-D36 Benign mesenchymal tumours of uncertain differentiation of unspecified site
- 2E8A/D10-D36 Other mixed or unspecified benign mesenchymal tumours
- 2E8Y/D10-D36 Other specified benign mesenchymal neoplasm
- 2E8Z/D10-D36 Benign mesenchymal neoplasms, unspecified
- 2E90.0/D10.0 Benign neoplasm of lip
- 2E90.1/D10.1 Benign neoplasm of tongue
- 2E90.2/D10.2 Benign neoplasm of floor of mouth
- 2E90.3/D10.3 Benign neoplasm of other or unspecified parts of mouth
- 2E90.4/D10.4 Benign neoplasm of tonsil
- 2E90.5/D10.5 Benign neoplasm of oropharynx
- 2E90.6/D10.6 Benign neoplasm of nasopharynx
- 2E90.7/D10.7 Benign neoplasm of hypopharynx
- 2E90.8/D10.9 Benign neoplasm of pharynx, unspecified
- 2E90/D10 Benign neoplasm of lip, oral cavity or pharynx
- 2E91.0/D11.0 Benign neoplasm of parotid gland
- 2E91.1/D11.7 Benign neoplasm of other specified major salivary glands
- 2E91/D11 Benign neoplasm of major salivary glands
- 2E91.Z/D11 Benign neoplasm of unspecified major salivary glands
- 2E92.0/D13 Benign neoplasm of oesophagus
- 2E92.1/D13.1 Benign neoplasm of stomach
- 2E92.2/D13.2 Benign neoplasm of duodenum
- 2E92.3/D13 Benign neoplasm of other or unspecified parts of small intestine
- 2E92.4/D12 Benign neoplasm of the large intestine
- 2E92.40/D12.6 Polyposis syndrome
- 2E92.4Y/D12.8 Other specified benign neoplasm of the large intestine
- 2E92.4Z/D12 Benign neoplasm of the large intestine, unspecified
- 2E92.5/D12.9 Benign neoplasm of anus or anal canal
- 2E92.6/D13.5 Benign neoplasm of gallbladder, extrahepatic bile ducts or ampulla of Vater
- 2E92.7/D13.4 Benign neoplasm of liver or intrahepatic bile ducts
- 2E92.8/D13.6 Benign neoplasm of pancreas
- 2E92.9/D13.7 Benign neoplasm of endocrine pancreas
- 2E92.A/D13.9 Benign neoplasm of ill-defined site within the digestive system
- 2E92/D13 Benign neoplasm of digestive organs
- 2E92.Y/D13 Benign neoplasm of other specified digestive organs
- 2E92.Z/D13 Benign neoplasm of unspecified digestive organs
- 2F00.0/D14.0 Middle ear endocrine tumour
- 2F00.1/D14 Recurrent respiratory papillomatosis
- 2F00.2/D14.1 Laryngeal endocrine tumour
- 2F00/D14 Benign neoplasm of middle ear or respiratory system
- 2F00.Y/D14 Other specified benign neoplasm of middle ear or respiratory system
- 2F00.Z/D14 Benign neoplasm of middle ear or respiratory system, unspecified
- 2F01/D15 Benign neoplasm of intrathoracic organs
- 2F0Y/D15.7 Benign neoplasms of other specified respiratory and intrathoracic organs
- 2F0Z/D15.7 Benign neoplasms of unspecified respiratory and intrathoracic organs
- 2F10/D19 Benign neoplasm of mesothelial tissue
- 2F20.0/D22 Common acquired melanocytic naevus
- 2F20.00/D22 Multiple benign melanocytic naevi
- 2F20.0Y/D22 Other specified common acquired melanocytic naevus
- 2F20.1/D22 Atypical melanocytic naevus
- 2F20.2/D22 Congenital melanocytic naevus
- 2F20.20/D22 Giant congenital melanocytic naevus
- 2F20.2Y/D22 Other specified congenital melanocytic naevus
- 2F20.2Z/D22 Congenital melanocytic naevus, unspecified
- 2F20.3/D22 Generalised eruptive melanocytic naevi
- 2F20/D22 Benign cutaneous melanocytic neoplasms
- 2F20.Y/D22 Other specific types of melanocytic naevus
- 2F20.Z/D22 Melanocytic naevus, unspecified
- 2F21.0/L82 Seborrhoeic keratosis
- 2F21/D23 Benign keratinocytic acanthomas
- 2F21.Y/D23 Other specified benign keratinocytic acanthomas
- 2F22/D23 Benign neoplasms of epidermal appendages
- 2F23.0/D23 Dermatofibroma
- 2F23/D23 Benign dermal fibrous or fibrohistiocytic neoplasms
- 2F23.Y/D23 Other specified benign dermal fibrous or fibrohistiocytic neoplasms
- 2F24/D23 Benign cutaneous neoplasms of neural or nerve sheath origin
- 2F25/D18.0 Cherry angioma
- 2F26/L98.0 Lobular capillary haemangioma
- 2F2Y/D23 Other specified benign cutaneous neoplasms
- 2F2Z/D23 Benign cutaneous neoplasm of unspecified type
- 2F30.0/D24 Tubular adenoma of breast
- 2F30.1/D24 Lactating adenoma of breast
- 2F30.2/D24 Intraductal papilloma of breast
- 2F30.3/D24 Benign phyllodes tumour of breast
- 2F30.4/D24 Fibromatosis of breast
- 2F30.5/D24 Fibroadenoma of breast
- 2F30.6/D24 Extensive adenomatosis of nipple
- 2F30/D24 Benign neoplasm of breast
- 2F30.Y/D24 Other specified benign neoplasm of breast
- 2F30.Z/D24 Benign neoplasm of breast, unspecified
- 2F31.0/D26.0 Benign non-mesenchymal neoplasm of uterus, cervix uteri
- 2F31.1/D26.1 Benign non-mesenchymal neoplasm of uterus, corpus uteri
- 2F31.2/D26.7 Benign non-mesenchymal neoplasms of uterus, other parts
- 2F31/D26 Benign non-mesenchymal neoplasms of uterus
- 2F32.0/D27 Cystic teratoma
- 2F32.1/D27 Ovarian fibroma
- 2F32.2/D27 Meigs’ Syndrome
- 2F32.3/D27 Serous ovarian cystadenoma
- 2F32/D27 Benign neoplasm of ovary
- 2F32.Y/D27 Other specified benign neoplasm of ovary
- 2F32.Z/D27 Benign neoplasm of ovary, unspecified
- 2F33/D28.9 Benign neoplasm of other or unspecified female genital organs
- 2F34/D29.7 Benign neoplasm of male genital organs
- 2F35/D30.9 Benign neoplasm of urinary organs
- 2F36.0/D31.3 Benign neoplasm of choroid
- 2F36.1/D31 Benign neoplasm of iris
- 2F36.2/D31.4 Benign neoplasm of ciliary body
- 2F36.3/D31.6 Teratoma of orbit
- 2F36.4/D23.1 Cysts of eyelid
- 2F36/D31 Benign neoplasm of eye or ocular adnexa
- 2F36.Y/D31 Other specified benign neoplasm of eye or ocular adnexa
- 2F36.Z/D31 Benign neoplasm of eye or ocular adnexa, unspecified
- 2F37.0/D35.9 Non-secreting pituitary adenoma
- 2F37/D35.9 Benign neoplasm of endocrine glands
- 2F37.Y/D35.9 Other specified benign neoplasm of endocrine glands
- 2F37.Z/D35.9 Benign neoplasm of endocrine glands, unspecified
- 2F3Y/D10-D36 Benign non-mesenchymal neoplasms of other specified site
- 2F3Z/D10-D36 Benign non-mesenchymal neoplasms of unspecified site
- 2F5Y/D10-D36 Other specified benign neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues
- 2F5Z/D10-D36 Benign neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues, unspecified
- 2F70.0/D37.0 Neoplasms of uncertain behaviour of lip, oral cavity or pharynx
- 2F70.1/D37.1 Neoplasms of uncertain behaviour of stomach
- 2F70.2/D37.2 Neoplasms of uncertain behaviour of small intestine
- 2F70.3/D37.4 Neoplasms of uncertain behaviour of colon
- 2F70.4/D37.5 Neoplasms of uncertain behaviour of rectum
- 2F70.5/D37.6 Neoplasms of uncertain behaviour of liver, gallbladder or bile ducts
- 2F70/D37 Neoplasms of uncertain behaviour of oral cavity or digestive organs
- 2F70.Y/D37 Neoplasms of uncertain behaviour of oral cavity and digestive organs, other specified site
- 2F70.Z/D37 Neoplasms of uncertain behaviour of oral cavity and digestive organs, unspecified site
- 2F71.0/D38.4 Neoplasms of uncertain behaviour of thymus
- 2F71.1/D38.0 Neoplasms of uncertain behaviour of larynx
- 2F71.2/D38.2 Neoplasms of uncertain behaviour of pleura
- 2F71.3/D38.1 Neoplasms of uncertain behaviour of trachea, bronchus or lung
- 2F71.4/D38.3 Neoplasms of uncertain behaviour of mediastinum
- 2F71/D37-D48 Neoplasms of uncertain behaviour of middle ear, respiratory or intrathoracic organs
- 2F71.Y/D37-D48 Neoplasms of uncertain behaviour of middle ear, respiratory and intrathoracic organs, other specified site
- 2F71.Z/D37-D48 Neoplasms of uncertain behaviour of middle ear, respiratory and intrathoracic organs, unspecified site
- 2F72.1/D48.5 Spitzoid tumour of uncertain malignant potential
- 2F72.2/D48.5 Melanocytic naevus with severe melanocytic dysplasia
- 2F72/D48.5 Neoplasms of uncertain behaviour of skin
- 2F72.Y/D48.5 Other specified neoplasms of uncertain behaviour of skin
- 2F73/D48.3 Neoplasms of uncertain behaviour of retroperitoneum
- 2F74/D48.4 Neoplasms of uncertain behaviour of peritoneum
- 2F75/D48.6 Neoplasms of uncertain behaviour of breast
- 2F76/D37-D48 Neoplasms of uncertain behaviour of female genital organs
- 2F77/D37-D48 Neoplasms of uncertain behaviour of male genital organs
- 2F78/D37-D48 Neoplasms of uncertain behaviour of urinary organs
- 2F79/D37-D48 Neoplasms of uncertain behaviour of eye or ocular adnexa
- 2F7A.0/D37-D48 Multiple polyglandular tumours
- 2F7A/D37-D48 Neoplasms of uncertain behaviour of endocrine glands
- 2F7A.Y/D37-D48 Other specified neoplasms of uncertain behaviour of endocrine glands
- 2F7A.Z/D37-D48 Neoplasms of uncertain behaviour of endocrine glands, unspecified
- 2F7B/D48.0 Neoplasms of uncertain behaviour of bone or articular cartilage
- 2F7C/D48.1 Neoplasms of uncertain behaviour of connective or other soft tissue
- 2F7Y/D37-D48 Neoplasms of uncertain behaviour of other specified site
- 2F7Z/D37-D48 Neoplasms of uncertain behaviour of unspecified site
- 2F90.0/D37.4 Neoplasms of unknown behaviour of colon
- 2F90.1/D37.5 Neoplasms of unknown behaviour of rectum
- 2F90/D37-D48 Neoplasms of unknown behaviour of oral cavity or digestive organs
- 2F90.Y/D37-D48 Neoplasms of unknown behaviour of oral cavity and digestive organs, other specified site
- 2F90.Z/D37-D48 Neoplasms of unknown behaviour of oral cavity and digestive organs, unspecified site
- 2F91.0/D38.0 Neoplasms of unknown behaviour of larynx
- 2F91.1/D38.1 Neoplasms of unknown behaviour of trachea, bronchus or lung
- 2F91/D38 Neoplasms of unknown behaviour of middle ear, respiratory or intrathoracic organs
- 2F91.Y/D38 Neoplasms of unknown behaviour of other specified middle ear, respiratory or intrathoracic organ
- 2F92/D48.5 Neoplasms of unknown behaviour of skin
- 2F93/D48.3 Neoplasms of unknown behaviour of retroperitoneum
- 2F94/D48.4 Neoplasms of unknown behaviour of peritoneum
- 2F95/D48.6 Neoplasms of unknown behaviour of breast
- 2F96/D39 Neoplasms of unknown behaviour of female genital organs
- 2F97/D40 Neoplasms of unknown behaviour of male genital organs
- 2F98/D41 Neoplasms of unknown behaviour of urinary organs
- 2F99/D37-D48 Neoplasms of unknown behaviour of eye or ocular adnexa
- 2F9A/D44 Neoplasms of unknown behaviour of endocrine glands
- 2F9B/D48.0 Neoplasms of unknown behaviour of bone or articular cartilage
- 2F9C/D48.1 Neoplasms of unknown behaviour of connective or other soft tissue
- 2F9Y/D37-D48 Neoplasms of unknown behaviour of other specified site
- 2F9Z/D37-D48 Neoplasms of unknown behaviour of unspecified site
- 3A00.0/D50.0 Acquired iron deficiency anaemia due to blood loss
- 3A00.01/D50.0 Chronic posthaemorrhagic anaemia
- 3A00.0Z/D50.0 Acquired iron deficiency anaemia due to blood loss, unspecified
- 3A00.1/D50 Acquired iron deficiency anaemia due to low intake
- 3A00.2/D50 Acquired iron deficiency anaemia due to decreased absorption
- 3A00.3/D50 Acquired iron deficiency anaemia due to increased requirement
- 3A00/D50.9 Iron deficiency anaemia
- 3A00.Y/D50.9 Other specified iron deficiency anaemia
- 3A00.Z/D50.9 Iron deficiency anaemia, unspecified
- 3A01.0/D51.8 Hereditary Vitamin B12 deficiency anaemia
- 3A01.1/D51.8 Neonatal vitamin B12 deficiency anaemia
- 3A01.2/D51.8 Vitamin B12 deficiency anaemia due to low intake
- 3A01.3/D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency
- 3A01.30/D51.0 Pernicious anaemia
- 3A01.3Y/D51.0 Other specified vitamin B12 deficiency anaemia due to intrinsic factor deficiency
- 3A01.4/D51.8 Vitamin B12 deficiency anaemia due to intestinal disease
- 3A01.5/D51.8 Drug-induced vitamin B12 deficiency anaemia
- 3A01/D51 Megaloblastic anaemia due to vitamin B12 deficiency
- 3A01.Y/D51.8 Other specified megaloblastic anaemia due to vitamin B12 deficiency
- 3A01.Z/D51 Megaloblastic anaemia due to vitamin B12 deficiency, unspecified
- 3A02.0/D52.8 Hereditary folate deficiency anaemia
- 3A02.1/D52.0 Folate deficiency anaemia due to low intake
- 3A02.2/D52.8 Folate deficiency anaemia due to increased requirements
- 3A02.3/D52 Folate deficiency anaemia due to decreased intestinal absorption
- 3A02.4/D52.1 Drug-induced folate deficiency anaemia
- 3A02/D52.9 Folate deficiency anaemia
- 3A02.Y/D52.9 Other specified folate deficiency anaemia
- 3A02.Z/D52.9 Folate deficiency anaemia, unspecified
- 3A03.0/D53 Hereditary orotic aciduria
- 3A03.1/D53.0 Protein deficiency anaemia
- 3A03.2/D53.2 Scorbutic anaemia
- 3A03.3/D53.8 Copper deficiency anaemia
- 3A03.4/D53.8 Acquired other vitamin B deficiency anaemia
- 3A03.40/D53.8 Acquired pyridoxine deficiency anaemia
- 3A03.41/D53.8 Acquired riboflavin deficiency anaemia
- 3A03.42/D53.8 Acquired thiamine deficiency anaemia
- 3A03.4Y/D53.8 Other specified acquired other vitamin B deficiency anaemia
- 3A03.5/D53.8 Acquired vitamin A deficiency anaemia
- 3A03.6/D53.8 Acquired vitamin E deficiency anaemia
- 3A03/D50-D53 Other nutritional or metabolic anaemias
- 3A03.Y/D50-D53 Other and unspecified nutritional or metabolic anaemia
- 3A10.0/D55.1 Haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies
- 3A10.00/D55.0 Haemolytic anaemia due to glucose-6-phosphate dehydrogenase deficiency
- 3A10.0Y/D55.1 Other specified haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies
- 3A10.0Z/D55.1 Haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies, unspecified
- 3A10.1/D55.3 Haemolytic anaemia due to adenosine deaminase excess
- 3A10.2/D58.1 Hereditary elliptocytosis
- 3A10.3/D58.8 Familial pseudohyperkalaemia
- 3A10/D55-D59 Hereditary haemolytic anaemia
- 3A10.Y/D55-D59 Other specified hereditary haemolytic anaemia
- 3A10.Z/D55-D59 Hereditary haemolytic anaemia, unspecified
- 3A1Y/D55-D59 Other specified congenital haemolytic anaemia
- 3A20.0/D59.1 Autoimmune haemolytic anaemia, warm type
- 3A20.1/D59 Autoimmune haemolytic anaemia, cold type
- 3A20.2/D59 Autoimmune haemolytic anaemia, mixed type, cold and warm
- 3A20.3/D59 Paroxysmal cold haemoglobinuria
- 3A20.4/D59 Alloimmune haemolytic anaemia
- 3A20.5/D59 Evans syndrome
- 3A20/D59 Acquired haemolytic anaemia, immune
- 3A20.Y/D59 Other specified acquired haemolytic anaemia, immune
- 3A21.0/D59.5 Paroxysmal nocturnal haemoglobinuria
- 3A21.1/D59 Microangiopathic haemolytic anaemia
- 3A21.2/D59.3 Haemolytic uraemic syndrome
- 3A21/D59 Acquired haemolytic anaemia, non-immune
- 3A21.Y/D59 Other specified acquired haemolytic anaemia, non-immune
- 3A2Z/D59 Acquired haemolytic anaemia, unspecified
- 3A4Z/D55-D59 Haemolytic anaemias, unspecified
- 3A50.0/D56.0 Alpha thalassaemia
- 3A50.00/D56.3 Mild alpha thalassaemia diseases
- 3A50.01/D56.0 Thalassaemic alpha-chain variants
- 3A50.02/D56.0 Haemoglobin H disease (– α/– – included)
- 3A50.03/D56.0 Homozygous or compound heterozygous alpha0 thalassaemia
- 3A50.0Y/D56.0 Other specified alpha thalassaemia
- 3A50.0Z/D56.0 Alpha thalassaemia, unspecified
- 3A50.1/D56 Alpha thalassaemia related syndromes
- 3A50.2/D56.1 Beta thalassaemia
- 3A50.3/D56.2 Delta, delta-beta or gamma-delta-beta thalassaemia
- 3A50.4/D56.4 Hereditary persistence of fetal haemoglobin
- 3A50/D56 Thalassaemias
- 3A50.Y/D56.8 Other specified thalassaemias
- 3A50.Z/D56 Thalassaemias, unspecified
- 3A51.0/D57.3 Sickle cell trait
- 3A51.1/D57.1 Sickle cell disease without crisis
- 3A51.2/D57.0 Sickle cell disease with crisis
- 3A51.3/D57.2 Compound heterozygous sickling disorders without crisis
- 3A51.4/D57 Compound heterozygous sickling disorders with crisis
- 3A51.5/D57 Haemoglobin C disease
- 3A51.6/D57 Haemoglobin D disease
- 3A51.7/D57 High affinity haemoglobin
- 3A51.8/D57 Low affinity haemoglobin
- 3A51.9/D57 Haemoglobin O disease
- 3A51.A/D57 Haemoglobin E disease
- 3A51.B/D57 Haemoglobin C/beta thalassaemia compound heterozygosity
- 3A51/D57 Sickle cell disorders or other haemoglobinopathies
- 3A51.Y/D57.8 Other specified sickle cell disorders or other haemoglobinopathies
- 3A51.Z/D57 Sickle cell disorders or other haemoglobinopathies, unspecified
- 3A60.0/D61.0 Congenital non-inherited pure red cell aplasia
- 3A60.1/D61.0 Hereditary pure red cell aplasia
- 3A60/D61.0 Congenital pure red cell aplasia
- 3A60.Z/D61.0 Congenital pure red cell aplasia, unspecified
- 3A61.0/D60.1 Acute acquired pure red cell aplasia
- 3A61.1/D60.0 Chronic acquired pure red cell aplasia
- 3A61/D60 Acquired pure red cell aplasia
- 3A61.Y/D60.8 Other specified acquired pure red cell aplasia
- 3A61.Z/D60 Acquired pure red cell aplasia, unspecified
- 3A6Z/D64.9 Pure red cell aplasia, unspecified
- 3A70.0/D61.0 Congenital aplastic anaemia
- 3A70.1/D61 Acquired aplastic anaemias
- 3A70.10/D61.1 Drug-induced aplastic anaemia
- 3A70.11/D61.2 Aplastic anaemia due to other external agents
- 3A70.12/D61.3 Idiopathic aplastic anaemia
- 3A70.1Y/D61.8 Other specified acquired aplastic anaemias
- 3A70.1Z/D61 Acquired aplastic anaemias, unspecified
- 3A70/D64.9 Aplastic anaemia
- 3A70.Z/D64.9 Aplastic anaemia, unspecified
- 3A71.0/D63 Anaemia in neoplastic disease
- 3A71.1/D63 Anaemia in chronic infectious diseases
- 3A71.2/D63 Anaemia in chronic kidney disease
- 3A71/D63 Anaemia due to chronic disease
- 3A71.Y/D63.8 Anaemia due to other specified chronic disease
- 3A71.Z/D63 Anaemia due to chronic disease, unspecified
- 3A72.0/D64 Congenital sideroblastic anaemias
- 3A72.00/D64.0 Hereditary sideroblastic anaemias
- 3A72.01/D64.0 Hereditary syndromic sideroblastic anaemia
- 3A72.0Y/D64 Other specified congenital sideroblastic anaemias
- 3A72.0Z/D64 Congenital sideroblastic anaemias, unspecified
- 3A72.1/D64 Acquired sideroblastic anaemias
- 3A72/D64 Sideroblastic anaemia
- 3A72.Z/D64 Sideroblastic anaemia, unspecified
- 3A73/D64.4 Congenital dyserythropoietic anaemia
- 3A80.0/D75.0 Primary inherited erythrocytosis
- 3A80/D75.0 Congenital polycythaemia
- 3A80.Y/D75.0 Other specified congenital polycythaemia
- 3A80.Z/D75.0 Congenital polycythaemia, unspecified
- 3A81.0/D75.1 Polycythaemia due to hypoxia, including high altitude
- 3A81.1/D75.1 Polycythaemia due to over-transfusion or blood doping
- 3A81.2/D75.1 Relative polycythaemia
- 3A81/D75.1 Acquired polycythaemia
- 3A81.Y/D75.1 Other specified acquired polycythaemia
- 3A81.Z/D75.1 Acquired polycythaemia, unspecified
- 3A8Z/D64.9 Polycythaemia, unspecified
- 3A90/D64.8 Anaemia due to acute disease
- 3A91/D74.0 Congenital methaemoglobinaemia
- 3A92/D74.0 Hereditary methaemoglobinaemia
- 3A93/D74.8 Acquired methaemoglobinaemia
- 3A94/D62 Acute posthaemorrhagic anaemia
- 3A9Y/D64.9 Other specified anaemias or erythrocyte disorders
- 3A9Z/D64.9 Anaemias or other erythrocyte disorders, unspecified
- 3B10.0/D66 Haemophilia A
- 3B10.1/D66 Hereditary factor VIII deficiency with anti-factor VIII inhibitor
- 3B10/D66 Hereditary factor VIII deficiency
- 3B10.Y/D66 Other specified hereditary factor VIII deficiency
- 3B10.Z/D66 Hereditary factor VIII deficiency, unspecified
- 3B11.0/D67 Haemophilia B
- 3B11/D67 Hereditary factor IX deficiency
- 3B11.Y/D67 Other specified hereditary factor IX deficiency
- 3B11.Z/D67 Hereditary factor IX deficiency, unspecified
- 3B12/D68.0 Von Willebrand disease
- 3B13/D68.1 Haemophilia C
- 3B14.0/D68.2 Hereditary deficiency of factor I
- 3B14.1/D68.2 Hereditary factor X deficiency
- 3B14.2/D68.2 Combined deficiency of vitamin K-dependent clotting factors
- 3B14/D68.2 Other inherited coagulation factor deficiency with bleeding tendency
- 3B14.Z/D68.2 Other inherited coagulation factor deficiency with bleeding tendency, unspecified
- 3B15/D68.2 Inherited coagulation factor deficiency without bleeding tendency
- 3B1Z/D65-D69 Congenital or constitutional haemorrhagic condition, unspecified
- 3B20/D65 Disseminated intravascular coagulation
- 3B21.0/D68.3 Haemorrhage due to thrombin inhibitor other than heparin
- 3B21.1/D68.3 Haemorrhage due to factor Xa inhibitor
- 3B21/D68.3 Haemorrhagic disorder due to circulating anticoagulants and coagulation factors
- 3B21.Y/D68.3 Haemorrhagic disorder due to other specified circulating anticoagulants
- 3B21.Z/D68.3 Haemorrhagic disorder due to unspecified circulating anticoagulants
- 3B22/D68.4 Acquired haemophilia
- 3B2Y/D68.4 Other specified haemorrhagic diseases due to acquired coagulation factor defects
- 3B4Z/D65-D69 Coagulation defects, unspecified
- 3B50.0/D68.8 Congenital alpha-2 antiplasmin deficiency
- 3B50.1/D68.8 Congenital plasminogen activator inhibitor type 1 deficiency
- 3B50/D68.8 Inherited fibrinolytic defects
- 3B50.Y/D68.8 Other specified inherited fibrinolytic defects
- 3B50.Z/D68.8 Inherited fibrinolytic defects, unspecified
- 3B51/D77 Acquired fibrinolytic defects
- 3B60.0/D69.2 Hereditary vascular purpura
- 3B60.1/D69.2 Acquired vascular purpura
- 3B60/D69.2 Non-thrombocytopenic purpura
- 3B61.0/D68.5 Hereditary thrombophilia
- 3B61.00/D68.5 Hyperhomocysteinaemia
- 3B61.0Y/D68.5 Other specified hereditary thrombophilia
- 3B61.1/D68.6 Acquired thrombophilia
- 3B61/D68 Thrombophilia
- 3B61.Y/D68.8 Other specified thrombophilia
- 3B61.Z/D68 Thrombophilia, unspecified
- 3B62.0/D69.1 Inherited qualitative platelet defects
- 3B62.00/D69.1 Alpha-granule diseases
- 3B62.01/D69.1 Inherited giant platelet disorder
- 3B62.0Y/D69.1 Other specified inherited qualitative platelet defects
- 3B62.0Z/D69.1 Inherited qualitative platelet defects, unspecified
- 3B62.1/D69.1 Bleeding diathesis due to thromboxane synthesis deficiency
- 3B62.2/D69.1 Isolated thrombocytopenia
- 3B62.3/D69.1 Dense granule disease
- 3B62.4/D69.1 Alpha-delta dense granule deficiency
- 3B62.5/D76.2 Haemophagocytic syndrome associated with infection
- 3B62/D69.1 Qualitative platelet defects
- 3B62.Y/D69.1 Other specified qualitative platelet defects
- 3B62.Z/D69.1 Qualitative platelet defects, unspecified
- 3B63.0/D47.3 Congenital thrombocytosis
- 3B63.1/D47.3 Acquired thrombocytosis
- 3B63.10/D47.3 Secondary thrombocytosis
- 3B63.1Y/D47.3 Other specified acquired thrombocytosis
- 3B63.1Z/D47.3 Acquired thrombocytosis, unspecified
- 3B63/D47.3 Thrombocytosis
- 3B63.Y/D47.3 Other specified thrombocytosis
- 3B63.Z/D47.3 Thrombocytosis, unspecified
- 3B64.0/D69.6 Congenital thrombocytopenia
- 3B64.00/D69.6 Congenital non-inherited thrombocytopenia
- 3B64.01/D69.6 Hereditary thrombocytopenia
- 3B64.0Z/D69.6 Congenital thrombocytopenia, unspecified
- 3B64.1/D69.5 Acquired thrombocytopenia
- 3B64.10/D69.3 Immune thrombocytopenic purpura
- 3B64.11/D69.5 Secondary thrombocytopenic purpura
- 3B64.12/D69.5 Drug-induced thrombocytopenic purpura
- 3B64.13/D69.5 Alloimmune thrombocytopenia
- 3B64.14/M31.1 Thrombotic thrombocytopenic purpura
- 3B64.1Y/D69.5 Other specified acquired thrombocytopenia
- 3B64/D69.6 Thrombocytopenia
- 3B64.Z/D69.6 Thrombocytopenia, unspecified
- 3B65/M31.1 Thrombotic microangiopathy, not elsewhere classified
- 3B6Y/D65-D69 Other specified coagulation defects, purpura or other haemorrhagic or related conditions
- 3B6Z/D65-D69 Coagulation defects, purpura or other haemorrhagic or related conditions, unspecified
- 3B80.0/D73 Splenomegaly in storage diseases
- 3B80/D73 Congenital disorders of spleen
- 3B81.0/D73 Tumour-like conditions of spleen
- 3B81.1/D73 Postsurgical asplenia
- 3B81.2/D73.0 Atrophy of spleen
- 3B81.3/D73 Nontraumatic laceration or rupture of spleen
- 3B81.4/D73 Splenosis
- 3B81.5/D73 Splenic cyst or pseudocyst
- 3B81.50/D73.4 Pseudocyst of spleen
- 3B81.51/D73.4 Epithelial cyst of spleen
- 3B81.5Y/D73 Other specified splenic cyst
- 3B81.5Z/D73 Splenic cyst, unspecified
- 3B81.6/D73.5 Infarction of spleen
- 3B81.7/D73 Infection of spleen
- 3B81.70/D73 Acute septic splenitis
- 3B81.71/D73.3 Abscess of spleen
- 3B81.7Y/D73 Other specified infection of spleen
- 3B81.7Z/D73 Infection of spleen, unspecified
- 3B81.8/D73 Torsion of spleen
- 3B81.9/D73 Fibrosis of spleen
- 3B81.A/D73 Perisplenitis
- 3B81.B/D73.1 Hypersplenism
- 3B81.C/D73.2 Chronic congestive splenomegaly
- 3B81/D73 Acquired disorders of spleen
- 3B81.Y/D73 Other specified acquired disorders of spleen
- 3B8Z/D73 Diseases of spleen, unspecified
- 3C0Y/III Other specified diseases of the blood or blood-forming organs
- 3C0Z/III Diseases of the blood or blood-forming organs, unspecified
- 4A00.0/D71 Functional neutrophil defects
- 4A00.00/D71 Neutrophil immunodeficiency syndrome
- 4A00.0Y/D71 Other specified functional neutrophil defects
- 4A00.0Z/D71 Functional neutrophil defects, unspecified
- 4A00.1/D84.1 Defects in the complement system
- 4A00.10/D84.1 Immunodeficiency with an early component of complement deficiency
- 4A00.11/D84.1 Immunodeficiency with a late component of complement deficiency
- 4A00.12/D84.1 Immunodeficiency with factor B deficiency
- 4A00.13/D84.1 Immunodeficiency with factor D anomaly
- 4A00.14/D84.1 Hereditary angioedema
- 4A00.15/D84.1 Acquired angioedema
- 4A00.1Y/D84.1 Other specified defects in the complement system
- 4A00.1Z/D84.1 Defects in the complement system, unspecified
- 4A00.2/D84.8 Genetic susceptibility to particular pathogens
- 4A00.3/D84.8 Immunodeficiency with natural-killer cell deficiency
- 4A00/D84.9 Primary immunodeficiencies due to disorders of innate immunity
- 4A00.Y/D84.9 Other specified primary immunodeficiencies due to disorders of innate immunity
- 4A00.Z/D84.9 Primary immunodeficiencies due to disorders of innate immunity, unspecified
- 4A01.0/D80 Immunodeficiencies with predominantly antibody defects
- 4A01.00/D80.0 Hereditary agammaglobulinaemia with profoundly reduced or absent B cells
- 4A01.01/D80.1 Immunodeficiencies with severe reduction in at least two serum immunoglobulin isotypes with normal or low numbers of B cells
- 4A01.02/D80.6 Specific antibody deficiency with normal immunoglobulin concentrations or normal number of B cells
- 4A01.03/D80.7 Transient hypogammaglobulinaemia of infancy
- 4A01.04/D80 Immunodeficiencies with isotype or light chain deficiencies with normal number of B cells
- 4A01.05/D80.5 Immunodeficiencies with severe reduction in serum IgG or IgA with normal or elevated IgM and normal numbers of B-cells
- 4A01.0Y/D80.8 Other specified immunodeficiencies with predominantly antibody defects
- 4A01.0Z/D80 Immunodeficiencies with predominantly antibody defects, unspecified
- 4A01.1/D81 Combined immunodeficiencies
- 4A01.10/D81 Severe combined immunodeficiencies
- 4A01.11/D81.6 Major histocompatibility complex class I deficiency
- 4A01.12/D81.7 Major histocompatibility complex class II deficiency
- 4A01.1Y/D81.8 Other specified combined immunodeficiencies
- 4A01.1Z/D81 Combined immunodeficiencies, unspecified
- 4A01.2/D76.3 Diseases of immune dysregulation
- 4A01.20/D89.8 Immune dysregulation syndromes with hypopigmentation
- 4A01.21/D89.8 Immune dysregulation syndromes presenting primarily with autoimmunity
- 4A01.22/D76.3 Immune dysregulation syndromes presenting primarily with lymphoproliferation
- 4A01.23/D76.1 Primary haemophagocytic lymphohistiocytosis
- 4A01.2Y/D76.3 Other specified diseases of immune dysregulation
- 4A01.2Z/D76.3 Diseases of immune dysregulation, unspecified
- 4A01.3/D84.9 Other well-defined immunodeficiency syndromes due to defects in adaptive immunity
- 4A01.30/D84.9 Immunodeficiency due to defects of the thymus
- 4A01.31/D84.9 DNA repair defects other than combined T-cell or B-cell immunodeficiencies
- 4A01.32/D84.9 Immuno-osseous dysplasia
- 4A01.33/D89.8 immunodeficiency syndrome
- 4A01.34/D82.4 Hyperimmunoglobulin E syndromes
- 4A01/D84.9 Primary immunodeficiencies due to disorders of adaptive immunity
- 4A01.Z/D84.9 Primary immunodeficiencies due to disorders of adaptive immunity, unspecified
- 4A0Y/D84.9 Other specified primary immunodeficiencies
- 4A0Z/D84.9 Primary immunodeficiencies, unspecified
- 4A20.0/D89.9 Adult-onset immunodeficiency
- 4A20.1/D89.9 Acquired immunodeficiency due to loss of immunoglobulin
- 4A20/D89.9 Acquired immunodeficiencies
- 4A20.Y/D89.9 Other specified acquired immunodeficiencies
- 4A20.Z/D89.9 Acquired immunodeficiencies, unspecified
- 4A40.0/M32 Systemic lupus erythematosus
- 4A40.00/M32.1 Systemic lupus erythematosus with skin involvement
- 4A40.0Y/M32.8 Other specified systemic lupus erythematosus
- 4A40.0Z/M32 Systemic lupus erythematosus, unspecified
- 4A40.1/M32.0 Drug-induced lupus erythematosus
- 4A40/L93 Lupus erythematosus
- 4A40.Y/L93 Other specified lupus erythematosus
- 4A40.Z/L93 Lupus erythematosus, unspecified
- 4A41.0/M33.1 Dermatomyositis
- 4A41.00/M33.1 Adult dermatomyositis
- 4A41.01/M33.0 Juvenile dermatomyositis
- 4A41.0Z/M33.1 Dermatomyositis, unspecified
- 4A41.1/M33.2 Polymyositis
- 4A41.10/M33.2 Juvenile polymyositis
- 4A41.11/M33.2 Paraneoplastic polymyositis
- 4A41.1Y/M33.2 Other specified polymyositis
- 4A41.1Z/M33.2 Polymyositis, unspecified
- 4A41.2/G72.8 Inclusion body myopathy
- 4A41.20/G72.4 Inflammatory inclusion body myositis
- 4A41.21/G72.8 Noninflammatory inclusion body myopathy
- 4A41.2Z/G72.8 Inclusion body myopathy, unspecified
- 4A41/M33.9 Idiopathic inflammatory myopathy
- 4A41.Y/M33.9 Other specified idiopathic inflammatory myopathy
- 4A41.Z/M33.9 Idiopathic inflammatory myopathy, unspecified
- 4A42.0/M34 Paediatric onset systemic sclerosis
- 4A42.1/M34.0 Diffuse systemic sclerosis
- 4A42.2/M34.1 Limited systemic sclerosis
- 4A42/M34 Systemic sclerosis
- 4A42.Z/M34 Systemic sclerosis, unspecified
- 4A43.0/M35.8 IgG4 related disease
- 4A43.1/K11.8 Mikulicz disease
- 4A43.2/M35.0 Sjögren syndrome
- 4A43.20/M35.0 Primary Sjögren syndrome
- 4A43.21/M35.0 Secondary Sjögren syndrome
- 4A43.22/M35.0 Paediatric onset Sjögren syndrome
- 4A43.2Y/M35.0 Other specified sjögren syndrome
- 4A43.3/M35.1 Mixed connective tissue disease
- 4A43.4/M35.4 Diffuse eosinophilic fasciitis
- 4A43/M35.1 Overlap or undifferentiated nonorgan specific systemic autoimmune disease
- 4A43.Y/M35.1 Other specified overlap non-organ specific systemic autoimmune disease
- 4A43.Z/M35.1 Undifferentiated non-organ specific systemic autoimmune disease
- 4A44.0/M35.3 Rhizomelic pseudopolyarthritis
- 4A44.1/M31.4 Aortic arch syndrome
- 4A44.2/M31.6 Giant cell arteritis
- 4A44.3/M30-M36 Single organ vasculitis
- 4A44.4/M30 Polyarteritis nodosa
- 4A44.5/M30.3 Mucocutaneous lymph node syndrome
- 4A44.6/I77.8 Sneddon syndrome
- 4A44.7/I67.7 Primary angiitis of the central nervous system
- 4A44.8/I73.1 Thromboangiitis obliterans
- 4A44.9/I77.6 Immune complex small vessel vasculitis
- 4A44.90/D89.1 Cryoglobulinaemic vasculitis
- 4A44.91/M31.8 Hypocomplementaemic urticarial vasculitis
- 4A44.92/D69.0 IgA vasculitis
- 4A44.9Y/I77.6 Other specified immune complex small vessel vasculitis
- 4A44.9Z/I77.6 Immune complex small vessel vasculitis, unspecified
- 4A44.A/I77.6 Antineutrophil cytoplasmic antibody-associated vasculitis
- 4A44.A0/M31.7 Microscopic polyangiitis
- 4A44.A1/M31.3 Granulomatosis with polyangiitis
- 4A44.A2/M30.1 Eosinophilic granulomatosis with polyangiitis
- 4A44.AY/I77.6 Other specified antineutrophil cytoplasmic antibody-associated vasculitis
- 4A44.AZ/I77.6 Antineutrophil cytoplasmic antibody-associated vasculitis, unspecified
- 4A44.B/M31.0 Leukocytoclastic vasculitis
- 4A44.B0/M31.0 Cutaneous leukocytoclastic vasculitis
- 4A44.BY/M31.0 Other specified leukocytoclastic vasculitis
- 4A44.BZ/M31.0 Leukocytoclastic vasculitis, unspecified
- 4A44/M30-M36 Vasculitis
- 4A44.Y/M30-M36 Other specified vasculitis
- 4A44.Z/M30-M36 Vasculitis, unspecified
- 4A45.0/D68.6 Primary antiphospholipid syndrome
- 4A45.1/D68.6 Secondary antiphospholipid syndrome
- 4A45.2/D68.6 Antiphospholipid syndrome in pregnancy
- 4A45.3/D68.6 Lupus anticoagulant-hypoprothrombinaemia syndrome
- 4A45/D68.6 Antiphospholipid syndrome
- 4A45.Z/D68.6 Antiphospholipid syndrome, unspecified
- 4A4Y/M30-M36 Other specified nonorgan specific systemic autoimmune disorders
- 4A4Z/M30-M36 Nonorgan specific systemic autoimmune disorders, unspecified
- 4A60.0/D89.8 Familial Mediterranean fever
- 4A60.1/D89.8 Cryopyrin-associated periodic syndromes
- 4A60.2/D89.8 Tumour necrosis factor receptor 1 associated periodic syndrome
- 4A60/D89.9 Monogenic autoinflammatory syndromes
- 4A60.Y/D89.9 Other specified monogenic autoinflammatory syndromes
- 4A60.Z/D89.9 Autoimflammatory syndrome, unspecified
- 4A61/M86.3 SAPHO syndrome
- 4A62/M35.2 Behçet disease
- 4A6Y/D89.9 Other specified autoinflammatory disorders
- 4A6Z/D89.9 Autoinflammatory disorders, unspecified
- 4A80.0/J39.3 Drug-induced bronchospasm
- 4A80.1/J39.3 Bronchospasm provoked by allergy to food substance
- 4A80/J39.3 Allergic or hypersensitivity disorders involving the respiratory tract
- 4A80.Y/J39.3 Other specified allergic or hypersensitivity disorders involving the respiratory tract
- 4A80.Z/J39.3 Allergic or hypersensitivity disorders involving the respiratory tract, unspecified
- 4A81/T78.4 Allergic or hypersensitivity disorders involving the eye
- 4A82/T78.4 Allergic or hypersensitivity disorders involving skin or mucous membranes
- 4A83.0/T78.4 Food-induced eosinophilic gastroenteritis
- 4A83.1/T78.4 Food-induced eosinophilic oesophagitis
- 4A83/T78.4 Allergic or hypersensitivity disorders involving the gastrointestinal tract
- 4A83.Y/T78.4 Other specified allergic or hypersensitivity disorders involving the gastrointestinal tract
- 4A83.Z/T78.4 Allergic or hypersensitivity disorders involving the gastrointestinal tract, unspecified
- 4A84.0/T78.0 Anaphylaxis due to allergic reaction to food
- 4A84.1/T88.6 Drug-induced anaphylaxis
- 4A84.2/T63.4 Anaphylaxis due to insect venom
- 4A84.3/T78.2 Anaphylaxis provoked by physical factors
- 4A84.30/T78.2 Exercise-induced anaphylaxis
- 4A84.31/T78.2 Cold-induced anaphylaxis
- 4A84.3Y/T78.2 Anaphylaxis provoked by other specified physical factors
- 4A84.3Z/T78.2 Anaphylaxis provoked by unspecified physical factors
- 4A84.4/T78.2 Anaphylaxis due to inhaled allergens
- 4A84.5/T78.2 Anaphylaxis due to contact with allergens
- 4A84.6/T78.2 Anaphylaxis secondary to mast cell disorder
- 4A84/T78.2 Anaphylaxis
- 4A84.Y/T78.2 Other specified anaphylaxis
- 4A84.Z/T78.2 Anaphylaxis, unspecified
- 4A85.0/T78.4 Drug or pharmacological agents hypersensitivity
- 4A85.00/K71 Drug-induced liver hypersensitivity disease
- 4A85.01/T78.4 Drug-induced kidney hypersensitivity
- 4A85.02/D69.5 Drug-induced cytopenia
- 4A85.03/D69.0 Drug-induced vasculitis
- 4A85.04/T78.4 Multiple drug hypersensitivity syndrome
- 4A85.0Y/T78.4 Drug hypersensitivity of other specified type
- 4A85.0Z/T78.4 Drug hypersensitivity of unspecified type
- 4A85.1/T78.4 Hypersensitivity to herbal and alternative medical therapies
- 4A85.2/T78.1 Food hypersensitivity
- 4A85.20/K52.2 Food-induced gastrointestinal hypersensitivity
- 4A85.21/T78.1 Food-induced urticaria or angioedema
- 4A85.22/L23.6 Allergic contact dermatitis due to food allergen
- 4A85.2Y/T78.1 Other specified food hypersensitivity
- 4A85.2Z/T78.1 Food hypersensitivity, unspecified
- 4A85.3/T78.4 Allergic or hypersensitivity reactions to arthropods
- 4A85.30/T63.4 Systemic allergic reaction due to Hymenoptera venom
- 4A85.31/T63.4 Cutaneous allergic or hypersensitivity reactions to Hymenoptera venom
- 4A85.32/T63.4 Cutaneous allergic or hypersensitivity reactions to arthropods
- 4A85/T78.4 Complex allergic or hypersensitivity conditions
- 4A85.Y/T78.4 Other specified complex allergic or hypersensitivity conditions
- 4A85.Z/T78.4 Complex allergic or hypersensitivity conditions, unspecified
- 4A8Y/T78.4 Allergic or hypersensitivity conditions of other specified type
- 4A8Z/T78.4 Allergic or hypersensitivity conditions of unspecified type
- 4B00.0/D89.9 Neutropaenia
- 4B00.00/D89.9 Constitutional neutropaenia
- 4B00.01/D89.9 Acquired neutropaenia
- 4B00.0Z/D89.9 Neutropenia, unspecified
- 4B00.1/D89.9 Neutrophilia
- 4B00.10/D72.0 Constitutional neutrophilia
- 4B00.11/D72.8 Acquired neutrophilia
- 4B00.1Z/D89.9 Neutrophilia, unspecified
- 4B00/D89.9 Disorders of neutrophil number
- 4B00.Y/D89.9 Other specified disorders of neutrophil number
- 4B01.0/D72.0 Constitutional disorders of neutrophil function
- 4B01.00/D72.0 Disorders of neutrophil adhesion
- 4B01.01/D72.0 Disorders of neutrophil chemotaxis
- 4B01.02/D72.0 Disorders of neutrophil granule formation or release
- 4B01.03/D72.0 Disorders of neutrophil oxidative metabolism
- 4B01.0Y/D72.0 Other specified constitutional disorders of neutrophil function
- 4B01.0Z/D72.0 Constitutional disorders of neutrophil function, unspecified
- 4B01.1/D72.8 Acquired disorders of neutrophil function
- 4B01/D89.9 Disorders of neutrophil function
- 4B01.Z/D89.9 Disorders of neutrophil function, unspecified
- 4B02.0/D72.0 Constitutional decrease in eosinophil number
- 4B02.1/D72.8 Acquired decrease in eosinophil number
- 4B02/D89.9 Eosinopenia
- 4B02.Z/D89.9 Eosinopenia, unspecified
- 4B03.0/D72.1 Constitutional eosinophilia
- 4B03.1/D72.1 Acquired eosinophilia
- 4B03/D72.1 Eosinophilia
- 4B03.Z/D72.1 Eosinophilia, unspecified
- 4B04/D72.8 Disorders with decreased monocyte counts
- 4B05/D72.8 Disorders with increased monocyte counts
- 4B06/D72.8 Acquired lymphopenia
- 4B07/D72.8 Acquired lymphocytosis
- 4B0Y/D89.9 Other specified immune system disorders involving white cell lineages
- 4B0Z/D89.9 Immune system disorders involving white cell lineages, unspecified
- 4B20.0/D86.0 Sarcoidosis of lung
- 4B20.1/D86.1 Sarcoidosis of lymph nodes
- 4B20.2/D86 Sarcoidosis of the digestive system
- 4B20.3/D86 Neurosarcoidosis
- 4B20.4/D86 Ocular sarcoidosis
- 4B20.5/D86.3 Cutaneous sarcoidosis
- 4B20/D86 Sarcoidosis
- 4B20.Y/D86.8 Other specified sarcoidosis
- 4B20.Z/D86 Sarcoidosis, unspecified
- 4B21/D89.0 Polyclonal hypergammaglobulinaemia
- 4B22/D89.1 Cryoglobulinaemia
- 4B23/D89.3 Immune reconstitution inflammatory syndrome
- 4B24.0/T86.0 Acute graft-versus-host disease
- 4B24.1/T86.0 Chronic graft-versus-host disease
- 4B24/D89.9 Graft-versus-host disease
- 4B24.Y/D89.9 Other specified graft-versus-host disease
- 4B24.Z/D89.9 Graft-versus-host disease, unspecified
- 4B2Y/D89.9 Other specified disorders involving the immune system
- 4B40.0/E32.0 Persistent hyperplasia of thymus
- 4B40.1/E32.1 Abscess of thymus
- 4B40.2/E32 Good syndrome
- 4B40/E32.9 Diseases of thymus
- 4B40.Y/E32.9 Other specified diseases of thymus
- 4B40.Z/E32.9 Diseases of thymus, unspecified
- 4B4Y/IV Other specified diseases of the immune system
- 4B4Z/IV Diseases of the immune system, unspecified
- 5A00.0/E03.9 Congenital hypothyroidism
- 5A00.00/E03.0 Permanent congenital hypothyroidism with diffuse goitre
- 5A00.01/E03.1 Permanent congenital hypothyroidism without goitre
- 5A00.02/E03.9 Pendred syndrome
- 5A00.03/E03.9 Transient congenital hypothyroidism
- 5A00.04/E00 Congenital hypothyroidism due to iodine deficiency
- 5A00.0Y/E03.9 Other specified congenital hypothyroidism
- 5A00.0Z/E03.9 Congenital hypothyroidism, unspecified
- 5A00.1/E01 Iodine-deficiency-related thyroid disorders or allied conditions
- 5A00.10/E01.0 Iodine-deficiency-related diffuse goitre
- 5A00.11/E01.1 Iodine-deficiency-related multinodular goitre
- 5A00.1Z/E01 Iodine-deficiency-related thyroid disorders or allied conditions, unspecified
- 5A00.2/E03.9 Acquired hypothyroidism
- 5A00.20/E03.2 Hypothyroidism due to medicaments or other exogenous substances
- 5A00.21/E03.5 Myxoedema coma
- 5A00.22/E02 Subclinical iodine-deficiency hypothyroidism
- 5A00.2Y/E03.9 Other specified acquired hypothyroidism
- 5A00.2Z/E03.9 Acquired hypothyroidism, unspecified
- 5A00/E03.9 Hypothyroidism
- 5A00.Z/E03.9 Hypothyroidism, unspecified
- 5A01.0/E04.0 Nontoxic diffuse goitre
- 5A01.1/E04.1 Nontoxic single thyroid nodule
- 5A01.2/E04.2 Nontoxic multinodular goitre
- 5A01/E04 Nontoxic goitre
- 5A01.Z/E04 Nontoxic goitre, unspecified
- 5A02.0/E05.0 Thyrotoxicosis with diffuse goitre
- 5A02.1/E05.1 Thyrotoxicosis with toxic single thyroid nodule
- 5A02.2/E05.2 Thyrotoxicosis with toxic multinodular goitre
- 5A02.3/E05.3 Thyrotoxicosis from ectopic thyroid tissue
- 5A02.4/E05.4 Thyrotoxicosis factitia
- 5A02.5/E05.5 Thyroid crisis
- 5A02.6/E05 Secondary hyperthyroidism
- 5A02/E05 Thyrotoxicosis
- 5A02.Y/E05.8 Other specified thyrotoxicosis
- 5A02.Z/E05 Thyrotoxicosis, unspecified
- 5A03.0/E06.0 Acute thyroiditis
- 5A03.1/E06.1 Subacute thyroiditis
- 5A03.2/E06.3 Autoimmune thyroiditis
- 5A03.20/E06.3 Hashimoto thyroiditis
- 5A03.21/E06.3 Painless thyroiditis
- 5A03.2Y/E06.3 Other specified autoimmune thyroiditis
- 5A03/E06 Thyroiditis
- 5A03.Y/E06 Other specified thyroiditis
- 5A03.Z/E06 Thyroiditis, unspecified
- 5A04/E07.0 Hypersecretion of calcitonin
- 5A05/E07 Generalised resistance to thyroid hormone
- 5A06/E07 Sick-euthyroid syndrome
- 5A0Y/E00-E07 Other specified disorders of the thyroid gland or thyroid hormones system
- 5A0Z/E00-E07 Disorders of the thyroid gland or thyroid hormones system, unspecified
- 5A10/E10-E14 Type 1 diabetes mellitus
- 5A11/E11 Type 2 diabetes mellitus
- 5A12/E12 Malnutrition-related diabetes mellitus
- 5A13.0/E13 Diabetes mellitus due to genetic defects of beta cell function
- 5A13.1/E13 Diabetes mellitus due to genetic defects in insulin action
- 5A13.2/E13 Diabetes mellitus due to diseases of the exocrine pancreas
- 5A13.3/E13 Diabetes mellitus due to endocrinopathies
- 5A13.4/E13 Diabetes mellitus due to drug or chemical
- 5A13.5/E13 Diabetes mellitus due to uncommon forms of immune-mediated diabetes
- 5A13.6/E13 Diabetes mellitus due to other genetic syndromes
- 5A13.7/E13 Diabetes mellitus due to clinically defined subtypes or syndromes
- 5A13/E13 Diabetes mellitus, other specified type
- 5A13.Y/E13.8 Diabetes mellitus due to other specified cause
- 5A14/E14 Diabetes mellitus, type unspecified
- 5A20.0/E10-E14 Hyperosmolar hyperglycaemic state without coma
- 5A20.1/E10-E14 Hyperosmolar hyperglycaemic state with coma
- 5A20/E10-E14 Diabetic hyperosmolar hyperglycaemic state
- 5A20.Z/E10-E14 Diabetic hyperosmolar hyperglycaemic state, unspecified
- 5A21.0/E10-E14 Hypoglycaemia in the context of diabetes mellitus without coma
- 5A21.1/E10-E14 Hypoglycaemia in the context of diabetes mellitus with coma
- 5A21/E10-E14 Hypoglycaemia in the context of diabetes mellitus
- 5A21.Z/E10-E14 Hypoglycaemia in the context of diabetes, unspecified
- 5A22.0/E14.1 Diabetic ketoacidosis without coma
- 5A22.1/E14.1 Diabetic lactic acidosis
- 5A22.2/E14.1 Diabetic metabolic acidosis
- 5A22.3/E10-E14 Diabetic ketoacidosis with coma
- 5A22/E14.1 Diabetic acidosis
- 5A22.Y/E14.1 Other specified diabetic acidosis
- 5A22.Z/E14.1 Diabetic acidosis, unspecified
- 5A23/E10-E14 Diabetic coma
- 5A24/E10-E14 Uncontrolled or unstable diabetes mellitus
- 5A2Y/E10-E14 Other specified acute complications of diabetes mellitus
- 5A40.0/E15-E16 Impaired fasting glucose
- 5A40.1/E15-E16 Impaired glucose tolerance
- 5A40/E15-E16 Intermediate hyperglycaemia
- 5A40.Y/E15-E16 Other specified intermediate hyperglycaemia
- 5A40.Z/E15-E16 Intermediate hyperglycaemia, unspecified
- 5A41/E16.2 Hypoglycaemia without associated diabetes
- 5A42/E16.3 Increased secretion of glucagon
- 5A43.0/E16.4 Drug-induced hypergastrinaemia
- 5A43.1/E16.4 Zollinger-Ellison syndrome
- 5A43/E16.4 Abnormal secretion of gastrin
- 5A43.Y/E16.4 Other specified abnormal secretion of gastrin
- 5A43.Z/E16.4 Abnormal secretion of gastrin, unspecified
- 5A44/E10-E14 Insulin-resistance syndromes
- 5A45/E16.1 Persistent hyperinsulinaemic hypoglycaemia of infancy
- 5A4Y/E15-E16 Other specified disorders of glucose regulation or pancreatic internal secretion
- 5A4Z/E15-E16 Disorders of glucose regulation or pancreatic internal secretion, unspecified
- 5A50.0/E20 Hypoparathyroidism due to impaired parathyroid hormone secretion
- 5A50.00/E20.0 Idiopathic hypoparathyroidism
- 5A50.01/E20 Secondary hypoparathyroidism
- 5A50.02/E20 Hypoparathyroidism due to destruction of the parathyroid glands
- 5A50.03/E20 Autoimmune hypoparathyroidism
- 5A50.0Y/E20 Other specified hypoparathyroidism due to impaired parathyroid hormone secretion
- 5A50.0Z/E20 Hypoparathyroidism due to impaired parathyroid hormone secretion, unspecified
- 5A50.1/E20.1 Pseudohypoparathyroidism
- 5A50/E20 Hypoparathyroidism
- 5A50.Y/E20.8 Other specified hypoparathyroidism
- 5A50.Z/E20 Hypoparathyroidism, unspecified
- 5A51.0/E21.0 Primary hyperparathyroidism
- 5A51.1/E21.1 Secondary hyperparathyroidism
- 5A51.2/E21.2 Familial hypocalciuric hypercalcaemia
- 5A51/IV Hyperparathyroidism
- 5A51.Y/IV Other specified hyperparathyroidism
- 5A51.Z/IV Hyperparathyroidism, unspecified
- 5A5Y/IV Other specified disorders of the parathyroids or parathyroid hormone system
- 5A5Z/IV Disorders of the parathyroids or parathyroid hormone system, unspecified
- 5A60.0/E22.0 Acromegaly or pituitary gigantism
- 5A60.1/E22.1 Hyperprolactinaemia
- 5A60.2/E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
- 5A60.20/E22.2 Nephrogenic syndrome of inappropriate antidiuresis
- 5A60.2Y/E22.2 Other specified syndrome of inappropriate secretion of antidiuretic hormone
- 5A60.2Z/E22.2 Syndrome of inappropriate secretion of antidiuretic hormone, unspecified
- 5A60.3/E22.8 Central precocious puberty
- 5A60/E22 Hyperfunction of pituitary gland
- 5A60.Y/E22.8 Other specified hyperfunction of pituitary gland
- 5A60.Z/E22 Hyperfunction of pituitary gland, unspecified
- 5A61.0/E23.0 Hypopituitarism
- 5A61.1/E23 Adrenocorticotropic hormone deficiency
- 5A61.2/E23 Gonadotropin deficiency
- 5A61.3/E23 Growth hormone deficiency
- 5A61.4/E23 Thyroid stimulating hormone deficiency
- 5A61.40/E23 Acquired central hypothyroidism
- 5A61.41/E23 Congenital central hypothyroidism
- 5A61.4Y/E23 Other specified thyroid stimulating hormone deficiency
- 5A61.4Z/E23 Thyroid stimulating hormone deficiency, unspecified
- 5A61.5/E23.2 Central diabetes insipidus
- 5A61.6/E23 Oxytocin deficiency
- 5A61/E23 Hypofunction or certain other specified disorders of pituitary gland
- 5A61.Y/E23 Other specified hypofunction or disorders of pituitary gland
- 5A6Z/IV Disorders of the pituitary hormone system, unspecified
- 5A70.0/E24.0 Pituitary-dependent Cushing disease
- 5A70.1/E24.3 Ectopic ACTH syndrome
- 5A70.2/E24 Pseudo-Cushing syndrome
- 5A70.3/E24.1 Nelson syndrome
- 5A70/E24 Cushing syndrome
- 5A70.Y/E24.8 Other specified Cushing syndrome
- 5A70.Z/E24 Cushing syndrome, unspecified
- 5A71.0/E25 46,XX disorders of sex development induced by androgens of fetal origin
- 5A71.00/E25 Glucocorticoid resistance
- 5A71.01/E25.0 Congenital adrenal hyperplasia
- 5A71.0Y/E25 Other specified 46,XX disorders of sex development induced by androgens of fetal origin
- 5A71.0Z/E25 46,XX disorders of sex development induced by androgens of fetal origin, unspecified
- 5A71.1/E25 46,XX disorders of sex development induced by androgens of maternal origin
- 5A71/E25 Adrenogenital disorders
- 5A71.Y/E25.8 Other specified adrenogenital disorders
- 5A71.Z/E25 Adrenogenital disorders, unspecified
- 5A72.0/E26.0 Primary hyperaldosteronism
- 5A72.1/E26.1 Secondary hyperaldosteronism
- 5A72/E26 Hyperaldosteronism
- 5A72.Z/E26 Hyperaldosteronism, unspecified
- 5A73/E27.4 Hypoaldosteronism
- 5A74.0/E27.1 Acquired adrenocortical insufficiency
- 5A74.1/E27.2 Adrenal crisis
- 5A74/E27.4 Adrenocortical insufficiency
- 5A74.Y/E27.4 Other specified adrenocortical insufficiency
- 5A74.Z/E27.4 Adrenocortical insufficiency, unspecified
- 5A75/E27.5 Adrenomedullary hyperfunction
- 5A76.0/E27.0 Premature adrenarche
- 5A76/E27.8 Certain specified disorders of adrenal gland
- 5A76.Y/E27.8 Other specified disorders of adrenal gland
- 5A7Z/IV Disorders of the adrenal glands or adrenal hormone system, unspecified
- 5A80.0/E28.1 Clinical hyperandrogenism
- 5A80.1/E28.2 Polycystic ovary syndrome
- 5A80.2/E28 Polycystic ovary
- 5A80.3/E28 Anovulation
- 5A80.4/E28 Oligo-ovulation
- 5A80.5/E28 Diminished ovarian reserve
- 5A80/E28 Ovarian dysfunction
- 5A80.Y/E28.8 Other specified ovarian dysfunction
- 5A80.Z/E28 Ovarian dysfunction, unspecified
- 5A81.0/E29.0 Testicular hyperfunction
- 5A81.1/E29.1 Testicular hypofunction
- 5A81/E29 Testicular dysfunction or testosterone-related disorders
- 5A81.Y/E29.8 Other specified testicular dysfunction or testosterone-related disorders
- 5A81.Z/E29 Testicular dysfunction or testosterone-related disorders, unspecified
- 5A8Z/IV Disorders of the gonadal hormone system, unspecified
- 5A90/E30 Disorder of puberty due to oestrogen resistance
- 5A91/E30.0 Delayed puberty
- 5A92/E30.1 Peripheral precocious puberty
- 5A9Y/E30.8 Other disorders of puberty
- 5A9Z/E30 Disorders of puberty, unspecified
- 5B00/E31.0 Autoimmune polyendocrinopathy
- 5B01/E31.1 Polyglandular hyperfunction
- 5B0Y/E31.8 Other specified polyglandular dysfunction
- 5B0Z/E31 Polyglandular dysfunction, unspecified
- 5B10/E34.0 Carcinoid syndrome
- 5B11/E34.3 Short stature, not elsewhere classified
- 5B12/E34.4 Constitutional tall stature
- 5B1Y/IV Other specified endocrine disorders, not elsewhere classified
- 5B3Y/IV Other specified endocrine diseases
- 5B3Z/IV Endocrine diseases, unspecified
- 5B50/E46 Underweight in infants, children or adolescents
- 5B51/E46 Wasting in infants, children or adolescents
- 5B52/E46 Acute malnutrition in infants, children or adolescents
- 5B53/E46 Stunting in infants, children or adolescents
- 5B54/E46 Underweight in adults
- 5B55.0/E50.5 Vitamin A deficiency with night blindness
- 5B55.1/E50.0 Vitamin A deficiency with conjunctival xerosis
- 5B55.2/E50.1 Vitamin A deficiency with conjunctival xerosis and Bitot’s spots
- 5B55.3/E50.2 Vitamin A deficiency with corneal xerosis
- 5B55.4/E50.3 Vitamin A deficiency with corneal ulceration or keratomalacia
- 5B55.5/E50.6 Vitamin A deficiency with xerophthalmic scars of cornea or blindness
- 5B55/E50 Vitamin A deficiency
- 5B55.Y/E50.8 Vitamin A deficiency with other specified manifestations
- 5B55.Z/E50 Vitamin A deficiency, unspecified
- 5B56.0/E54 Scurvy
- 5B56/E54 Vitamin C deficiency
- 5B56.Y/E54 Other specified vitamin C deficiency
- 5B56.Z/E54 Vitamin C deficiency, unspecified
- 5B57.0/E55.0 Vitamin D deficiency rickets
- 5B57.1/E55 Vitamin D deficiency osteomalacia
- 5B57/E55 Vitamin D deficiency
- 5B57.Y/E55 Other specified vitamin D deficiency
- 5B57.Z/E55 Vitamin D deficiency, unspecified
- 5B58/E56.0 Vitamin E deficiency
- 5B59/E56.1 Vitamin K deficiency
- 5B5A.0/E51.1 Beriberi
- 5B5A.00/E51.1 Dry beriberi
- 5B5A.01/E51.1 Wet beriberi
- 5B5A.0Z/E51.1 Beriberi, unspecified
- 5B5A.1/E51 Wernicke-Korsakoff Syndrome
- 5B5A.10/E51.2 Wernicke encephalopathy
- 5B5A.11/E51 Korsakoff syndrome
- 5B5A.1Y/E51 Other specified Wernicke-Korsakoff Syndrome
- 5B5A.1Z/E51 Wernicke-Korsakoff Syndrome, unspecified
- 5B5A/E51 Vitamin B1 deficiency
- 5B5A.Y/E51.8 Other specified vitamin B1 deficiency
- 5B5A.Z/E51 Vitamin B1 deficiency, unspecified
- 5B5B/E53.0 Vitamin B2 deficiency
- 5B5C.0/E52 Pellagra
- 5B5C/E52 Vitamin B3 deficiency
- 5B5C.Y/E52 Other specified vitamin B3 deficiency
- 5B5D/E53.1 Vitamin B6 deficiency
- 5B5E/E53.8 Folate deficiency
- 5B5F/E53.8 Vitamin B12 deficiency
- 5B5G/E53.8 Biotin deficiency
- 5B5H/E53.8 Pantothenic acid deficiency
- 5B5J/E53.8 Choline deficiency
- 5B5K.0/E61.1 Iron deficiency
- 5B5K.1/E58 Calcium deficiency
- 5B5K.10/E58 Tetany due to acute calcium deficiency
- 5B5K.1Y/E58 Other specified calcium deficiency
- 5B5K.1Z/E58 Calcium deficiency, unspecified
- 5B5K.2/E60 Zinc deficiency
- 5B5K.3/E61.8 Iodine deficiency
- 5B5K.4/E61.8 Fluorine deficiency
- 5B5K.5/E61.8 Sodium chloride deficiency
- 5B5K.6/E61.0 Copper deficiency
- 5B5K.7/E59 Selenium deficiency
- 5B5K.8/E61.4 Chromium deficiency
- 5B5K.9/E61.3 Manganese deficiency
- 5B5K.A/E61.5 Molybdenum deficiency
- 5B5K.B/E61.6 Vanadium deficiency
- 5B5K/E61.9 Mineral deficiencies
- 5B5K.Y/E61.9 Other specified mineral deficiency
- 5B5K.Z/E61.9 Mineral deficiency, unspecified
- 5B60/E64.0 Sequelae of protein-energy malnutrition
- 5B61/E64 Sequelae of vitamin A deficiency
- 5B62/E64.2 Sequelae of vitamin C deficiency
- 5B63/E64 Sequelae of rickets
- 5B6Y/E64.8 Other specified sequelae of malnutrition or certain specified nutritional deficiencies
- 5B6Z/E64 Sequelae of malnutrition or certain specified nutritional deficiencies, unspecified
- 5B70/E63.0 Essential fatty acid deficiency
- 5B71/E63 Protein deficiency
- 5B7Y/E90 Other specified undernutrition
- 5B7Z/E90 Unspecified undernutrition
- 5B80.0/E66.9 Overweight
- 5B80.00/E66.9 Overweight in infants, children or adolescents
- 5B80.01/E66.9 Overweight in adults
- 5B80.0Z/E66.9 Overweight, unspecified
- 5B80.1/E65 Localised adiposity
- 5B80/E65-E68 Overweight or localised adiposity
- 5B81.0/E66.0 Obesity due to energy imbalance
- 5B81.00/E66.0 Obesity in children or adolescents
- 5B81.01/E66.0 Obesity in adults
- 5B81.1/E66.1 Drug-induced obesity
- 5B81/E66 Obesity
- 5B81.Y/E66.8 Other specified obesity
- 5B81.Z/E66 Obesity, unspecified
- 5B90.0/E67.0 Hypervitaminosis A
- 5B90.1/E67.1 Hypercarotenaemia
- 5B90.2/E67.3 Hypervitaminosis D
- 5B90.3/E67.2 Megavitamin-B6 syndrome
- 5B90/E67 Vitamin excesses
- 5B90.Y/E67 Other specified vitamin excess
- 5B90.Z/E67 Unspecified vitamin excesses
- 5B91.0/E67 Hypercalcaemia
- 5B91.1/E67.8 Zinc excess
- 5B91.2/E67.8 Sodium chloride excess
- 5B91.3/E67.8 Fluorine excess
- 5B91.4/E67.8 Aluminium excess
- 5B91.5/E67.8 Manganese excess
- 5B91/E67 Mineral excesses
- 5B91.Y/E67 Other specified mineral excess
- 5B91.Z/E67 Unspecified mineral excess
- 5B9Y/E67.8 Other specified nutrient excesses
- 5B9Z/E67 Certain specified nutrient excesses, unspecified
- 5C1Y/E65-E68 Other specified overweight, obesity or specific nutrient excesses
- 5C1Z/E65-E68 Overweight, obesity or specific nutrient excesses, unspecified
- 5C3Y/E90 Other specified nutritional disorders
- 5C3Z/E90 Nutritional disorders, unspecified
- 5C50.0/E70 Phenylketonuria
- 5C50.00/E70.0 Classical phenylketonuria
- 5C50.01/E70.1 Nonclassical phenylketonuria
- 5C50.02/E70.1 Embryofetopathy due to maternal phenylketonuria
- 5C50.0Y/E70.8 Other specified phenylketonuria
- 5C50.0Z/E70 Phenylketonuria, unspecified
- 5C50.1/E70.2 Disorders of tyrosine metabolism
- 5C50.10/E70.2 Alkaptonuria
- 5C50.11/E70.2 Tyrosinaemia type 1
- 5C50.12/E70.2 Tyrosinaemia type 2
- 5C50.1Y/E70.2 Other specified disorders of tyrosine metabolism
- 5C50.1Z/E70.2 Disorders of tyrosine metabolism, unspecified
- 5C50.2/E70.8 Disorders of histidine metabolism
- 5C50.20/E70.8 Histidinaemia
- 5C50.21/E70.8 Urocanic aciduria
- 5C50.2Y/E70.8 Other specified disorders of histidine metabolism
- 5C50.2Z/E70.8 Disorders of histidine metabolism, unspecified
- 5C50.3/E70.8 Disorders of tryptophan metabolism
- 5C50.4/E72.3 Disorders of lysine or hydroxylysine metabolism
- 5C50.5/E72.8 Disorders of the gamma-glutamyl cycle
- 5C50.6/E72.8 Disorders of serine metabolism
- 5C50.7/E72.5 Disorders of glycine metabolism
- 5C50.70/E72.5 Glycine encephalopathy
- 5C50.71/E72.5 Sarcosinaemia
- 5C50.7Y/E72.5 Other specified disorders of glycine metabolism
- 5C50.7Z/E72.5 Disorders of glycine metabolism, unspecified
- 5C50.8/E72.8 Disorders of proline or hydroxyproline metabolism
- 5C50.9/E72.4 Disorders of ornithine metabolism
- 5C50.A/E72.2 Disorders of urea cycle metabolism
- 5C50.A0/E72.2 Argininosuccinic aciduria
- 5C50.A1/E72.2 Carbamoylphosphate synthetase deficiency
- 5C50.A2/E72.2 Argininaemia
- 5C50.A3/E72.2 Citrullinaemia
- 5C50.AY/E72.2 Other specified disorders of urea cycle metabolism
- 5C50.AZ/E72.2 Disorders of urea cycle metabolism, unspecified
- 5C50.B/E72.1 Disorders of methionine cycle or sulphur amino acid metabolism
- 5C50.C/E72.8 Disorders of beta or omega amino acid metabolism
- 5C50.D/E71.2 Disorders of branched-chain amino acid metabolism
- 5C50.D0/E71.0 Maple-syrup-urine disease
- 5C50.DY/E71.2 Other specified disorders of branched-chain amino acid metabolism
- 5C50.DZ/E71.2 Disorders of branched-chain amino acid metabolism, unspecified
- 5C50.E/E71.1 Organic aciduria
- 5C50.E0/E71.1 Classical organic aciduria
- 5C50.E1/E71.1 Cerebral organic aciduria
- 5C50/E70-E90 Inborn errors of amino acid or other organic acid metabolism
- 5C50.EY/E71.1 Other specified organic aciduria
- 5C50.EZ/E71.1 Organic aciduria, unspecified
- 5C50.F/E70-E90 Disorders of peptide metabolism
- 5C50.F0/E72.8 Prolidase deficiency
- 5C50.F1/E70.8 Carnosinaemia
- 5C50.F2/E72.8 Homocarnosinosis
- 5C50.FY/E70-E90 Other specified disorders of peptide metabolism
- 5C50.FZ/E70-E90 Disorders of peptide metabolism, unspecified
- 5C50.G/E88.8 Trimethylaminuria
- 5C50.Y/E70-E90 Other specified inborn errors of amino acid or other organic acid metabolism
- 5C50.Z/E70-E90 Inborn errors of amino acid or other organic acid metabolism, unspecified
- 5C51.0/E74 Disorders of the pentose phosphate pathway
- 5C51.1/E74 Disorders of glycerol metabolism
- 5C51.2/E74 Disorders of glyoxylate metabolism
- 5C51.20/E74 Primary hyperoxaluria type 1
- 5C51.2Y/E74 Other specified disorders of glyoxylate metabolism
- 5C51.2Z/E74 Disorders of glyoxylate metabolism, unspecified
- 5C51.3/E74.0 Glycogen storage disease
- 5C51.4/E74.2 Disorders of galactose metabolism
- 5C51.40/E74.2 Galactose-1-phosphate uridyltransferase deficiency
- 5C51.41/E74.2 Galactokinase deficiency
- 5C51.42/E74.2 Glucose or galactose intolerance of newborn
- 5C51.4Y/E74.2 Other specified disorders of galactose metabolism
- 5C51.4Z/E74.2 Disorders of galactose metabolism, unspecified
- 5C51.5/E74.1 Disorders of fructose metabolism
- 5C51.50/E74.1 Hereditary fructose intolerance
- 5C51.5Y/E74.1 Other specified disorders of fructose metabolism
- 5C51.5Z/E74.1 Disorders of fructose metabolism, unspecified
- 5C51/E74 Inborn errors of carbohydrate metabolism
- 5C51.Y/E74.8 Other specified inborn errors of carbohydrate metabolism
- 5C51.Z/E74 Inborn errors of carbohydrate metabolism, unspecified
- 5C52.0/E71.3 Inborn errors of fatty acid oxidation or ketone body metabolism
- 5C52.00/E71.3 Disorders of carnitine transport or the carnitine cycle
- 5C52.01/E71.3 Disorders of mitochondrial fatty acid oxidation
- 5C52.02/E71.3 Disorders of ketone body metabolism
- 5C52.03/E71.3 Sjögren-Larsson syndrome
- 5C52.0Y/E71.3 Other specified inborn errors of fatty acid oxidation or ketone body metabolism
- 5C52.0Z/E71.3 Inborn errors of fatty acid oxidation or ketone body metabolism, unspecified
- 5C52.1/E75 Inborn errors of sterol metabolism
- 5C52.10/E75 Disorders of cholesterol synthesis
- 5C52.11/E75 Bile acid synthesis defect with cholestasis
- 5C52.1Y/E75 Other specified inborn errors of sterol metabolism
- 5C52.1Z/E75 Inborn errors of sterol metabolism, unspecified
- 5C52.2/E75 Neutral lipid storage disease
- 5C52/E75 Inborn errors of lipid metabolism
- 5C52.Y/E75 Other specified inborn errors of lipid metabolism
- 5C52.Z/E75 Inborn errors of lipid metabolism, unspecified
- 5C53.0/E74.4 Disorders of pyruvate metabolism
- 5C53.00/E74.4 Pyruvate kinase deficiency
- 5C53.01/E74.4 Lactate dehydrogenase deficiency
- 5C53.02/E74.4 Pyruvate dehydrogenase complex deficiency
- 5C53.03/E74.4 Pyruvate carboxylase deficiency
- 5C53.0Y/E74.4 Other specified disorders of pyruvate metabolism
- 5C53.0Z/E74.4 Disorders of pyruvate metabolism, unspecified
- 5C53.1/E88.8 Disorders of the citric acid cycle
- 5C53.2/E88.8 Disorders of mitochondrial oxidative phosphorylation
- 5C53.20/E88.8 Mitochondrial DNA depletion syndromes
- 5C53.21/E88.8 Multiple mitochondrial DNA deletion syndromes
- 5C53.22/E88.8 Coenzyme Q10 deficiency
- 5C53.23/E88.8 Mitochondrial protein translation defects
- 5C53.24/G31.8 Leigh syndrome
- 5C53.25/E88.8 Isolated ATP synthase deficiency
- 5C53.2Y/E88.8 Other specified disorders of mitochondrial oxidative phosphorylation
- 5C53.2Z/E88.8 Disorders of mitochondrial oxidative phosphorylation, unspecified
- 5C53.3/E88.8 Disorders of mitochondrial membrane transport
- 5C53.30/E88.8 Mitochondrial substrate carrier disorders
- 5C53.31/E88.8 Mitochondrial protein import disorders
- 5C53.3Y/E88.8 Other specified disorders of mitochondrial membrane transport
- 5C53.3Z/E88.8 Disorders of mitochondrial membrane transport, unspecified
- 5C53.4/E72.8 Disorders of creatine metabolism
- 5C53/E70-E90 Inborn errors of energy metabolism
- 5C53.Y/E70-E90 Other specified inborn errors of energy metabolism
- 5C53.Z/E70-E90 Inborn errors of energy metabolism, unspecified
- 5C54.0/E77.8 Disorders of protein N-glycosylation
- 5C54.1/E77.8 Disorders of protein O-glycosylation
- 5C54.2/E77.8 Disorders of multiple glycosylation or other pathways
- 5C54/E70-E90 Inborn errors of glycosylation or other specified protein modification
- 5C54.Y/E70-E90 Other specified congenital disorders of glycosylation and protein modification
- 5C54.Z/E70-E90 Congenital disorders of glycosylation and protein modification, unspecified
- 5C55.0/E79 Disorders of purine metabolism
- 5C55.00/E79.8 Xanthinuria
- 5C55.01/E79.1 Lesch-Nyhan syndrome
- 5C55.0Y/E79 Other specified disorders of purine metabolism
- 5C55.0Z/E79 Disorders of purine metabolism, unspecified
- 5C55.1/E79 Disorders of pyrimidine metabolism
- 5C55.2/E79 Disorders of nucleotide metabolism
- 5C55/E79 Inborn errors of purine, pyrimidine or nucleotide metabolism
- 5C55.Y/E79.8 Other specified inborn errors of purine, pyrimidine or nucleotide metabolism
- 5C55.Z/E79 Inborn errors of purine, pyrimidine or nucleotide metabolism, unspecified
- 5C56.0/E75.3 Sphingolipidosis
- 5C56.00/E75.3 Gangliosidosis
- 5C56.01/E75.3 Fabry disease
- 5C56.02/E75.2 Metachromatic leukodystrophy
- 5C56.0Y/E75.3 Other specified sphingolipidosis
- 5C56.0Z/E75.3 Sphingolipidosis, unspecified
- 5C56.1/E75.4 Neuronal ceroid lipofuscinosis
- 5C56.2/E77 Glycoproteinosis
- 5C56.20/E77 Mucolipidosis
- 5C56.21/E77 Oligosaccharidosis
- 5C56.2Y/E77.8 Other specified glycoproteinosis
- 5C56.2Z/E77 Glycoproteinosis, unspecified
- 5C56.3/E76.3 Mucopolysaccharidosis
- 5C56.30/E76.0 Mucopolysaccharidosis type 1
- 5C56.31/E76.1 Mucopolysaccharidosis type 2
- 5C56.32/E76.2 Mucopolysaccharidosis type 4
- 5C56.33/E76.2 Mucopolysaccharidosis type 6
- 5C56.3Y/E76.3 Other specified mucopolysaccharidosis
- 5C56.3Z/E76.3 Mucopolysaccharidosis, unspecified
- 5C56.4/E77.1 Disorders of sialic acid metabolism
- 5C56/E70-E90 Lysosomal diseases
- 5C56.Y/E70-E90 Other specified lysosomal diseases
- 5C56.Z/E70-E90 Lysosomal diseases, unspecified
- 5C57.0/Q87.8 Disorders of peroxisome biogenesis
- 5C57.1/Q87.8 or omega-oxidation
- 5C57/E70-E90 Peroxisomal diseases
- 5C57.Y/E70-E90 Other specified peroxisomal diseases
- 5C57.Z/E70-E90 Peroxisomal diseases, unspecified
- 5C58.0/E80.7 Disorders of bilirubin metabolism or excretion
- 5C58.00/E80.5 Crigler-Najjar syndrome
- 5C58.01/E80.4 Gilbert syndrome
- 5C58.02/E80.6 Dubin-Johnson syndrome
- 5C58.03/K76.8 Progressive familial intrahepatic cholestasis
- 5C58.04/K83.1 Benign recurrent intrahepatic cholestasis
- 5C58.0Y/E80.7 Other specified disorders of bilirubin metabolism or excretion
- 5C58.0Z/E80.7 Disorders of bilirubin metabolism or excretion, unspecified
- 5C58.1/E80 Porphyrias
- 5C58.10/E80.1 Porphyria cutanea tarda
- 5C58.12/E80.0 Erythropoietic porphyrias
- 5C58.13/E80.2 Variegate porphyria
- 5C58.1Y/E80 Other specified porphyrias
- 5C58.1Z/E80 Porphyrias, unspecified
- 5C58/E80 Inborn errors of porphyrin or heme metabolism
- 5C58.Y/E80 Other specified inborn errors of porphyrin or heme metabolism
- 5C58.Z/E80 Inborn errors of porphyrin or heme metabolism, unspecified
- 5C59.0/E88.8 Disorders of biogenic amine metabolism
- 5C59.00/E88.8 Disorders of catecholamine synthesis
- 5C59.01/E88.8 Disorders of pterin metabolism
- 5C59.0Y/E88.8 Other specified disorders of biogenic amine metabolism
- 5C59.0Z/E88.8 Disorders of biogenic amine metabolism, unspecified
- 5C59.1/E88.8 Disorders of gamma aminobutyric acid metabolism
- 5C59.2/E88.8 Disorders of pyridoxine metabolism
- 5C59/E88.8 Inborn errors of neurotransmitter metabolism
- 5C59.Y/E88.8 Other specified inborn errors of neurotransmitter metabolism
- 5C59.Z/E88.8 Inborn errors of neurotransmitter metabolism, unspecified
- 5C5A/E88.0 Alpha-1-antitrypsin deficiency
- 5C5Y/E70-E90 Other specified inborn errors of metabolism
- 5C5Z/E70-E90 Inborn errors of metabolism, unspecified
- 5C60.0/E72.0 Oculocerebrorenal syndrome
- 5C60.1/E72.0 Cystinosis
- 5C60.2/E72.0 Cystinuria
- 5C60/E72.0 Disorders of amino acid absorption or transport
- 5C60.Y/E72.0 Other specified disorders of amino acid absorption or transport
- 5C60.Z/E72.0 Disorders of amino acid absorption or transport, unspecified
- 5C61.0/E74.3 Glucose-galactose malabsorption
- 5C61.1/E74.3 Maltase-glucoamylase deficiency
- 5C61.2/E74.3 Congenital sucrase-isomaltase deficiency
- 5C61.3/E74.8 Alpha, alpha trehalase deficiency
- 5C61.4/E74.3 Acquired monosaccharide malabsorption
- 5C61.40/E74.1 Fructose malabsorption
- 5C61.4Y/E74.3 Other specified acquired monosaccharide malabsorption
- 5C61.4Z/E74.3 Acquired monosaccharide malabsorption, unspecified
- 5C61.5/E74.8 Disorders of facilitated glucose transport
- 5C61.6/E73 Lactose intolerance
- 5C61.60/E73 Primary lactase deficiency
- 5C61.61/E73.0 Congenital lactase deficiency
- 5C61.62/E73.1 Secondary lactase deficiency
- 5C61.6Z/E73 Lactose intolerance, unspecified
- 5C61/E70-E90 Disorders of carbohydrate absorption or transport
- 5C61.Y/E70-E90 Other specified disorders of carbohydrate absorption or transport
- 5C61.Z/E70-E90 Disorders of carbohydrate absorption or transport, unspecified
- 5C62/E78.8 Disorders of lipid absorption or transport
- 5C63.0/E88.8 Disorders of cobalamin metabolism or transport
- 5C63.1/E88.8 Disorders of folate metabolism or transport
- 5C63.2/E88.8 Disorders of vitamin D metabolism or transport
- 5C63.20/E88.8 Hypocalcaemic vitamin D dependent rickets
- 5C63.21/E88.8 Hypocalcaemic vitamin D resistant rickets
- 5C63.22/E88.8 Hypophosphataemic rickets
- 5C63.2Y/E88.8 Other specified disorders of vitamin D metabolism or transport
- 5C63.2Z/E88.8 Disorders of vitamin D metabolism or transport, unspecified
- 5C63/E88.8 Disorders of vitamin or non-protein cofactor absorption or transport
- 5C63.Y/E88.8 Other specified disorders of vitamin or non-protein cofactor absorption or transport
- 5C63.Z/E88.8 Disorders of vitamin or non-protein cofactor absorption or transport, unspecified
- 5C64.0/E83.0 Disorders of copper metabolism
- 5C64.00/E83.0 Wilson disease
- 5C64.0Y/E83.0 Other specified disorders of copper metabolism
- 5C64.0Z/E83.0 Disorders of copper metabolism, unspecified
- 5C64.1/E83.1 Disorders of iron metabolism
- 5C64.10/E83.1 Iron overload diseases
- 5C64.1Y/E83.1 Other specified disorders of iron metabolism
- 5C64.1Z/E83.1 Disorders of iron metabolism, unspecified
- 5C64.2/E83.2 Disorders of zinc metabolism
- 5C64.20/E83.2 Acrodermatitis enteropathica
- 5C64.21/E83.2 Zinc deficiency syndromes
- 5C64.2Y/E83.2 Other specified disorders of zinc metabolism
- 5C64.2Z/E83.2 Disorders of zinc metabolism, unspecified
- 5C64.3/E83.3 Disorders of phosphorus metabolism or phosphatases
- 5C64.4/E83.4 Disorders of magnesium metabolism
- 5C64.40/E83.4 Hypermagnesaemia
- 5C64.41/E61.2 Hypomagnesaemia
- 5C64.4Z/E83.4 Disorders of magnesium metabolism, unspecified
- 5C64.5/E83.5 Disorders of calcium metabolism
- 5C64.6/E83 Disorders of sodium metabolism
- 5C64.7/E83 Disorders of chloride metabolism
- 5C64/E83 Disorders of mineral absorption or transport
- 5C64.Y/E83.8 Disorders of other specified mineral absorption and transport
- 5C64.Z/E83 Disorders of mineral absorption or transport, unspecified
- 5C6Y/E70-E90 Other specified disorders of metabolite absorption or transport
- 5C6Z/E70-E90 Disorders of metabolite absorption or transport, unspecified
- 5C70.0/E86 Dehydration
- 5C70.1/E86 Hypovolaemia
- 5C70/E86 Volume depletion
- 5C70.Y/E86 Other specified volume depletion
- 5C70.Z/E86 Volume depletion, unspecified
- 5C71/E87.0 Hyperosmolality or hypernatraemia
- 5C72/E87.1 Hypo-osmolality or hyponatraemia
- 5C73.0/E87.2 Acute respiratory acidosis
- 5C73.1/E87.2 Chronic respiratory acidosis
- 5C73.2/E87.2 Anion gap metabolic acidosis
- 5C73/E87.2 Acidosis
- 5C73.Y/E87.2 Other specified acidosis
- 5C73.Z/E87.2 Acidosis, unspecified
- 5C74/E87.3 Alkalosis
- 5C75/E87.4 Mixed disorder of acid-base balance
- 5C76/E87.5 Hyperkalaemia
- 5C77/E87.6 Hypokalaemia
- 5C78/E87.7 Fluid overload
- 5C7Y/E70-E90 Other specified disorders of fluid, electrolyte or acid-base balance
- 5C7Z/E70-E90 Disorders of fluid, electrolyte or acid-base balance, unspecified
- 5C80.0/E78.5 Hypercholesterolaemia
- 5C80.00/E78.0 Primary hypercholesterolaemia
- 5C80.01/E78.5 Secondary hypercholesterolaemia
- 5C80.0Z/E78.5 Hypercholesterolaemia, unspecified
- 5C80.1/E78.1 Hypertriglyceridaemia
- 5C80.2/E78.2 Mixed hyperlipidaemia
- 5C80.3/E78.5 Hyperalphalipoproteinaemia
- 5C80/E78.5 Hyperlipoproteinaemia
- 5C80.Y/E78.5 Other specified hyperlipoproteinaemia
- 5C80.Z/E78.5 Hyperlipoproteinaemia, unspecified
- 5C81.0/E78.6 Hypoalphalipoproteinaemia
- 5C81.1/E78.6 Hypobetalipoproteinaemia
- 5C81/E78.6 Hypolipoproteinaemia
- 5C81.Y/E78.6 Other specified hypolipoproteinaemia
- 5C81.Z/E78.6 Hypolipoproteinaemia, unspecified
- 5C8Y/E78.9 Other specified disorders of lipoprotein metabolism or lipidaemias
- 5C8Z/E78.9 Unspecified disorders of lipoprotein metabolism or lipidaemias
- 5C90.0/E70-E90 Liver diseases due to urea cycle defects
- 5C90.1/E70-E90 Liver diseases due to disorders of porphyrin or bilirubin metabolism or transport
- 5C90.2/E70-E90 Liver diseases due to disorders of amino acid metabolism
- 5C90.3/E75 Liver disease due to disorders of lysosomal storage
- 5C90.4/E70-E90 Liver diseases due to mitochondrial disorders
- 5C90.5/E83 Liver diseases due to disorders of mineral metabolism
- 5C90/E70-E90 Metabolic or transporter liver disease
- 5C90.Y/E70-E90 Other specified metabolic or transporter liver disease
- 5C90.Z/E70-E90 Metabolic or transporter liver disease, unspecified
- 5D00.0/E85.8 AL amyloidosis
- 5D00.1/E85.3 AA amyloidosis
- 5D00.2/E85.2 Hereditary amyloidosis
- 5D00.20/E85.1 Hereditary ATTR amyloidosis
- 5D00.21/E85.0 Non-neuropathic heredofamilial amyloidosis
- 5D00.2Y/E85.2 Other specified hereditary amyloidosis
- 5D00.2Z/E85.2 Hereditary amyloidosis, unspecified
- 5D00.3/E85 Dialysis-associated amyloidosis
- 5D00/E85 Amyloidosis
- 5D00.Y/E85.8 Other specified amyloidosis
- 5D00.Z/E85 Amyloidosis, unspecified
- 5D01/E88.3 Tumour lysis syndrome
- 5D0Y/E88.8 Other specified metabolic disorders
- 5D2Z/E70-E90 Metabolic disorders, unspecified
- 5D40.0/E89.0 Postirridation hypothyroidism
- 5D40.00/E89.0 Hypothyroidism postradioactive iodine ablation
- 5D40.0Y/E89.0 Other specified postirridation hypothyroidism
- 5D40.0Z/E89.0 Postirridation hypothyroidism, unspecified
- 5D40/E89.0 Postprocedural hypothyroidism
- 5D40.Y/E89.0 Other specified postprocedural hypothyroidism
- 5D40.Z/E89.0 Postprocedural hypothyroidism, unspecified
- 5D41/E89.1 Postprocedural hypoinsulinaemia
- 5D42/E89.2 Postprocedural hypoparathyroidism
- 5D43/E89.3 Postprocedural hypopituitarism
- 5D44/E89.4 Postprocedural ovarian failure
- 5D45/E89.5 Postprocedural testicular hypofunction
- 5D46/E89.6 Postprocedural adrenocortical hypofunction
- 6A00.0/F70 Disorder of intellectual development, mild
- 6A00.1/F71 Disorder of intellectual development, moderate
- 6A00.2/F72 Disorder of intellectual development, severe
- 6A00.3/F73 Disorder of intellectual development, profound
- 6A00.4/F70-F79 Disorder of intellectual development, provisional
- 6A00/F70-F79 Disorders of intellectual development
- 6A00.Z/F70-F79 Disorders of intellectual development, unspecified
- 6A01.0/F80.0 Developmental speech sound disorder
- 6A01.1/F80.8 Developmental speech fluency disorder
- 6A01.2/F80.9 Developmental language disorder
- 6A01.20/F80.2 Developmental language disorder with impairment of receptive and expressive language
- 6A01.21/F80.1 Developmental language disorder with impairment of mainly expressive language
- 6A01.22/F80.8 Developmental language disorder with impairment of mainly pragmatic language
- 6A01.23/F80.8 Developmental language disorder, with other specified language impairment
- 6A01/F80-F89 Developmental speech or language disorders
- 6A01.Y/F80-F89 Other specified developmental speech or language disorders
- 6A01.Z/F80-F89 Developmental speech or language disorders, unspecified
- 6A02.0/F80-F89 Autism spectrum disorder without disorder of intellectual development and with mild or no impairment of functional language
- 6A02.1/F80-F89 Autism spectrum disorder with disorder of intellectual development and with mild or no impairment of functional language
- 6A02.2/F80-F89 Autism spectrum disorder without disorder of intellectual development and with impaired functional language
- 6A02.3/F80-F89 Autism spectrum disorder with disorder of intellectual development and with impaired functional language
- 6A02.5/F80-F89 Autism spectrum disorder with disorder of intellectual development and with absence of functional language
- 6A02/F80-F89 Autism spectrum disorder
- 6A02.Y/F80-F89 Other specified autism spectrum disorder
- 6A02.Z/F80-F89 Autism spectrum disorder, unspecified
- 6A03.0/F81.0 Developmental learning disorder with impairment in reading
- 6A03.1/F81.1 Developmental learning disorder with impairment in written expression
- 6A03.2/F81.2 Developmental learning disorder with impairment in mathematics
- 6A03.3/F81 Developmental learning disorder with other specified impairment of learning
- 6A03/F81 Developmental learning disorder
- 6A03.Z/F81 Developmental learning disorder, unspecified
- 6A04/F82 Developmental motor coordination disorder
- 6A05.0/F80-F89 Attention deficit hyperactivity disorder, predominantly inattentive presentation
- 6A05.1/F80-F89 Attention deficit hyperactivity disorder, predominantly hyperactive-impulsive presentation
- 6A05.2/F80-F89 Attention deficit hyperactivity disorder, combined presentation
- 6A05/F80-F89 Attention deficit hyperactivity disorder
- 6A05.Y/F80-F89 Attention deficit hyperactivity disorder, other specified presentation
- 6A05.Z/F80-F89 Attention deficit hyperactivity disorder, presentation unspecified
- 6A06.0/F98.4 Stereotyped movement disorder without self-injury
- 6A06.1/F98.4 Stereotyped movement disorder with self-injury
- 6A06/F98.4 Stereotyped movement disorder
- 6A06.Z/F98.4 Stereotyped movement disorder, unspecified
- 6A0Y/F80-F89 Other specified neurodevelopmental disorders
- 6A0Z/F80-F89 Neurodevelopmental disorders, unspecified
- 6A20.0/F20 Schizophrenia, first episode
- 6A20.00/F20 Schizophrenia, first episode, currently symptomatic
- 6A20.01/F20 Schizophrenia, first episode, in partial remission
- 6A20.02/F20 Schizophrenia, first episode, in full remission
- 6A20.0Z/F20 Schizophrenia, first episode, unspecified
- 6A20.1/F20 Schizophrenia, multiple episodes
- 6A20.10/F20 Schizophrenia, multiple episodes, currently symptomatic
- 6A20.11/F20 Schizophrenia, multiple episodes, in partial remission
- 6A20.12/F20 Schizophrenia, multiple episodes, in full remission
- 6A20.1Z/F20 Schizophrenia, multiple episodes, unspecified
- 6A20.2/F20 Schizophrenia, continuous
- 6A20.20/F20 Schizophrenia, continuous, currently symptomatic
- 6A20.21/F20 Schizophrenia, continuous, in partial remission
- 6A20.22/F20 Schizophrenia, continuous, in full remission
- 6A20.2Z/F20 Schizophrenia, continuous, unspecified
- 6A20/F20 Schizophrenia
- 6A20.Y/F20.8 Other specified episode of schizophrenia
- 6A20.Z/F20 Schizophrenia, episode unspecified
- 6A21.0/F25 Schizoaffective disorder, first episode
- 6A21.00/F25 Schizoaffective disorder, first episode, currently symptomatic
- 6A21.01/F25 Schizoaffective disorder, first episode, in partial remission
- 6A21.02/F25 Schizoaffective disorder, first episode, in full remission
- 6A21.0Z/F25 Schizoaffective disorder, first episode, unspecified
- 6A21.1/F25 Schizoaffective disorder, multiple episodes
- 6A21.10/F25 Schizoaffective disorder, multiple episodes, currently symptomatic
- 6A21.11/F25 Schizoaffective disorder, multiple episodes, in partial remission
- 6A21.12/F25 Schizoaffective disorder, multiple episodes, in full remission
- 6A21.1Z/F25 Schizoaffective disorder, multiple episodes, unspecified
- 6A21.2/F25 Schizoaffective disorder, continuous
- 6A21.20/F25 Schizoaffective disorder, continuous, currently symptomatic
- 6A21.21/F25 Schizoaffective disorder, continuous, in partial remission
- 6A21.22/F25 Schizoaffective disorder, continuous, in full remission
- 6A21.2Z/F25 Schizoaffective disorder, continuous, unspecified
- 6A21/F25 Schizoaffective disorder
- 6A21.Y/F25.8 Other specified schizoaffective disorder
- 6A21.Z/F25 Schizoaffective disorder, unspecified
- 6A22/F21 Schizotypal disorder
- 6A23.0/F23 Acute and transient psychotic disorder, first episode
- 6A23.00/F23 Acute and transient psychotic disorder, first episode, currently symptomatic
- 6A23.01/F23 Acute and transient psychotic disorder, first episode, in partial remission
- 6A23.02/F23 Acute and transient psychotic disorder, first episode, in full remission
- 6A23.0Z/F23 Acute and transient psychotic disorder, first episode, unspecified
- 6A23.1/F23 Acute and transient psychotic disorder, multiple episodes
- 6A23.10/F23 Acute and transient psychotic disorder, multiple episodes, currently symptomatic
- 6A23.11/F23 Acute and transient psychotic disorder, multiple episodes, in partial remission
- 6A23.12/F23 Acute and transient psychotic disorder, multiple episodes, in full remission
- 6A23.1Z/F23 Acute and transient psychotic disorder, multiple episodes, unspecified
- 6A23/F23 Acute and transient psychotic disorder
- 6A23.Y/F23.8 Other specified acute and transient psychotic disorder
- 6A23.Z/F23 Acute and transient psychotic disorder, unspecified
- 6A24.0/F22.9 Delusional disorder, currently symptomatic
- 6A24.1/F22.9 Delusional disorder, in partial remission
- 6A24.2/F22.9 Delusional disorder, in full remission
- 6A24/F22.9 Delusional disorder
- 6A24.Z/F22.9 Delusional disorder, unspecified
- 6A25.0/F20-F29 Positive symptoms in primary psychotic disorders
- 6A25.1/F20-F29 Negative symptoms in primary psychotic disorders
- 6A25.2/F20-F29 Depressive mood symptoms in primary psychotic disorders
- 6A25.3/F20-F29 Manic mood symptoms in primary psychotic disorders
- 6A25.4/F20-F29 Psychomotor symptoms in primary psychotic disorders
- 6A25.5/F20-F29 Cognitive symptoms in primary psychotic disorders
- 6A25/F20-F29 Symptomatic manifestations of primary psychotic disorders
- 6A2Y/F20-F29 Other specified primary psychotic disorder
- 6A2Z/F20-F29 Schizophrenia or other primary psychotic disorders, unspecified
- 6A40/F06.1 Catatonia associated with another mental disorder
- 6A41/F06.1 Catatonia induced by substances or medications
- 6A4Z/F06.1 Catatonia, unspecified
- 6A60.0/F31.1 Bipolar type I disorder, current episode manic, without psychotic symptoms
- 6A60.1/F31.2 Bipolar type I disorder, current episode manic, with psychotic symptoms
- 6A60.2/F31.0 Bipolar type I disorder, current episode hypomanic
- 6A60.3/F31.3 Bipolar type I disorder, current episode depressive, mild
- 6A60.4/F31 Bipolar type I disorder, current episode depressive, moderate without psychotic symptoms
- 6A60.5/F31 Bipolar type I disorder, current episode depressive, moderate with psychotic symptoms
- 6A60.6/F31.4 Bipolar type I disorder, current episode depressive, severe without psychotic symptoms
- 6A60.7/F31.5 Bipolar type I disorder, current episode depressive, severe with psychotic symptoms
- 6A60.8/F31 Bipolar type I disorder, current episode depressive, unspecified severity
- 6A60.9/F31.6 Bipolar type I disorder, current episode mixed, without psychotic symptoms
- 6A60.A/F31 Bipolar type I disorder, current episode mixed, with psychotic symptoms
- 6A60.B/F31 Bipolar type I disorder, currently in partial remission, most recent episode manic or hypomanic
- 6A60.C/F31 Bipolar type I disorder, currently in partial remission, most recent episode depressive
- 6A60.D/F31 Bipolar type I disorder, currently in partial remission, most recent episode mixed
- 6A60.E/F31 Bipolar type I disorder, currently in partial remission, most recent episode unspecified
- 6A60.F/F31.7 Bipolar type I disorder, currently in full remission
- 6A60/F31 Bipolar type I disorder
- 6A60.Y/F31.8 Other specified bipolar type I disorder
- 6A60.Z/F31 Bipolar type I disorder, unspecified
- 6A61.0/F31 Bipolar type II disorder, current episode hypomanic
- 6A61.1/F31 Bipolar type II disorder, current episode depressive, mild
- 6A61.2/F31 Bipolar type II disorder, current episode depressive, moderate without psychotic symptoms
- 6A61.3/F31 Bipolar type II disorder, current episode depressive, moderate with psychotic symptoms
- 6A61.4/F31 Bipolar type II disorder, current episode depressive, severe without psychotic symptoms
- 6A61.5/F31 Bipolar type II disorder, current episode depressive, severe with psychotic symptoms
- 6A61.6/F31 Bipolar type II disorder, current episode depressive, unspecified severity
- 6A61.7/F31 Bipolar type II disorder, currently in partial remission, most recent episode hypomanic
- 6A61.8/F31 Bipolar type II disorder, currently in partial remission, most recent episode depressive
- 6A61.9/F31 Bipolar type II disorder, currently in partial remission, most recent episode unspecified
- 6A61.A/F31 Bipolar type II disorder, currently in full remission
- 6A61/F31 Bipolar type II disorder
- 6A61.Y/F31.8 Other specified bipolar type II disorder
- 6A61.Z/F31 Bipolar type II disorder, unspecified
- 6A62/F34.0 Cyclothymic disorder
- 6A6Y/F31.9 Other specified bipolar or related disorders
- 6A6Z/F31.9 Bipolar or related disorders, unspecified
- 6A70.0/F32.0 Single episode depressive disorder, mild
- 6A70.1/F32.1 Single episode depressive disorder, moderate, without psychotic symptoms
- 6A70.2/F32 Single episode depressive disorder, moderate, with psychotic symptoms
- 6A70.3/F32.2 Single episode depressive disorder, severe, without psychotic symptoms
- 6A70.4/F32.3 Single episode depressive disorder, severe, with psychotic symptoms
- 6A70.5/F32 Single episode depressive disorder, unspecified severity
- 6A70.6/F32 Single episode depressive disorder, currently in partial remission
- 6A70.7/F32 Single episode depressive disorder, currently in full remission
- 6A70/F32 Single episode depressive disorder
- 6A70.Y/F32.8 Other specified single episode depressive disorder
- 6A70.Z/F32 Single episode depressive disorder, unspecified
- 6A71.0/F33.0 Recurrent depressive disorder, current episode mild
- 6A71.1/F33.1 Recurrent depressive disorder, current episode moderate, without psychotic symptoms
- 6A71.2/F33 Recurrent depressive disorder, current episode moderate, with psychotic symptoms
- 6A71.3/F33.2 Recurrent depressive disorder, current episode severe, without psychotic symptoms
- 6A71.4/F33.3 Recurrent depressive disorder, current episode severe, with psychotic symptoms
- 6A71.5/F33 Recurrent depressive disorder, current episode, unspecified severity
- 6A71.6/F33 Recurrent depressive disorder, currently in partial remission
- 6A71.7/F33.4 Recurrent depressive disorder, currently in full remission
- 6A71/F33 Recurrent depressive disorder
- 6A71.Y/F33.8 Other specified recurrent depressive disorder
- 6A71.Z/F33 Recurrent depressive disorder, unspecified
- 6A72/F34.1 Dysthymic disorder
- 6A73/F41.2 Mixed depressive and anxiety disorder
- 6A7Y/F32.9 Other specified depressive disorders
- 6A7Z/F32.9 Depressive disorders, unspecified
- 6A80.0/F30.9 Prominent anxiety symptoms in mood episodes
- 6A80.1/F30.9 Panic attacks in mood episodes
- 6A80.2/F30.9 Current depressive episode persistent
- 6A80.3/F30.9 Current depressive episode with melancholia
- 6A80.4/F30.9 Seasonal pattern of mood episode onset
- 6A80.5/F30.9 Rapid cycling
- 6A80/F30.9 Symptomatic and course presentations for mood episodes in mood disorders
- 6A8Y/F30.9 Other specified mood disorders
- 6A8Z/F30.9 Mood disorders, unspecified
- 6B00/F41.1 Generalised anxiety disorder
- 6B01/F41.0 Panic disorder
- 6B02/F40.0 Agoraphobia
- 6B03/F40.2 Specific phobia
- 6B04/F40.1 Social anxiety disorder
- 6B05/F93.0 Separation anxiety disorder
- 6B06/F94.0 Selective mutism
- 6B0Y/F41.8 Other specified anxiety or fear-related disorders
- 6B0Z/F41 Anxiety or fear-related disorders, unspecified
- 6B20.0/F42 Obsessive-compulsive disorder with fair to good insight
- 6B20.1/F42 Obsessive-compulsive disorder with poor to absent insight
- 6B20/F42 Obsessive-compulsive disorder
- 6B20.Z/F42 Obsessive-compulsive disorder, unspecified
- 6B21.0/F45.2 Body dysmorphic disorder with fair to good insight
- 6B21.1/F45.2 Body dysmorphic disorder with poor to absent insight
- 6B21/F45.2 Body dysmorphic disorder
- 6B21.Z/F45.2 Body dysmorphic disorder, unspecified
- 6B22.0/F42.8 Olfactory reference disorder with fair to good insight
- 6B22.1/F42.8 Olfactory reference disorder with poor to absent insight
- 6B22/F42.8 Olfactory reference disorder
- 6B22.Z/F42.8 Olfactory reference disorder, unspecified
- 6B23.0/F45.2 Hypochondriasis with fair to good insight
- 6B23.1/F45.2 Hypochondriasis with poor to absent insight
- 6B23/F45.2 Hypochondriasis
- 6B23.Z/F45.2 Hypochondriasis, unspecified
- 6B24.0/F63.8 Hoarding disorder with fair to good insight
- 6B24.1/F63.8 Hoarding disorder with poor to absent insight
- 6B24/F63.8 Hoarding disorder
- 6B24.Z/F63.8 Hoarding disorder, unspecified
- 6B25.0/F63.3 Trichotillomania
- 6B25.1/L98.1 Excoriation disorder
- 6B25/F42.8 Body-focused repetitive behaviour disorders
- 6B25.Y/F42.8 Other specified body-focused repetitive behaviour disorders
- 6B25.Z/F42.8 Body-focused repetitive behaviour disorders, unspecified
- 6B2Y/F99-F99 Other specified obsessive-compulsive or related disorders
- 6B2Z/F99-F99 Obsessive-compulsive or related disorders, unspecified
- 6B40/F43.1 Post traumatic stress disorder
- 6B41/F62.0 Complex post traumatic stress disorder
- 6B42/F43 Prolonged grief disorder
- 6B43/F43.2 Adjustment disorder
- 6B44/F94.1 Reactive attachment disorder
- 6B45/F94.2 Disinhibited social engagement disorder
- 6B4Y/F43.8 Other specified disorders specifically associated with stress
- 6B4Z/F43 Disorders specifically associated with stress, unspecified
- 6B60.0/F48.9 Dissociative neurological symptom disorder, with visual disturbance
- 6B60.1/F48.9 Dissociative neurological symptom disorder, with auditory disturbance
- 6B60.2/F48.9 Dissociative neurological symptom disorder, with vertigo or dizziness
- 6B60.3/F44.6 Dissociative neurological symptom disorder, with other sensory disturbance
- 6B60.4/F44.5 Dissociative neurological symptom disorder, with non-epileptic seizures
- 6B60.5/F48.9 Dissociative neurological symptom disorder, with speech disturbance
- 6B60.6/F48.9 Dissociative neurological symptom disorder, with paresis or weakness
- 6B60.7/F48.9 Dissociative neurological symptom disorder, with gait disturbance
- 6B60.8/F44.4 Dissociative neurological symptom disorder, with movement disturbance
- 6B60.80/F44.4 Dissociative neurological symptom disorder, with chorea
- 6B60.81/F44.4 Dissociative neurological symptom disorder, with myoclonus
- 6B60.82/F44.4 Dissociative neurological symptom disorder, with tremor
- 6B60.83/F44.4 Dissociative neurological symptom disorder, with dystonia
- 6B60.84/F44.4 Dissociative neurological symptom disorder, with facial spasm
- 6B60.85/F44.4 Dissociative neurological symptom disorder, with Parkinsonism
- 6B60.8Y/F44.4 Dissociative neurological symptom disorder, with other specified movement disturbance
- 6B60.8Z/F44.4 Dissociative neurological symptom disorder, with unspecified movement disturbance
- 6B60.9/F48.9 Dissociative neurological symptom disorder, with cognitive symptoms
- 6B60/F48.9 Dissociative neurological symptom disorder
- 6B60.Y/F48.9 Dissociative neurological symptom disorder, with other specified symptoms
- 6B60.Z/F48.9 Dissociative neurological symptom disorder, with unspecified symptoms
- 6B61.0/F44.1 Dissociative amnesia with dissociative fugue
- 6B61.1/F44.0 Dissociative amnesia without dissociative fugue
- 6B61/F44.0 Dissociative amnesia
- 6B61.Z/F44.0 Dissociative amnesia, unspecified
- 6B62/F48.9 Trance disorder
- 6B63/F44.3 Possession trance disorder
- 6B64/F48.9 Dissociative identity disorder
- 6B65/F48.9 Partial dissociative identity disorder
- 6B66/F48.1 Depersonalization-derealization disorder
- 6B6Y/F48.9 Other specified dissociative disorders
- 6B6Z/F48.9 Dissociative disorders, unspecified
- 6B80.0/F50 Anorexia Nervosa with significantly low body weight
- 6B80.00/F50 Anorexia Nervosa with significantly low body weight, restricting pattern
- 6B80.01/F50 Anorexia Nervosa with significantly low body weight, binge-purge pattern
- 6B80.0Z/F50 Anorexia Nervosa with significantly low body weight, unspecified
- 6B80.1/F50 Anorexia Nervosa with dangerously low body weight
- 6B80.10/F50 Anorexia Nervosa with dangerously low body weight, restricting pattern
- 6B80.11/F50 Anorexia Nervosa with dangerously low body weight, binge-purge pattern
- 6B80.1Z/F50 Anorexia Nervosa with dangerously low body weight, unspecified
- 6B80.2/F50 Anorexia Nervosa in recovery with normal body weight
- 6B80/F50 Anorexia Nervosa
- 6B80.Y/F50.8 Other specified anorexia Nervosa
- 6B80.Z/F50 Anorexia Nervosa, unspecified
- 6B81/F50 Bulimia Nervosa
- 6B82/F50 Binge eating disorder
- 6B83/F50 Avoidant-restrictive food intake disorder
- 6B84/F98.3 Pica
- 6B85/F50 Rumination-regurgitation disorder
- 6B8Y/F50.8 Other specified feeding or eating disorders
- 6B8Z/F50 Feeding or eating disorders, unspecified
- 6C00.0/F98.0 Nocturnal enuresis
- 6C00.1/F98.0 Diurnal enuresis
- 6C00.2/F98.0 Nocturnal and diurnal enuresis
- 6C00/F98.0 Enuresis
- 6C00.Z/F98.0 Enuresis, unspecified
- 6C01.0/F99-F99 Encopresis with constipation or overflow incontinence
- 6C01.1/F99-F99 Encopresis without constipation or overflow incontinence
- 6C01/F99-F99 Encopresis
- 6C01.Z/F99-F99 Encopresis, unspecified
- 6C0Z/F99-F99 Elimination disorders, unspecified
- 6C20.0/F45 Mild bodily distress disorder
- 6C20.1/F45 Moderate bodily distress disorder
- 6C20.2/F45 Severe bodily distress disorder
- 6C20/F45 Bodily distress disorder
- 6C20.Z/F45 Bodily distress disorder, unspecified
- 6C21/F99-F99 Body integrity dysphoria
- 6C2Y/F99-F99 Other specified disorders of bodily distress or bodily experience
- 6C2Z/F99-F99 Disorders of bodily distress or bodily experience, unspecified
- 6C40.0/F10 Episode of harmful use of alcohol
- 6C40.1/F10.1 Harmful pattern of use of alcohol
- 6C40.10/F10.1 Harmful pattern of use of alcohol, episodic
- 6C40.11/F10.1 Harmful pattern of use of alcohol, continuous
- 6C40.1Z/F10.1 Harmful pattern of use of alcohol, unspecified
- 6C40.2/F10.2 Alcohol dependence
- 6C40.20/F10.2 Alcohol dependence, current use, continuous
- 6C40.21/F10.2 Alcohol dependence, current use, episodic
- 6C40.22/F10.2 Alcohol dependence, early full remission
- 6C40.23/F10.2 Alcohol dependence, sustained partial remission
- 6C40.24/F10.2 Alcohol dependence, sustained full remission
- 6C40.2Z/F10.2 Alcohol dependence, unspecified
- 6C40.3/F10.0 Alcohol intoxication
- 6C40.4/F10.3 Alcohol withdrawal
- 6C40.40/F10.3 Alcohol withdrawal, uncomplicated
- 6C40.41/F10.3 Alcohol withdrawal with perceptual disturbances
- 6C40.42/F10.3 Alcohol withdrawal with seizures
- 6C40.43/F10.3 Alcohol withdrawal with perceptual disturbances and seizures
- 6C40.4Z/F10.3 Alcohol withdrawal, unspecified
- 6C40.5/F10.4 Alcohol-induced delirium
- 6C40.6/F10.5 Alcohol-induced psychotic disorder
- 6C40.60/F10.5 Alcohol-induced psychotic disorder with hallucinations
- 6C40.61/F10.5 Alcohol-induced psychotic disorder with delusions
- 6C40.62/F10.5 Alcohol-induced psychotic disorder with mixed psychotic symptoms
- 6C40.6Z/F10.5 Alcohol-induced psychotic disorder, unspecified
- 6C40.7/F10 Certain specified alcohol-induced mental or behavioural disorders
- 6C40.70/F10 Alcohol-induced mood disorder
- 6C40.71/F10 Alcohol-induced anxiety disorder
- 6C40/F10 Disorders due to use of alcohol
- 6C40.Y/F10.8 Other specified disorders due to use of alcohol
- 6C40.Z/F10 Disorders due to use of alcohol, unspecified
- 6C41.0/F12 Episode of harmful use of cannabis
- 6C41.1/F12.1 Harmful pattern of use of cannabis
- 6C41.10/F12.1 Harmful pattern of use of cannabis, episodic
- 6C41.11/F12.1 Harmful pattern of use of cannabis, continuous
- 6C41.1Z/F12.1 Harmful pattern of use of cannabis, unspecified
- 6C41.2/F12.2 Cannabis dependence
- 6C41.20/F12.2 Cannabis dependence, current use
- 6C41.21/F12.2 Cannabis dependence, early full remission
- 6C41.22/F12.2 Cannabis dependence, sustained partial remission
- 6C41.23/F12.2 Cannabis dependence, sustained full remission
- 6C41.2Z/F12.2 Cannabis dependence, unspecified
- 6C41.3/F12.0 Cannabis intoxication
- 6C41.4/F12.3 Cannabis withdrawal
- 6C41.5/F12.4 Cannabis-induced delirium
- 6C41.6/F12 Cannabis-induced psychotic disorder
- 6C41.7/F12 Certain specified cannabis-induced mental or behavioural disorders
- 6C41.70/F12 Cannabis-induced mood disorder
- 6C41.71/F12 Cannabis-induced anxiety disorder
- 6C41/F12 Disorders due to use of cannabis
- 6C41.Y/F12.8 Other specified disorders due to use of cannabis
- 6C41.Z/F12 Disorders due to use of cannabis, unspecified
- 6C42.0/F12.1 Episode of harmful use of synthetic cannabinoids
- 6C42.1/F12.1 Harmful pattern of use of synthetic cannabinoids
- 6C42.10/F12.1 Harmful pattern of use of synthetic cannabinoids, episodic
- 6C42.11/F12.1 Harmful pattern of use of synthetic cannabinoids, continuous
- 6C42.1Y/F12.1 Other specified harmful pattern of use of synthetic cannabinoids
- 6C42.1Z/F12.1 Harmful pattern of use of synthetic cannabinoids, unspecified
- 6C42.2/F12.2 Synthetic cannabinoid dependence
- 6C42.20/F12.2 Synthetic cannabinoid dependence, current use
- 6C42.21/F12.2 Synthetic cannabinoid dependence, early full remission
- 6C42.22/F12.2 Synthetic cannabinoid dependence, sustained partial remission
- 6C42.23/F12.2 Synthetic cannabinoid dependence, sustained full remission
- 6C42.2Y/F12.2 Other specified synthetic cannabinoid dependence
- 6C42.2Z/F12.2 Synthetic cannabinoid dependence, unspecified
- 6C42.3/F12.0 Synthetic cannabinoid intoxication
- 6C42.4/F12.3 Synthetic cannabinoid withdrawal
- 6C42.5/F12.4 Synthetic cannabinoid-induced delirium
- 6C42.6/F12 Synthetic cannabinoid-induced psychotic disorder
- 6C42.7/F12.9 Certain specified synthetic cannabinoids-induced mental or behavioural disorders
- 6C42.70/F12.9 Synthetic cannabinoid-induced mood disorder
- 6C42.71/F12.8 Synthetic cannabinoid-induced anxiety disorder
- 6C42/F12.9 Disorders due to use of synthetic cannabinoids
- 6C42.Y/F12.9 Other specified disorders due to use of synthetic cannabinoids
- 6C42.Z/F12.9 Disorders due to use of synthetic cannabinoids, unspecified
- 6C43.0/F11 Episode of harmful use of opioids
- 6C43.1/F11.1 Harmful pattern of use of opioids
- 6C43.10/F11.1 Harmful pattern of use of opioids, episodic
- 6C43.11/F11.1 Harmful pattern of use of opioids, continuous
- 6C43.1Z/F11.1 Harmful pattern of use of opioids, unspecified
- 6C43.2/F11.2 Opioid dependence
- 6C43.20/F11.2 Opioid dependence, current use
- 6C43.21/F11.2 Opioid dependence, early full remission
- 6C43.22/F11.2 Opioid dependence, sustained partial remission
- 6C43.23/F11.2 Opioid dependence, sustained full remission
- 6C43.2Z/F11.2 Opioid dependence, unspecified
- 6C43.3/F11.0 Opioid intoxication
- 6C43.4/F11.3 Opioid withdrawal
- 6C43.5/F11.4 Opioid-induced delirium
- 6C43.6/F11 Opioid-induced psychotic disorder
- 6C43.7/F11 Certain specified opioid-induced mental or behavioural disorders
- 6C43.70/F11 Opioid-induced mood disorder
- 6C43.71/F11 Opioid-induced anxiety disorder
- 6C43/F11 Disorders due to use of opioids
- 6C43.Y/F11.8 Other specified disorders due to use of opioids
- 6C43.Z/F11 Disorders due to use of opioids, unspecified
- 6C44.0/F13 Episode of harmful use of sedatives, hypnotics or anxiolytics
- 6C44.1/F13.1 Harmful pattern of use of sedatives, hypnotics or anxiolytics
- 6C44.10/F13.1 Harmful pattern of use of sedatives, hypnotics or anxiolytics, episodic
- 6C44.11/F13.1 Harmful pattern of use of sedatives, hypnotics or anxiolytics, continuous
- 6C44.1Z/F13.1 Harmful pattern of use of sedatives, hypnotics or anxiolytics, unspecified
- 6C44.2/F13.2 Sedative, hypnotic or anxiolytic dependence
- 6C44.20/F13.2 Sedative, hypnotic or anxiolytic dependence, current use
- 6C44.21/F13.2 Sedative, hypnotic or anxiolytic dependence, early full remission
- 6C44.22/F13.2 Sedative, hypnotic or anxiolytic dependence, sustained partial remission
- 6C44.23/F13.2 Sedative, hypnotic or anxiolytic dependence, sustained full remission
- 6C44.2Z/F13.2 Sedative, hypnotic or anxiolytic dependence, unspecified
- 6C44.3/F13.0 Sedative, hypnotic or anxiolytic intoxication
- 6C44.4/F13.3 Sedative, hypnotic or anxiolytic withdrawal
- 6C44.40/F13.3 Sedative, hypnotic or anxiolytic withdrawal, uncomplicated
- 6C44.41/F13.3 Sedative, hypnotic or anxiolytic withdrawal, with perceptual disturbances
- 6C44.42/F13.3 Sedative, hypnotic or anxiolytic withdrawal, with seizures
- 6C44.43/F13.3 Sedative, hypnotic or anxiolytic withdrawal, with perceptual disturbances and seizures
- 6C44.4Z/F13.3 Sedative, hypnotic or anxiolytic withdrawal, unspecified
- 6C44.5/F13.4 Sedative, hypnotic or anxiolytic-induced delirium
- 6C44.6/F13 Sedative, hypnotic or anxiolytic-induced psychotic disorder
- 6C44.7/F13 Certain specified sedatives, hypnotics or anxiolytic-induced mental or behavioural disorders
- 6C44.70/F13.8 Sedative, hypnotic or anxiolytic-induced mood disorder
- 6C44.71/F13.8 Sedative, hypnotic or anxiolytic-induced anxiety disorder
- 6C44/F13 Disorders due to use of sedatives, hypnotics or anxiolytics
- 6C44.Y/F13.8 Other specified disorders due to use of sedatives, hypnotics or anxiolytics
- 6C44.Z/F13 Disorders due to use of sedatives, hypnotics or anxiolytics, unspecified
- 6C45.0/F14 Episode of harmful use of cocaine
- 6C45.1/F14.1 Harmful pattern of use of cocaine
- 6C45.10/F14.1 Harmful pattern of use of cocaine, episodic
- 6C45.11/F14.1 Harmful pattern of use of cocaine, continuous
- 6C45.1Z/F14.1 Harmful pattern of use of cocaine, unspecified
- 6C45.2/F14.2 Cocaine dependence
- 6C45.20/F14.2 Cocaine dependence, current use
- 6C45.21/F14.2 Cocaine dependence, early full remission
- 6C45.22/F14.2 Cocaine dependence, sustained partial remission
- 6C45.23/F14.2 Cocaine dependence, sustained full remission
- 6C45.2Z/F14.2 Cocaine dependence, unspecified
- 6C45.3/F14.0 Cocaine intoxication
- 6C45.4/F14.3 Cocaine withdrawal
- 6C45.5/F14.4 Cocaine-induced delirium
- 6C45.6/F14 Cocaine-induced psychotic disorder
- 6C45.60/F14 Cocaine-induced psychotic disorder with hallucinations
- 6C45.61/F14 Cocaine-induced psychotic disorder with delusions
- 6C45.62/F14 Cocaine-induced psychotic disorder with mixed psychotic symptoms
- 6C45.6Z/F14 Cocaine-induced psychotic disorder, unspecified
- 6C45.7/F14 Certain specified cocaine-induced mental or behavioural disorders
- 6C45.70/F14 Cocaine-induced mood disorder
- 6C45.71/F14 Cocaine-induced anxiety disorder
- 6C45.72/F14 Cocaine-induced obsessive-compulsive or related disorder
- 6C45.73/F14 Cocaine-induced impulse control disorder
- 6C45/F14 Disorders due to use of cocaine
- 6C45.Y/F14.8 Other specified disorders due to use of cocaine
- 6C45.Z/F14 Disorders due to use of cocaine, unspecified
- 6C46.0/F15.9 Episode of harmful use of stimulants including amphetamines, methamphetamine or methcathinone
- 6C46.1/F15.1 Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone
- 6C46.10/F15.1 Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone, episodic
- 6C46.11/F15.1 Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone, continuous
- 6C46.1Z/F15.1 Harmful pattern of use of stimulants including amphetamines, methamphetamine and methcathinone, unspecified
- 6C46.2/F15.2 Stimulant dependence including amphetamines, methamphetamine or methcathinone
- 6C46.20/F15.2 Stimulant dependence including amphetamines, methamphetamine or methcathinone, current use
- 6C46.21/F15.2 Stimulant dependence including amphetamines, methamphetamine or methcathinone, early full remission
- 6C46.22/F15.2 Stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained partial remission
- 6C46.23/F15.2 Stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained full remission
- 6C46.2Z/F15.2 Stimulant dependence including amphetamines, methamphetamine or methcathinone, unspecified
- 6C46.3/F15.0 Stimulant intoxication including amphetamines, methamphetamine or methcathinone
- 6C46.4/F15.3 Stimulant withdrawal including amphetamines, methamphetamine or methcathinone
- 6C46.5/F15.4 Stimulant-induced delirium including amphetamines, methamphetamine or methcathinone
- 6C46.6/F15 Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone
- 6C46.60/F15 Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone with hallucinations
- 6C46.61/F15 Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone with delusions
- 6C46.62/F15 Stimulant-induced psychotic disorder including amphetamines but excluding caffeine or cocaine with mixed psychotic symptoms
- 6C46.6Z/F15 Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone, unspecified
- 6C46.7/F15.9 Certain specified stimulant-induced mental or behavioural disorders including amphetamines, methamphetamine or methcathinone
- 6C46.70/F15.8 Stimulant-induced mood disorder including amphetamines, methamphetamine or methcathinone
- 6C46.71/F15.8 Stimulant-induced anxiety disorder including amphetamines, methamphetamine or methcathinone
- 6C46.72/F15.8 Stimulant-induced obsessive-compulsive or related disorder including amphetamines, methamphetamine or methcathinone
- 6C46.73/F15.9 Stimulant-induced impulse control disorder including amphetamines, methamphetamine or methcathinone
- 6C46/F15.9 Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone
- 6C46.Y/F15.9 Other specified disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone
- 6C46.Z/F15.9 Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone, unspecified
- 6C47.0/F19.1 Episode of harmful use of synthetic cathinones
- 6C47.1/F19.1 Harmful pattern of use of synthetic cathinones
- 6C47.10/F19.1 Harmful pattern of use of synthetic cathinones, episodic
- 6C47.11/F19.1 Harmful use of synthetic cathinones, continuous
- 6C47.1Y/F19.1 Other specified harmful pattern of use of synthetic cathinones
- 6C47.1Z/F19.1 Harmful pattern of use of synthetic cathinones, unspecified
- 6C47.2/F19.2 Synthetic cathinone dependence
- 6C47.20/F19.2 Synthetic cathinone dependence, current use
- 6C47.21/F19.2 Synthetic cathinone dependence, early full remission
- 6C47.22/F19.2 Synthetic cathinone dependence, sustained partial remission
- 6C47.23/F19.2 Synthetic cathinone dependence, sustained full remission
- 6C47.2Y/F19.2 Other specified synthetic cathinone dependence
- 6C47.2Z/F19.2 Synthetic cathinone dependence, unspecified
- 6C47.3/F19.0 Synthetic cathinone intoxication
- 6C47.4/F19 Synthetic cathinone withdrawal
- 6C47.5/F19 Synthetic cathinone-induced delirium
- 6C47.6/F19.5 Synthetic cathinone-induced psychotic disorder
- 6C47.60/F19.5 Synthetic cathinone-induced psychotic disorder with hallucinations
- 6C47.61/F19.5 Synthetic cathinone-induced psychotic disorder with delusions
- 6C47.62/F19.5 Synthetic cathinone-induced psychotic disorder with mixed psychotic symptoms
- 6C47.6Z/F19.5 Synthetic cathinone-induced psychotic disorder, unspecified
- 6C47.7/F12.9 Certain specified synthetic cathinone-induced mental or behavioural disorders
- 6C47.70/F19 Synthetic cathinone-induced mood disorder
- 6C47.71/F19.8 Synthetic cathinone-induced anxiety disorder
- 6C47.72/F19 Synthetic cathinone-induced obsessive-compulsive or related syndrome
- 6C47.73/F12.9 Synthetic cathinone-induced impulse control disorder
- 6C47/F12.9 Disorders due to use of synthetic cathinones
- 6C47.Y/F12.9 Other specified disorders due to use of synthetic cathinones
- 6C47.Z/F12.9 Disorders due to use of synthetic cathinones, unspecified
- 6C48.0/F15 Episode of harmful use of caffeine
- 6C48.1/F15.1 Harmful pattern of use of caffeine
- 6C48.10/F15.1 Harmful pattern of use of caffeine, episodic
- 6C48.11/F15.1 Harmful pattern of use of caffeine, continuous
- 6C48.1Z/F15.1 Harmful pattern of use of caffeine, unspecified
- 6C48.2/F15.0 Caffeine intoxication
- 6C48.3/F15.3 Caffeine withdrawal
- 6C48.4/F15 Certain specified caffeine-induced mental or behavioural disorders
- 6C48.40/F15 Caffeine-induced anxiety disorder
- 6C48/F15 Disorders due to use of caffeine
- 6C48.Y/F15.8 Other specified disorders due to use of caffeine
- 6C48.Z/F15 Disorders due to use of caffeine, unspecified
- 6C49.0/F16 Episode of harmful use of hallucinogens
- 6C49.1/F16.1 Harmful pattern of use of hallucinogens
- 6C49.10/F16.1 Harmful pattern of use of hallucinogens, episodic
- 6C49.11/F16.1 Harmful pattern of use of hallucinogens, continuous
- 6C49.1Z/F16.1 Harmful pattern of use of hallucinogens, unspecified
- 6C49.2/F16.2 Hallucinogen dependence
- 6C49.20/F16.2 Hallucinogen dependence, current use
- 6C49.21/F16.2 Hallucinogen dependence, early full remission
- 6C49.22/F16.2 Hallucinogen dependence, sustained partial remission
- 6C49.23/F16.2 Hallucinogen dependence, sustained full remission
- 6C49.2Z/F16.2 Hallucinogen dependence, unspecified
- 6C49.3/F16.0 Hallucinogen intoxication
- 6C49.4/F16 Hallucinogen-induced delirium
- 6C49.5/F16 Hallucinogen-induced psychotic disorder
- 6C49.6/F16 Certain specified hallucinogen-induced mental or behavioural disorders
- 6C49.60/F16 Hallucinogen-induced mood disorder
- 6C49.61/F16 Hallucinogen-induced anxiety disorder
- 6C49/F16 Disorders due to use of hallucinogens
- 6C49.Y/F16.8 Other specified disorders due to use of hallucinogens
- 6C49.Z/F16 Disorders due to use of hallucinogens, unspecified
- 6C4A.0/F17 Episode of harmful use of nicotine
- 6C4A.1/F17.1 Harmful pattern of use of nicotine
- 6C4A.10/F17.1 Harmful pattern of use of nicotine, episodic
- 6C4A.11/F17.1 Harmful pattern of use of nicotine, continuous
- 6C4A.1Z/F17.1 Harmful pattern of use of nicotine, unspecified
- 6C4A.2/F17.2 Nicotine dependence
- 6C4A.20/F17.2 Nicotine dependence, current use
- 6C4A.21/F17.2 Nicotine dependence, early full remission
- 6C4A.22/F17.2 Nicotine dependence, sustained partial remission
- 6C4A.23/F17.2 Nicotine dependence, sustained full remission
- 6C4A.2Z/F17.2 Nicotine dependence, unspecified
- 6C4A.3/F17.0 Nicotine intoxication
- 6C4A.4/F17 Nicotine withdrawal
- 6C4A/F17 Disorders due to use of nicotine
- 6C4A.Y/F17.8 Other specified disorders due to use of nicotine
- 6C4A.Z/F17 Disorders due to use of nicotine, unspecified
- 6C4B.0/F18 Episode of harmful use of volatile inhalants
- 6C4B.1/F18.1 Harmful pattern of use of volatile inhalants
- 6C4B.10/F18.1 Harmful pattern of use of volatile inhalants, episodic
- 6C4B.11/F18.1 Harmful pattern of use of volatile inhalants, continuous
- 6C4B.1Z/F18.1 Harmful pattern of use of volatile inhalants, unspecified
- 6C4B.2/F18.2 Volatile inhalant dependence
- 6C4B.20/F18.2 Volatile inhalant dependence, current use
- 6C4B.21/F18.2 Volatile inhalant dependence, early full remission
- 6C4B.22/F18.2 Volatile inhalant dependence, sustained partial remission
- 6C4B.23/F18.2 Volatile inhalant dependence, sustained full remission
- 6C4B.2Z/F18.2 Volatile inhalant dependence, unspecified
- 6C4B.3/F18.0 Volatile inhalant intoxication
- 6C4B.4/F18.3 Volatile inhalant withdrawal
- 6C4B.5/F18.4 Volatile inhalant-induced delirium
- 6C4B.6/F18 Volatile inhalant-induced psychotic disorder
- 6C4B.7/F18 Certain specified volatile inhalants-induced mental or behavioural disorders
- 6C4B.70/F18 Volatile inhalant-induced mood disorder
- 6C4B.71/F18 Volatile inhalant-induced anxiety disorder
- 6C4B/F18 Disorders due to use of volatile inhalants
- 6C4B.Y/F18.8 Other specified disorders due to use of volatile inhalants
- 6C4B.Z/F18 Disorders due to use of volatile inhalants, unspecified
- 6C4C.0/F15.8 Episode of harmful use of MDMA or related drugs, including MDA
- 6C4C.1/F15.1 Harmful pattern of use of MDMA or related drugs, including MDA
- 6C4C.10/F15.1 Harmful use of MDMA or related drugs, including MDA, episodic
- 6C4C.11/F15.1 Harmful use of MDMA or related drugs, including MDA, continuous
- 6C4C.1Z/F15.1 Harmful pattern of use of MDMA or related drugs, including MDA, unspecified
- 6C4C.2/F15.2 MDMA or related drug dependence, including MDA
- 6C4C.20/F15.2 MDMA or related drug dependence, including MDA, current use
- 6C4C.21/F15.2 MDMA or related drug dependence, including MDA, early full remission
- 6C4C.22/F15.2 MDMA or related drug dependence, including MDA, sustained partial remission
- 6C4C.23/F15.2 MDMA or related drug dependence, including MDA, sustained full remission
- 6C4C.2Z/F15.2 MDMA or related drug dependence, including MDA, unspecified
- 6C4C.3/F15.0 MDMA or related drug intoxication, including MDA
- 6C4C.4/F15.3 MDMA or related drug withdrawal, including MDA
- 6C4C.5/F15.4 MDMA or related drug-induced delirium, including MDA
- 6C4C.6/F15.5 MDMA or related drug-induced psychotic disorder, including MDA
- 6C4C.7/F15 Certain specified MDMA or related drug-induced mental or behavioural disorders, including MDA
- 6C4C.70/F15.8 MDMA or related drug-induced mood disorder, including MDA
- 6C4C.71/F15.8 MDMA or related drug-induced anxiety disorder
- 6C4C/F15 Disorders due to use of MDMA or related drugs, including MDA
- 6C4C.Y/F15.8 Other specified disorders due to use of MDMA or related drugs, including MDA
- 6C4C.Z/F15 Disorders due to use of MDMA or related drugs, including MDA, unspecified
- 6C4D.0/F19 Episode of harmful use of dissociative drugs including ketamine or PCP
- 6C4D.1/F19.1 Harmful pattern of use of dissociative drugs, including ketamine or PCP
- 6C4D.10/F19.1 Harmful pattern of use of dissociative drugs including ketamine or PCP, episodic
- 6C4D.11/F19.1 Harmful pattern of use of dissociative drugs including ketamine or PCP, continuous
- 6C4D.1Z/F19.1 Harmful pattern of use of dissociative drugs, including ketamine or PCP, unspecified
- 6C4D.2/F19.2 Dissociative drug dependence including ketamine or PCP
- 6C4D.20/F19.2 Dissociative drug dependence including Ketamine or PCP, current use
- 6C4D.21/F19.2 Dissociative drug dependence including Ketamine or PCP, early full remission
- 6C4D.22/F19.2 Dissociative drug dependence including Ketamine or PCP, sustained partial remission
- 6C4D.23/F19.2 Dissociative drug dependence including Ketamine or PCP, sustained full remission
- 6C4D.2Z/F19.2 Dissociative drug dependence including ketamine or PCP, unspecified
- 6C4D.3/F19.0 Dissociative drug intoxication including Ketamine or PCP
- 6C4D.4/F19 Dissociative drug-induced delirium including ketamine or PCP
- 6C4D.5/F19 Dissociative drug-induced psychotic disorder including Ketamine or PCP
- 6C4D.6/F19 Certain specified dissociative drugs -induced mental or behavioural disorders, including ketamine and phencyclidine [PCP]
- 6C4D.60/F19 Dissociative drug-induced mood disorder including Ketamine or PCP
- 6C4D.61/F19 Dissociative drug-induced anxiety disorder including Ketamine or PCP
- 6C4D/F19 Disorders due to use of dissociative drugs including ketamine and phencyclidine [PCP]
- 6C4D.Y/F19.8 Other specified disorders due to use of dissociative drugs including ketamine and phencyclidine [PCP]
- 6C4D.Z/F19 Disorders due to use of dissociative drugs including ketamine and phencyclidine [PCP], unspecified
- 6C4E.0/F19.9 Episode of harmful use of other specified psychoactive substance
- 6C4E.1/F19.1 Harmful pattern of use of other specified psychoactive substance
- 6C4E.10/F19.1 Harmful pattern of use of other specified psychoactive substance, episodic
- 6C4E.11/F19.1 Harmful pattern of use of other specified psychoactive substance, continuous
- 6C4E.1Z/F19.1 Harmful pattern of use of other specified psychoactive substance, unspecified
- 6C4E.2/F19.2 Other specified psychoactive substance dependence
- 6C4E.20/F19.2 Other specified psychoactive substance dependence, current use
- 6C4E.21/F19.2 Other specified psychoactive substance dependence, early full remission
- 6C4E.22/F19.2 Other specified psychoactive substance dependence, sustained partial remission
- 6C4E.23/F19.2 Other specified psychoactive substance dependence, sustained full remission
- 6C4E.2Z/F19.2 Other specified psychoactive substance dependence, unspecified
- 6C4E.3/F19.0 Other specified psychoactive substance intoxication
- 6C4E.4/F19 Other specified psychoactive substance withdrawal
- 6C4E.40/F19 Other specified psychoactive substance withdrawal, uncomplicated
- 6C4E.41/F19 Other specified psychoactive substance withdrawal, with perceptual disturbances
- 6C4E.42/F19 Other specified psychoactive substance withdrawal, with seizures
- 6C4E.43/F19 Other specified psychoactive substance withdrawal, with perceptual disturbances and seizures
- 6C4E.4Z/F19 Other specified psychoactive substance withdrawal, unspecified
- 6C4E.5/F19 Delirium induced by other specified psychoactive substance including medications
- 6C4E.6/F19 Psychotic disorder induced by other specified psychoactive substance
- 6C4E.7/F19.9 Certain other specified psychoactive substance-induced mental or behavioural disorders
- 6C4E.70/F19.9 Mood disorder induced by other specified psychoactive substance
- 6C4E.71/F19.9 Anxiety disorder induced by other specified psychoactive substance
- 6C4E.72/F19.9 Obsessive-compulsive or related disorder induced by other specified psychoactive substance
- 6C4E.73/F19.9 Impulse control disorder induced by other specified psychoactive substance
- 6C4E/F19.9 Disorders due to use of other specified psychoactive substances, including medications
- 6C4E.Y/F19.9 Other specified disorders due to use of other specified psychoactive substances, including medications
- 6C4E.Z/F19.9 Disorders due to use of other specified psychoactive substances, including medications, unspecified
- 6C4F.0/F99-F99 Episode of harmful use of multiple specified psychoactive substances
- 6C4F.1/F99-F99 Harmful pattern of use of multiple specified psychoactive substances
- 6C4F.10/F99-F99 Harmful pattern of use of multiple specified psychoactive substances, episodic
- 6C4F.11/F99-F99 Harmful pattern of use of multiple specified psychoactive substances, continuous
- 6C4F.1Z/F99-F99 Harmful pattern of use of multiple specified psychoactive substances, unspecified
- 6C4F.2/F99-F99 Multiple specified psychoactive substances dependence
- 6C4F.20/F99-F99 Multiple specified psychoactive substances dependence, current use
- 6C4F.21/F99-F99 Multiple specified psychoactive substances dependence, early full remission
- 6C4F.22/F99-F99 Multiple specified psychoactive substances dependence, sustained partial remission
- 6C4F.23/F99-F99 Multiple specified psychoactive substances dependence, sustained full remission
- 6C4F.2Z/F99-F99 Multiple specified psychoactive substances dependence, unspecified
- 6C4F.3/F99-F99 Intoxication due to multiple specified psychoactive substances
- 6C4F.4/F99-F99 Multiple specified psychoactive substances withdrawal
- 6C4F.40/F99-F99 Multiple specified psychoactive substances withdrawal, uncomplicated
- 6C4F.41/F99-F99 Multiple specified psychoactive substances withdrawal, with perceptual disturbances
- 6C4F.42/F99-F99 Multiple specified psychoactive substances withdrawal, with seizures
- 6C4F.43/F99-F99 Multiple specified psychoactive substances withdrawal, with perceptual disturbances and seizures
- 6C4F.4Y/F99-F99 Other specified multiple specified psychoactive substances withdrawal
- 6C4F.4Z/F99-F99 Multiple specified psychoactive substances withdrawal, unspecified
- 6C4F.5/F99-F99 Delirium induced by multiple specified psychoactive substances including medications
- 6C4F.6/F99-F99 Psychotic disorder induced by multiple specified psychoactive substances
- 6C4F.7/F99-F99 Certain multiple specified psychoactive substances-induced mental or behavioural disorders
- 6C4F.70/F99-F99 Mood disorder induced by multiple specified psychoactive substances
- 6C4F.71/F99-F99 Anxiety disorder induced by multiple specified psychoactive substances
- 6C4F.72/F99-F99 Obsessive-compulsive or related disorder induced by multiple specified psychoactive substances
- 6C4F.73/F99-F99 Impulse control syndrome induced by multiple specified psychoactive substances
- 6C4F/F99-F99 Disorders due to use of multiple specified psychoactive substances, including medications
- 6C4F.Y/F99-F99 Other specified disorders due to use of multiple specified psychoactive substances, including medications
- 6C4F.Z/F99-F99 Disorders due to use of multiple specified psychoactive substances, including medications, unspecified
- 6C4G.0/F19 Episode of harmful use of unknown or unspecified psychoactive substances
- 6C4G.1/F19.1 Harmful pattern of use of unknown or unspecified psychoactive substance
- 6C4G.10/F19.1 Harmful pattern of use of unknown or unspecified psychoactive substance, episodic
- 6C4G.11/F19.1 Harmful pattern of use of unknown or unspecified psychoactive substance, continuous
- 6C4G.1Z/F19.1 Harmful pattern of use of unknown or unspecified psychoactive substance, unspecified
- 6C4G.2/F19.2 Unknown or unspecified psychoactive substance dependence
- 6C4G.20/F19.2 Unknown or unspecified psychoactive substance dependence, current use
- 6C4G.21/F19.2 Unknown or unspecified psychoactive substance dependence, early full remission
- 6C4G.22/F19.2 Unknown or unspecified psychoactive substance dependence, sustained partial remission
- 6C4G.23/F19.2 Unknown or unspecified psychoactive substance dependence, sustained full remission
- 6C4G.2Z/F19.2 Unknown or unspecified psychoactive substance dependence, substance and state of remission unspecified
- 6C4G.3/F19.0 Intoxication due to unknown or unspecified psychoactive substance
- 6C4G.4/F19 Withdrawal due to unknown or unspecified psychoactive substance
- 6C4G.40/F19 Withdrawal due to unknown or unspecified psychoactive substance, uncomplicated
- 6C4G.41/F19 Withdrawal due to unknown or unspecified psychoactive substance, with perceptual disturbances
- 6C4G.42/F19 Withdrawal due to unknown or unspecified psychoactive substance, with seizures
- 6C4G.43/F19 Withdrawal due to unknown or unspecified psychoactive, with perceptual disturbances and seizures
- 6C4G.4Z/F19 Withdrawal due to unknown or unspecified psychoactive substance, unspecified
- 6C4G.5/F19 Delirium induced by unknown or unspecified psychoactive substance
- 6C4G.6/F19 Psychotic disorder induced by unknown or unspecified psychoactive substance
- 6C4G.7/F19 Certain unknown or unspecified psychoactive substance-induced mental or behavioural disorders
- 6C4G.70/F19 Mood disorder induced by unknown or unspecified psychoactive substance
- 6C4G.71/F19 Anxiety disorder induced by unknown or unspecified psychoactive substance
- 6C4G.72/F19 Obsessive-compulsive or related disorder induced by unknown or unspecified psychoactive substance
- 6C4G.73/F19 Impulse control disorder induced by unknown or unspecified psychoactive substance
- 6C4G/F19 Disorders due to use of unknown or unspecified psychoactive substances
- 6C4G.Y/F19.8 Other specified disorders due to use of unknown or unspecified psychoactive substances
- 6C4G.Z/F19 Disorders due to use of unknown or unspecified psychoactive substances, unspecified
- 6C4H.0/F19 Episode of harmful use of non-psychoactive substances
- 6C4H.1/F55 Harmful pattern of use of non-psychoactive substances
- 6C4H.10/F55 Harmful pattern of use of non-psychoactive substances, episodic
- 6C4H.11/F55 Harmful pattern of use of non-psychoactive substances, continuous
- 6C4H.1Z/F55 Harmful pattern of use of non-psychoactive substances, unspecified
- 6C4H/F19 Disorders due to use of non-psychoactive substances
- 6C4H.Y/F19.8 Other specified disorders due to use of non-psychoactive substances
- 6C4H.Z/F19 Disorders due to use of non-psychoactive substances, unspecified
- 6C4Y/F99-F99 Other specified disorders due to substance use
- 6C4Z/F99-F99 Disorders due to substance use, unspecified
- 6C50.0/F63.0 Gambling disorder, predominantly offline
- 6C50.1/F63.0 Gambling disorder, predominantly online
- 6C50/F63.0 Gambling disorder
- 6C50.Z/F63.0 Gambling disorder, unspecified
- 6C51.0/F63.8 Gaming disorder, predominantly online
- 6C51.1/F63.8 Gaming disorder, predominantly offline
- 6C51/F63.8 Gaming disorder
- 6C51.Z/F63.8 Gaming disorder, unspecified
- 6C5Y/F63.8 Other specified disorders due to addictive behaviours
- 6C5Z/F63.8 Disorders due to addictive behaviours, unspecified
- 6C70/F63.1 Pyromania
- 6C71/F63.2 Kleptomania
- 6C72/F52.7 Compulsive sexual behaviour disorder
- 6C73/F63.8 Intermittent explosive disorder
- 6C7Y/F63.8 Other specified impulse control disorders
- 6C7Z/F63 Impulse control disorders, unspecified
- 6C90.0/F91.3 Oppositional defiant disorder with chronic irritability-anger
- 6C90.00/F91.3 Oppositional defiant disorder with chronic irritability-anger with limited prosocial emotions
- 6C90.01/F91.3 Oppositional defiant disorder with chronic irritability-anger with typical prosocial emotions
- 6C90.0Z/F91.3 Oppositional defiant disorder with chronic irritability-anger, unspecified
- 6C90.1/F91.3 Oppositional defiant disorder without chronic irritability-anger
- 6C90.10/F91.3 Oppositional defiant disorder without chronic irritability-anger with limited prosocial emotions
- 6C90.11/F91.3 Oppositional defiant disorder without chronic irritability-anger with typical prosocial emotions
- 6C90.1Z/F91.3 Oppositional defiant disorder without chronic irritability-anger, unspecified
- 6C90/F91.3 Oppositional defiant disorder
- 6C90.Z/F91.3 Oppositional defiant disorder, unspecified
- 6C91.0/F91 Conduct-dissocial disorder, childhood onset
- 6C91.00/F91 Conduct-dissocial disorder, childhood onset with limited prosocial emotions
- 6C91.01/F91 Conduct-dissocial disorder, childhood onset with typical prosocial emotions
- 6C91.0Z/F91 Conduct-dissocial disorder, childhood onset, unspecified
- 6C91.1/F91 Conduct-dissocial disorder, adolescent onset
- 6C91.10/F91 Conduct-dissocial disorder, adolescent onset with limited prosocial emotions
- 6C91.11/F91 Conduct-dissocial disorder, adolescent onset with typical prosocial emotions
- 6C91.1Y/F91 Other specified conduct-dissocial disorder, adolescent onset
- 6C91/F91 Conduct-dissocial disorder
- 6C91.Z/F91 Conduct-dissocial disorder, unspecified
- 6C9Y/F92.9 Other specified disruptive behaviour or dissocial disorders
- 6C9Z/F92.9 Disruptive behaviour or dissocial disorders, unspecified
- 6D10.0/F60.9 Mild personality disorder
- 6D10.1/F60.9 Moderate personality disorder
- 6D10.2/F60.9 Severe personality disorder
- 6D10/F60.9 Personality disorder
- 6D10.Z/F60.9 Personality disorder, severity unspecified
- 6D11.0/F60.8 Negative affectivity in personality disorder or personality difficulty
- 6D11.1/F60.8 Detachment in personality disorder or personality difficulty
- 6D11.2/F60.2 Dissociality in personality disorder or personality difficulty
- 6D11.3/F60.8 Disinhibition in personality disorder or personality difficulty
- 6D11.4/F60.5 Anankastia in personality disorder or personality difficulty
- 6D11.5/F99-F99 Borderline pattern
- 6D11/F99-F99 Prominent personality traits or patterns
- 6D30/F65.2 Exhibitionistic disorder
- 6D31/F65.3 Voyeuristic disorder
- 6D32/F65.4 Pedophilic disorder
- 6D33/F65.9 Coercive sexual sadism disorder
- 6D34/F65.9 Frotteuristic disorder
- 6D35/F65.8 Other paraphilic disorder involving non-consenting individuals
- 6D36/F65.5 Paraphilic disorder involving solitary behaviour or consenting individuals
- 6D3Z/F65.9 Paraphilic disorders, unspecified
- 6D50/F68.1 Factitious disorder imposed on self
- 6D51/F68 Factitious disorder imposed on another
- 6D5Z/F68 Factitious disorders, unspecified
- 6D70.0/F05.8 Delirium due to disease classified elsewhere
- 6D70.1/F19.8 Delirium due to psychoactive substances including medications
- 6D70.2/F05.8 Delirium due to multiple etiological factors
- 6D70/F09 Delirium
- 6D70.Y/F09 Delirium, other specified cause
- 6D70.Z/F09 Delirium, unspecified or unknown cause
- 6D71/F06.7 Mild neurocognitive disorder
- 6D72.0/F04 Amnestic disorder due to diseases classified elsewhere
- 6D72.1/F10-F19 Amnestic disorder due to psychoactive substances including medications
- 6D72.10/F10.6 Amnestic disorder due to use of alcohol
- 6D72.11/F13.6 Amnestic disorder due to use of sedatives, hypnotics or anxiolytics
- 6D72.12/F10-F19 Amnestic disorder due to other specified psychoactive substance including medications
- 6D72.13/F10-F19 Amnestic disorder due to use of volatile inhalants
- 6D72.2/R41.3 Amnestic disorder due to unknown or unspecified aetiological factors
- 6D72/R41.8 Amnestic disorder
- 6D72.Y/R41.8 Amnestic disorder, other specified cause
- 6D72.Z/R41.8 Amnestic disorder, unknown or unspecified cause
- 6D80.0/F00.0 Dementia due to Alzheimer disease with early onset
- 6D80.1/F00.1 Dementia due to Alzheimer disease with late onset
- 6D80.2/F00.2 Alzheimer disease dementia, mixed type, with cerebrovascular disease
- 6D80.3/F00.2 Alzheimer disease dementia, mixed type, with other nonvascular aetiologies
- 6D80/F00 Dementia due to Alzheimer disease
- 6D80.Z/F00 Dementia due to Alzheimer disease, onset unknown or unspecified
- 6D81/F01 Dementia due to cerebrovascular disease
- 6D82/F02 Dementia due to Lewy body disease
- 6D83/F02 Frontotemporal dementia
- 6D84.0/F10.7 Dementia due to use of alcohol
- 6D84.1/F02.8 Dementia due to use of sedatives, hypnotics or anxiolytics
- 6D84.2/F02.8 Dementia due to use of volatile inhalants
- 6D84/F02.8 Dementia due to psychoactive substances including medications
- 6D84.Y/F02.8 Dementia due to other specified psychoactive substance
- 6D85.0/F02.3 Dementia due to Parkinson disease
- 6D85.1/F02.2 Dementia due to Huntington disease
- 6D85.2/F02.8 Dementia due to exposure to heavy metals and other toxins
- 6D85.3/F02.4 Dementia due to human immunodeficiency virus
- 6D85.4/F02.8 Dementia due to multiple sclerosis
- 6D85.5/F02.8 Dementia due to prion disease
- 6D85.6/F02.8 Dementia due to normal pressure hydrocephalus
- 6D85.7/F02.8 Dementia due to injury to the head
- 6D85.8/F02 Dementia due to pellagra
- 6D85.9/F02.8 Dementia due to Down syndrome
- 6D85/F02 Dementia due to diseases classified elsewhere
- 6D85.Y/F02.8 Dementia due to other specified diseases classified elsewhere
- 6D86.0/F00-F09 Psychotic symptoms in dementia
- 6D86.1/F00-F09 Mood symptoms in dementia
- 6D86.2/F00-F09 Anxiety symptoms in dementia
- 6D86.3/F00-F09 Apathy in dementia
- 6D86.4/F00-F09 Agitation or aggression in dementia
- 6D86.5/F00-F09 Disinhibition in dementia
- 6D86.6/F00-F09 Wandering in dementia
- 6D86/F00-F09 Behavioural or psychological disturbances in dementia
- 6D86.Y/F00-F09 Other specified behavioural or psychological disturbances in dementia
- 6D86.Z/F00-F09 Behavioural or psychological disturbances in dementia, unspecified
- 6D8Y/F00-F09 Dementia, other specified cause
- 6D8Z/F00-F09 Dementia, unknown or unspecified cause
- 6E0Y/F09 Other specified neurocognitive disorders
- 6E0Z/F09 Neurocognitive disorders, unspecified
- 6E20/F53 Mental or behavioural disorders associated with pregnancy, childbirth or the puerperium, without psychotic symptoms
- 6E21/F53 Mental or behavioural disorders associated with pregnancy, childbirth or the puerperium, with psychotic symptoms
- 6E2Z/F53 Mental or behavioural disorders associated with pregnancy, childbirth or the puerperium, unspecified
- 6E40.0/F54 Mental disorder affecting disorders or diseases classified elsewhere
- 6E40.1/F54 Psychological symptoms affecting disorders or diseases classified elsewhere
- 6E40.2/F54 Personality traits or coping style affecting disorders or diseases classified elsewhere
- 6E40.3/F54 Maladaptive health behaviours affecting disorders or diseases classified elsewhere
- 6E40.4/F54 Stress-related physiological response affecting disorders or diseases classified elsewhere
- 6E40/F54 Psychological or behavioural factors affecting disorders or diseases classified elsewhere
- 6E40.Y/F54 Other specified psychological or behavioural factors affecting disorders or diseases classified elsewhere
- 6E40.Z/F54 Psychological or behavioural factors affecting disorders or diseases classified elsewhere, unspecified
- 6E60.0/F06 Secondary speech or language syndrome
- 6E60/F06 Secondary neurodevelopmental syndrome
- 6E60.Y/F06 Other specified secondary neurodevelopmental syndrome
- 6E60.Z/F06 Secondary neurodevelopmental syndrome, unspecified
- 6E61.0/F06.0 Secondary psychotic syndrome, with hallucinations
- 6E61.1/F06.2 Secondary psychotic syndrome, with delusions
- 6E61.2/F06 Secondary psychotic syndrome, with hallucinations and delusions
- 6E61.3/F06 Secondary psychotic syndrome, with unspecified symptoms
- 6E61/F06 Secondary psychotic syndrome
- 6E62.0/F06.3 Secondary mood syndrome, with depressive symptoms
- 6E62.1/F06.3 Secondary mood syndrome, with manic symptoms
- 6E62.2/F06.3 Secondary mood syndrome, with mixed symptoms
- 6E62.3/F06.3 Secondary mood syndrome, with unspecified symptoms
- 6E62/F06.3 Secondary mood syndrome
- 6E63/F06.4 Secondary anxiety syndrome
- 6E64/F06 Secondary obsessive-compulsive or related syndrome
- 6E65/F06.5 Secondary dissociative syndrome
- 6E66/F06 Secondary impulse control syndrome
- 6E67/F06 Secondary neurocognitive syndrome
- 6E68/F06.6 Secondary personality change
- 6E69/F06 Secondary catatonia syndrome
- 6E6Y/F06.8 Other specified secondary mental or behavioural syndrome
- 6E6Z/F06 Secondary mental or behavioural syndrome, unspecified
- 6E8Y/F99-F99 Other specified mental, behavioural or neurodevelopmental disorders
- 6E8Z/F99-F99 Mental, behavioural or neurodevelopmental disorders, unspecified
- 7A00/F51.0 Chronic insomnia
- 7A01/F51.0 Short-term insomnia
- 7A0Z/G47.0 Insomnia disorders, unspecified
- 7A20.0/G47.4 Narcolepsy, Type 1
- 7A20.1/G47.4 Narcolepsy, Type 2
- 7A20/G47.4 Narcolepsy
- 7A20.Z/G47.4 Narcolepsy, unspecified
- 7A21/G47.1 Idiopathic hypersomnia
- 7A22/G47.8 Kleine-Levin syndrome
- 7A23/F51.9 Hypersomnia due to a medical condition
- 7A24/G47.1 Hypersomnia due to a medication or substance
- 7A25/F51.9 Hypersomnia associated with a mental disorder
- 7A26/F51.1 Insufficient sleep syndrome
- 7A2Y/F51.9 Other specified hypersomnolence disorders
- 7A2Z/F51.9 Hypersomnolence disorders, unspecified
- 7A40.0/G47.3 Primary central sleep apnoea
- 7A40.1/P28.3 Primary central sleep apnoea of infancy
- 7A40.2/G47.3 Primary central sleep apnoea of prematurity
- 7A40.3/G47.3 Central sleep apnoea due to a medical condition with Cheyne-Stokes breathing
- 7A40.4/G47.3 Central sleep apnoea due to a medical condition without Cheyne-Stokes breathing
- 7A40.5/G47.3 Central sleep apnoea due to high-altitude periodic breathing
- 7A40.6/G47.3 Central sleep apnoea due to a medication or substance
- 7A40.7/G47.3 Treatment-emergent central sleep apnoea
- 7A40/G47.3 Central sleep apnoeas
- 7A40.Y/G47.3 Other specified central sleep apnoeas
- 7A40.Z/G47.3 Central sleep apnoeas, unspecified
- 7A41/G47.3 Obstructive sleep apnoea
- 7A42.0/E66.2 Obesity hypoventilation syndrome
- 7A42.1/G47.3 Congenital central alveolar sleep-related hypoventilation
- 7A42.2/G47.3 Non-congenital central hypoventilation with hypothalamic abnormalities
- 7A42.3/G47.3 Idiopathic central alveolar hypoventilation
- 7A42.4/G47.3 Sleep-related hypoventilation due to a medication or substance
- 7A42.5/G47.3 Sleep-related hypoventilation due to medical condition
- 7A42.6/G47.3 Sleep-related hypoxemia due to a medical condition
- 7A42/G47.3 Sleep-related hypoventilation or hypoxemia disorders
- 7A42.Y/G47.3 Other specified sleep-related hypoventilation or hypoxemia disorders
- 7A42.Z/G47.3 Sleep-related hypoventilation or hypoxemia disorders, unspecified
- 7A4Y/G47.3 Other specified sleep-related breathing disorders
- 7A4Z/G47.3 Sleep-related breathing disorders, unspecified
- 7A60/G47.2 Delayed sleep-wake phase disorder
- 7A61/G47.2 Advanced sleep-wake phase disorder
- 7A62/G47.2 Irregular sleep-wake rhythm disorder
- 7A63/G47.2 Non-24 hour sleep-wake rhythm disorder
- 7A64/G47.2 Circadian rhythm sleep-wake disorder, shift work type
- 7A65/G47.2 Circadian rhythm sleep-wake disorder, jet lag type
- 7A6Z/G47.2 Circadian rhythm sleep-wake disorders, unspecified
- 7A80/G25.8 Restless legs syndrome
- 7A81/G25.8 Periodic limb movement disorder
- 7A82/R25.2 Sleep-related leg cramps
- 7A83/F45.8 Sleep-related bruxism
- 7A84/G25.8 Sleep-related rhythmic movement disorder
- 7A85/F51.9 Benign sleep myoclonus of infancy
- 7A86/F51.9 Propriospinal myoclonus at sleep onset
- 7A87/G25.8 Sleep-related movement disorder due to a medical condition
- 7A88/F51.9 Sleep-related movement disorder due to a medication or substance
- 7A8Y/F51.9 Other specified sleep-related movement disorders
- 7A8Z/F51.9 Sleep-related movement disorders, unspecified
- 7B00.0/G47.8 Confusional arousals
- 7B00.1/F51.3 Sleepwalking disorder
- 7B00.2/F51.4 Sleep terrors
- 7B00.3/G47.8 Sleep-related eating disorder
- 7B00/G47.8 Disorders of arousal from non-REM sleep
- 7B00.Y/G47.8 Other specified disorders of arousal from non-REM sleep
- 7B00.Z/G47.8 Disorders of arousal from non-REM sleep, unspecified
- 7B01.0/G47.8 REM sleep behaviour disorder
- 7B01.1/G47.8 Recurrent isolated sleep paralysis
- 7B01.2/F51.5 Nightmare disorder
- 7B01/F51.9 Parasomnias related to REM sleep
- 7B01.Y/F51.9 Other specified parasomnias related to REM sleep
- 7B01.Z/F51.9 Parasomnias related to REM sleep, unspecified
- 7B02.0/G47.8 Hypnagogic exploding head syndrome
- 7B02.1/G47.8 Sleep-related hallucinations
- 7B02.2/F51.9 Parasomnia disorder due to a medical condition
- 7B02.3/G47.8 Parasomnia disorder due to a medication or substance
- 7B02/F51.9 Other parasomnias
- 7B0Y/F51.9 Other specified parasomnia disorders
- 7B0Z/VI Parasomnia disorders, unspecified
- 7B2Y/VI Other specified sleep-wake disorders
- 7B2Z/VI Sleep-wake disorders, unspecified
- 8A00.0/G20 Parkinson disease
- 8A00.00/G20 Sporadic Parkinson disease
- 8A00.01/G20 Familial Parkinson disease
- 8A00.0Y/G20 Other specified Parkinson disease
- 8A00.0Z/G20 Parkinson disease, unspecified
- 8A00.1/VI Atypical parkinsonism
- 8A00.10/VI Progressive supranuclear palsy
- 8A00.1Y/VI Other specified atypical parkinsonism
- 8A00.1Z/VI Atypical parkinsonism, unspecified
- 8A00.2/G21.9 Secondary parkinsonism
- 8A00.20/G21.9 Parkinsonism due to heredodegenerative disorders
- 8A00.21/G21.9 Hemiparkinsonism hemiatrophy syndrome
- 8A00.22/G21.9 Infectious or postinfectious parkinsonism
- 8A00.23/G21.4 Vascular parkinsonism
- 8A00.24/G21.1 Drug-induced parkinsonism
- 8A00.25/G21.9 Post traumatic Parkinsonism
- 8A00.26/G21.9 Parkinsonism due to structural lesions
- 8A00.2Y/G21.9 Other specified secondary parkinsonism
- 8A00.2Z/G21.9 Secondary parkinsonism, unspecified
- 8A00.3/VI Functional parkinsonism
- 8A00/VI Parkinsonism
- 8A00.Y/VI Other specified parkinsonism
- 8A00.Z/VI Parkinsonism, unspecified
- 8A01.0/G25.5 Benign hereditary chorea
- 8A01.1/G25.4 Secondary Chorea
- 8A01.10/G10 Huntington disease
- 8A01.11/G25.4 Chorea due to Huntington disease-like conditions
- 8A01.12/G25.4 Chorea due to Dentatorubral pallidoluysian atrophy
- 8A01.13/G25.4 Chorea due to Wilson disease
- 8A01.14/G25.4 Chorea due to infectious or para-infectious causes
- 8A01.15/G25.4 Chorea due to systemic lupus erythematosus
- 8A01.16/G25.4 Drug-induced chorea
- 8A01.1Y/G25.4 Other specified secondary chorea
- 8A01.1Z/G25.4 Secondary chorea, unspecified
- 8A01.2/G25.5 Hemichorea or hemiballismus
- 8A01.20/G25.5 Hemichorea
- 8A01.21/G25.5 Ballism
- 8A01.22/G25.5 Hemiballism
- 8A01.2Y/G25.5 Other specified hemichorea or hemiballismus
- 8A01.2Z/G25.5 Hemichorea or hemiballismus, unspecified
- 8A01/G25.4 Choreiform disorders
- 8A01.Y/G25.4 Other specified choreiform disorders
- 8A01.Z/G25.4 Choreiform disorders, unspecified
- 8A02.0/G24.9 Primary dystonia
- 8A02.00/G24.5 Benign essential blepharospasm
- 8A02.0Y/G24.9 Other specified primary dystonia
- 8A02.0Z/G24.9 Primary dystonia, unspecified
- 8A02.1/G24 Secondary dystonia
- 8A02.10/G24.0 Drug-induced dystonia
- 8A02.11/G24 Dystonia-plus
- 8A02.12/G24 Dystonia associated with heredodegenerative disorders
- 8A02.1Y/G24 Other specified secondary dystonia
- 8A02.1Z/G24 Secondary dystonia, unspecified
- 8A02.2/G24 Paroxysmal dystonia
- 8A02.3/G24 Functional dystonia or spasms
- 8A02/G24 Dystonic disorders
- 8A02.Y/G24.8 Other specified dystonic disorders
- 8A02.Z/G24 Dystonic disorders, unspecified
- 8A03.0/G11.0 Congenital ataxia
- 8A03.1/G11 Hereditary ataxia
- 8A03.10/G11 Friedreich ataxia
- 8A03.11/G11 Ataxia due to Cerebrotendinous xanthomatosis
- 8A03.12/G11 Ataxia due to Refsum disease
- 8A03.13/G11 Ataxia due to abetalipoproteinemia
- 8A03.14/G11 Hereditary episodic ataxia
- 8A03.15/G11 Ataxia due to mitochondrial mutations
- 8A03.16/G11 Spinocerebellar ataxia
- 8A03.1Y/G11.8 Other specified hereditary ataxia
- 8A03.1Z/G11 Hereditary ataxia, unspecified
- 8A03.2/G11 Non-hereditary degenerative ataxia
- 8A03.20/G11 Late onset cerebellar cortical atrophy
- 8A03.2Y/G11 Other specified non-hereditary degenerative ataxia
- 8A03.2Z/G11 Non-hereditary degenerative ataxia, unspecified
- 8A03.3/G11 Acquired ataxia
- 8A03.30/G11 Ataxia due to alcoholic cerebellar degeneration
- 8A03.3Y/G11 Other specified acquired ataxia
- 8A03.3Z/G11 Acquired ataxia, unspecified
- 8A03/G11 Ataxic disorders
- 8A03.Y/G11.8 Other specified ataxic disorders
- 8A03.Z/G11 Ataxic disorders, unspecified
- 8A04.0/G25.2 Enhanced physiological tremor
- 8A04.1/G25.0 Essential tremor or related tremors
- 8A04.2/G25.2 Rest tremor
- 8A04.3/G25.2 Secondary tremor
- 8A04.30/G25.2 Tremor due to metabolic disorders
- 8A04.31/G25.1 Tremor due to chronic or acute substance use
- 8A04.32/G25.2 Tremor due to drug withdrawal
- 8A04.33/G25.2 Tremor due to certain specified central nervous system diseases
- 8A04.3Y/G25.2 Other specified secondary tremor
- 8A04.3Z/G25.2 Secondary tremor, unspecified
- 8A04.4/G25.2 Functional tremor
- 8A04/G25.2 Disorders associated with tremor
- 8A04.Y/G25.2 Other specified disorders associated with tremor
- 8A04.Z/G25.2 Disorders associated with tremor, unspecified
- 8A05.0/F95.1 Primary tics or tic disorders
- 8A05.00/F95.2 Tourette syndrome
- 8A05.01/F95.1 Chronic motor tic disorder
- 8A05.02/F95.1 Chronic phonic tic disorder
- 8A05.03/F95.0 Transient motor tics
- 8A05.0Y/F95.1 Other specified primary tics or tic disorders
- 8A05.0Z/F95.1 Primary tics or tic disorders, unspecified
- 8A05.1/F95.8 Secondary tics
- 8A05.10/F95.8 Infectious or postinfectious tics
- 8A05.11/G25.6 Tics associated with developmental disorders
- 8A05.1Y/F95.8 Other specified secondary tics
- 8A05.1Z/F95.8 Secondary tics, unspecified
- 8A05/F95 Tic disorders
- 8A05.Y/F95.8 Other specified tic disorders
- 8A05.Z/F95 Tic disorders, unspecified
- 8A06.0/G25.3 Essential myoclonus
- 8A06.1/G25.3 Segmental myoclonus
- 8A06.2/G25.3 Focal myoclonus
- 8A06.20/G25.3 Palatal myoclonus
- 8A06.21/G25.3 Chronic hiccups
- 8A06.2Y/G25.3 Other specified focal myoclonus
- 8A06.2Z/G25.3 Focal myoclonus, unspecified
- 8A06/G25.3 Myoclonic disorders
- 8A06.Y/G25.3 Other specified myoclonic disorders
- 8A06.Z/G25.3 Myoclonic disorders, unspecified
- 8A07.0/F98.4 Stereotypies
- 8A07.00/F98.4 Primary stereotypy
- 8A07.01/F98.4 Secondary stereotypy
- 8A07.0Y/F98.4 Other specified stereotypies
- 8A07.0Z/F98.4 Stereotypies, unspecified
- 8A07.1/G25.8 Akathisia
- 8A07.2/G25.8 Excessive startle reflex
- 8A07/VI Certain specified movement disorder
- 8A0Y/VI Other specified movement disorders
- 8A0Z/VI Movement disorders, unspecified
- 8A20/G30 Alzheimer disease
- 8A21.0/G31.8 Posterior cortical atrophy
- 8A21/G30-G32 Progressive focal atrophies
- 8A21.Y/G30-G32 Other specified progressive focal atrophies
- 8A21.Z/G30-G32 Progressive focal atrophies, unspecified
- 8A22/G30-G32 Lewy body disease
- 8A23/G30-G32 Frontotemporal lobar degeneration
- 8A2Y/G30-G32 Other specified disorders with neurocognitive impairment as a major feature
- 8A2Z/G30-G32 Disorders with neurocognitive impairment as a major feature, unspecified
- 8A40.0/G35 Relapsing-remitting multiple sclerosis
- 8A40.1/G35 Primary progressive multiple sclerosis
- 8A40.2/G35 Secondary progressive multiple sclerosis
- 8A40/G35 Multiple sclerosis
- 8A40.Y/G35 Other specified multiple sclerosis
- 8A40.Z/G35 Multiple sclerosis, unspecified
- 8A41.0/G35-G37 Transverse myelitis
- 8A41.1/G35-G37 Neuromyelitis optica myelin oligodendrocyte glycoprotein antibody-positive
- 8A41/G35-G37 Isolated demyelinating syndromes of the central nervous system
- 8A41.Y/G35-G37 Other specified isolated demyelinating syndromes of the central nervous system
- 8A41.Z/G35-G37 Isolated demyelinating syndromes of the central nervous system, unspecified
- 8A42.0/G36.1 Acute haemorrhagic leukoencephalitis
- 8A42/T88.0 Acute disseminated encephalomyelitis
- 8A42.Y/T88.0 Other specified acute disseminated encephalomyelitis
- 8A42.Z/T88.0 Acute disseminated encephalomyelitis, unspecified
- 8A43.0/G36.0 Neuromyelitis optica aquaporin-4 antibody positive
- 8A43.1/G36.0 Neuromyelitis optica aquaporin-4 antibody negative
- 8A43.2/G36.0 Single transverse myelitis aquaporin-4 antibody positive
- 8A43.3/G36.0 Recurrent transverse myelitis aquaporin-4 antibody positive
- 8A43.4/G36.0 Single optic neuritis aquaporin-4 antibody positive
- 8A43.5/G36.0 Recurrent optic neuritis aquaporin-4 antibody positive
- 8A43/G36.0 Neuromyelitis optica
- 8A43.Y/G36.0 Other specified neuromyelitis optica
- 8A43.Z/G36.0 Neuromyelitis optica, unspecified
- 8A44.0/E75.2 Pelizaeus-Merzbacher disease
- 8A44.1/G35-G37 Adrenoleukodystrophy
- 8A44.2/G35-G37 Alexander disease
- 8A44.3/G35-G37 Certain specified leukodystrophies
- 8A44.4/G35-G37 Krabbe disease
- 8A44/G35-G37 Leukodystrophies
- 8A44.Z/G35-G37 Leukodystrophies, unspecified
- 8A45.0/G35-G37 White matter disorders due to infections
- 8A45.00/G04.1 Human T-cell lymphotropic virus-associated myelopathy
- 8A45.01/A81.1 Subacute sclerosing panencephalitis
- 8A45.02/A81.2 Progressive multifocal leukoencephalopathy
- 8A45.0Y/G35-G37 Other specified white matter disorders due to infections
- 8A45.0Z/G35-G37 White matter disorders due to infections, unspecified
- 8A45.1/G35-G37 White matter disorders due to toxicity
- 8A45.2/G35-G37 White matter disorders due to vascular abnormality or ischemia
- 8A45.20/G35-G37 White matter disorder due to CADASIL
- 8A45.21/G37.4 Subacute necrotising myelitis
- 8A45.2Y/G35-G37 Other specified white matter disorders due to vascular abnormality or ischemia
- 8A45.2Z/G35-G37 White matter disorders due to vascular abnormality or ischemia, unspecified
- 8A45.3/G35-G37 White matter disorders due to nutritional deficiency
- 8A45.30/G35-G37 White matter disorder due to vitamin B12 deficiency
- 8A45.31/G37.2 Central pontine myelinolysis
- 8A45.3Y/G35-G37 Other specified white matter disorders due to nutritional deficiency
- 8A45.3Z/G35-G37 White matter disorders due to nutritional deficiency, unspecified
- 8A45.4/G35-G37 White matter disorders due to certain specified systemic disease
- 8A45.40/G35-G37 Demyelination due to sarcoidosis
- 8A45.41/G35-G37 Demyelination due to systemic lupus erythematosus
- 8A45.42/G35-G37 Demyelination due to Sjögren disease
- 8A45.43/G35-G37 Demyelination due to Behcet disease
- 8A45.44/G35-G37 Demyelination due to systemic vasculitis
- 8A45.45/G35-G37 Demyelination due to mitochondrial disease
- 8A45.4Z/G35-G37 White matter disorders due to certain specified systemic disease, unspecified
- 8A45/G35-G37 Secondary white matter disorders
- 8A45.Y/G35-G37 Other specified secondary white matter disorders
- 8A45.Z/G35-G37 Secondary white matter disorders, unspecified
- 8A46/G37.1 Central demyelination of corpus callosum
- 8A4Y/G35-G37 Other specified multiple sclerosis or other white matter disorders
- 8A4Z/G35-G37 Multiple sclerosis or other white matter disorders, unspecified
- 8A60.0/G40 Epilepsy due to prenatal or perinatal brain insults
- 8A60.00/G40 Epilepsy due to prenatal or perinatal vascular insults
- 8A60.01/G40 Epilepsy due to neonatal hypoxic ischemic encephalopathy
- 8A60.0Y/G40 Epilepsy due to other prenatal or perinatal brain insults
- 8A60.0Z/G40 Epilepsy due to unspecified prenatal or perinatal brain insults
- 8A60.1/G40 Epilepsy due to cerebrovascular disorders
- 8A60.2/G40 Epilepsy due to degenerative brain disorders
- 8A60.3/G40 Epilepsy due to dementias
- 8A60.4/G40 Epilepsy due to central nervous system infections or infestations
- 8A60.5/G40 Epilepsy due to injuries to the head
- 8A60.6/G40 Epilepsy due to tumours of the nervous system
- 8A60.7/G40 Epilepsy with mesial temporal sclerosis
- 8A60.8/G40 Epilepsy due to immune disorders
- 8A60.9/G40 Epilepsy due to abnormalities of brain development
- 8A60.A/G40 Epilepsy due to genetic syndromes with widespread or progressive effects
- 8A60.B/G40 Epilepsy due to multiple sclerosis or other demyelinating disorders
- 8A60/G40 Epilepsy due to structural or metabolic conditions or diseases
- 8A60.Y/G40 Epilepsy due to other structural or metabolic condition or disease
- 8A60.Z/G40 Epilepsy due to unspecified structural or metabolic condition or disease
- 8A61.0/G40.0 Genetic epileptic syndromes with neonatal onset
- 8A61.00/G40.0 Pyridoxal dependent epilepsy
- 8A61.0Y/G40.0 Other specified genetic epileptic syndromes with neonatal onset
- 8A61.0Z/G40.0 Genetic epileptic syndromes with neonatal onset, unspecified
- 8A61.1/G40.0 Genetic epileptic syndromes with onset in infancy
- 8A61.10/G40.0 Benign familial infantile epilepsy
- 8A61.11/G40.0 Dravet syndrome
- 8A61.12/G40.0 Epilepsy of infancy with migrating focal seizures
- 8A61.1Y/G40.0 Other specified genetic epileptic syndromes with onset in infancy
- 8A61.1Z/G40.0 Genetic epileptic syndromes with onset in infancy, unspecified
- 8A61.2/G40.0 Genetic epileptic syndromes with childhood onset
- 8A61.20/G40.0 Benign childhood epilepsy with centro-temporal spikes
- 8A61.21/G40.7 Childhood absence epilepsy
- 8A61.22/G40.0 Epilepsy with myoclonic-astatic seizures
- 8A61.23/G40.0 Myoclonic absences or absences with myoclonias
- 8A61.2Y/G40.0 Other specified genetic epileptic syndromes with childhood onset
- 8A61.2Z/G40.0 Genetic epileptic syndromes with childhood onset, unspecified
- 8A61.3/G40.0 Genetic epileptic syndrome with adolescent or adult onset
- 8A61.30/G40.0 Juvenile myoclonic epilepsy
- 8A61.31/G40.0 Juvenile absence epilepsy
- 8A61.32/G40.0 Benign adult familial myoclonus epilepsy
- 8A61.3Y/G40.0 Other specified genetic epileptic syndrome with adolescent or adult onset
- 8A61.3Z/G40.0 Genetic epileptic syndrome with adolescent or adult onset, unspecified
- 8A61.4/G40.0 Genetic epileptic syndromes with variable age of onset
- 8A61.40/G40.0 Reflex epilepsies
- 8A61.41/G40.0 Progressive myoclonic epilepsy
- 8A61.4Y/G40.0 Other specified genetic epileptic syndromes with variable age of onset
- 8A61.4Z/G40.0 Genetic epileptic syndromes with variable age of onset, unspecified
- 8A61/G40.0 Genetic or presumed genetic syndromes primarily expressed as epilepsy
- 8A61.Y/G40.0 Other specified genetic or presumed genetic syndromes primarily expressed as epilepsy
- 8A61.Z/G40.0 Genetic or presumed genetic syndromes primarily expressed as epilepsy, unspecified
- 8A62.0/G40.4 Infantile spasms
- 8A62.1/G40.4 Lennox-Gastaut syndrome
- 8A62.2/F80.3 Acquired epileptic aphasia
- 8A62/G40.4 Epileptic encephalopathies
- 8A62.Y/G40.4 Other specified epileptic encephalopathies
- 8A62.Z/G40.4 Epileptic encephalopathies, unspecified
- 8A63.0/R56.0 Febrile seizures
- 8A63.00/R56.0 Simple febrile seizures
- 8A63.01/R56.0 Complex febrile seizures
- 8A63.0Y/R56.0 Other specified febrile seizures
- 8A63/R56.8 Seizure due to acute causes
- 8A63.Y/R56.8 Seizure due to other acute cause
- 8A63.Z/R56.8 Seizure due to unspecified acute cause
- 8A64/R56.8 Single seizure due to remote causes
- 8A65/G40.6 Single unprovoked seizure
- 8A66.0/G41 Convulsive status epilepticus
- 8A66.1/G41.1 Non-convulsive status epilepticus
- 8A66.10/G41.1 Absence status epilepticus
- 8A66.1Y/G41.1 Other specified non-convulsive status epilepticus
- 8A66.1Z/G41.1 Non-convulsive status epilepticus, unspecified
- 8A66/G41 Status epilepticus
- 8A66.Y/G41.8 Other specified status epilepticus
- 8A66.Z/G41 Status epilepticus, unspecified
- 8A67/G41.2 Acute repetitive seizures
- 8A68.0/R56 Focal unaware seizure
- 8A68.1/R56 Absence seizures, atypical
- 8A68.2/R56 Absence seizures, typical
- 8A68.3/R56 Focal aware seizure
- 8A68.4/G40.6 Generalised tonic-clonic seizure
- 8A68.5/R56 Generalised myoclonic seizure
- 8A68.6/R56 Generalised tonic seizure
- 8A68.7/R56 Generalised atonic seizure
- 8A68/R56 Types of seizures
- 8A68.Y/R56.8 Other specified type of seizure
- 8A68.Z/R56 Type of seizure, unspecified
- 8A6Y/G40.8 Other specified epilepsy or seizures
- 8A6Z/G40 Epilepsy or seizures, unspecified
- 8A80.0/G43.0 Migraine without aura
- 8A80.1/G43.1 Migraine with aura
- 8A80.10/G43.1 Hemiplegic migraine
- 8A80.1Y/G43.1 Other specified migraine with aura
- 8A80.1Z/G43.1 Migraine with aura, unspecified
- 8A80.2/G43 Chronic migraine
- 8A80.3/G43.8 Complications related to migraine
- 8A80.30/G43.2 Status migrainosus
- 8A80.3Y/G43.8 Other specified complications related to migraine
- 8A80.4/G43 Cyclic vomiting syndrome
- 8A80/G43 Migraine
- 8A80.Y/G43.8 Other specified migraine
- 8A80.Z/G43 Migraine, unspecified
- 8A81.0/G44.0 Infrequent episodic tension-type headache
- 8A81.1/G44 Frequent episodic tension-type headache
- 8A81.2/G44 Chronic tension-type headache
- 8A81/G44 Tension-type headache
- 8A81.Y/G44.8 Other specified tension-type headache
- 8A81.Z/G44 Tension-type headache, unspecified
- 8A82/G44.1 Trigeminal autonomic cephalalgias
- 8A83/G44.2 Other primary headache disorder
- 8A84.0/G44.3 Acute headache associated with traumatic injury to the head
- 8A84.1/G44.3 Persistent headache associated with traumatic injury to the head
- 8A84/G44 Secondary headache
- 8A84.Y/G44.8 Other specified secondary headache
- 8A84.Z/G44 Secondary headache, unspecified
- 8A85/No Mapping Painful cranial neuropathies or other facial pains
- 8A8Y/No Mapping Other specified headache disorders
- 8A8Z/No Mapping Headache disorders, unspecified
- 8B00.0/I61.0 Deep hemispheric haemorrhage
- 8B00.1/I61.1 Lobar haemorrhage
- 8B00.2/I61.3 Brainstem haemorrhage
- 8B00.3/I61.4 Cerebellar haemorrhage
- 8B00.4/I61.5 Intraventricular haemorrhage without parenchymal haemorrhage
- 8B00.5/I61.6 Haemorrhage of multiple sites
- 8B00/I61 Intracerebral haemorrhage
- 8B00.Z/I61 Intracerebral haemorrhage, site unspecified
- 8B01.0/I60 Aneurysmal subarachnoid haemorrhage
- 8B01.1/I60.8 Non-aneurysmal subarachnoid haemorrhage
- 8B01.2/I60 Subarachnoid haemorrhage not known if aneurysmal or non-aneurysmal
- 8B01/I60 Subarachnoid haemorrhage
- 8B02/I62.0 Nontraumatic subdural haemorrhage
- 8B03/I62.1 Nontraumatic epidural haemorrhage
- 8B0Z/I60-I69 Intracranial haemorrhage, unspecified
- 8B10.0/G45.3 Amaurosis fugax
- 8B10/G45 Transient ischaemic attack
- 8B10.Y/G45.8 Other specified transient ischaemic attack
- 8B10.Z/G45 Transient ischaemic attack, unspecified
- 8B11.0/I63.0 Cerebral ischaemic stroke due to extracranial large artery atherosclerosis
- 8B11.1/I63.3 Cerebral ischaemic stroke due to intracranial large artery atherosclerosis
- 8B11.2/I63 Cerebral ischaemic stroke due to embolic occlusion
- 8B11.20/I63 Cerebral ischaemic stroke due to cardiac embolism
- 8B11.21/I63 Cerebral ischaemic stroke due to aortic arch embolism
- 8B11.22/I63 Cerebral ischaemic stroke due to paradoxical embolism
- 8B11.2Y/I63 Cerebral ischaemic stroke due to other specified embolic occlusion
- 8B11.2Z/I63 Cerebral ischaemic stroke due to embolic occlusion, unspecified
- 8B11.3/I63 Cerebral ischaemic stroke due to small artery occlusion
- 8B11.4/I63 Cerebral ischaemic stroke due to other known cause
- 8B11.40/I63 Cerebral ischaemic stroke due to global hypoperfusion with watershed infarct
- 8B11.41/I63.6 Cerebral ischaemic stroke due to other non-atherosclerotic arteriopathy
- 8B11.42/I63 Cerebral ischaemic stroke due to hypercoagulable state
- 8B11.43/I63 Cerebral ischaemic stroke in association with subarachnoid haemorrhage
- 8B11.44/I63 Cerebral ischemic stroke from dissection
- 8B11.5/I63 Cerebral ischaemic stroke of unknown cause
- 8B11.50/I63.2 Cerebral ischaemic stroke due to unspecified occlusion or stenosis of extracranial large artery
- 8B11.51/I63.5 Cerebral ischaemic stroke due to unspecified occlusion or stenosis of intracranial large artery
- 8B11.5Z/I63 Cerebral ischaemic stroke, unspecified
- 8B11/I63 Cerebral ischaemic stroke
- 8B1Y/I67.8 Other specified cerebral ischaemia
- 8B1Z/I67.8 Cerebral ischaemia, unspecified
- 8B20/I64 Stroke not known if ischaemic or haemorrhagic
- 8B21.0/I60-I69 Silent cerebral infarct
- 8B21.1/I60-I69 Silent cerebral microbleed
- 8B21/I60-I69 Cerebrovascular disease with no acute cerebral symptom
- 8B21.Y/I60-I69 Other specified cerebrovascular disease with no acute cerebral symptom
- 8B21.Z/I60-I69 Cerebrovascular disease with no acute cerebral symptom, unspecified
- 8B22.0/I67.0 Dissection of cerebral arteries
- 8B22.1/I67.6 Cerebral venous thrombosis
- 8B22.2/I67 Cerebral vasoconstriction syndromes
- 8B22.3/I67 Isolated cerebral amyloid angiopathy
- 8B22.4/I67 Intracranial vascular malformation
- 8B22.40/Q28.2 Arteriovenous malformation of cerebral vessels
- 8B22.41/I67 Cerebral cavernous malformation
- 8B22.42/I67 Dural arteriovenous fistula
- 8B22.43/I67 Carotid cavernous fistula
- 8B22.4Y/I67 Other specified intracranial vascular malformation
- 8B22.4Z/I67 Intracranial vascular malformation, unspecified
- 8B22.5/I67.1 Cerebral aneurysm, nonruptured
- 8B22.6/I67 Familial cerebral saccular aneurysm
- 8B22.7/I67.7 Cerebral arteritis, not elsewhere classified
- 8B22.70/I67.7 Primary cerebral arteritis
- 8B22.7Y/I67.7 Other specified cerebral arteritis, not elsewhere classified
- 8B22.7Z/I67.7 Cerebral arteritis, not elsewhere classified, unspecified
- 8B22.8/I67.4 Hypertensive encephalopathy
- 8B22.9/I67 Migraine-induced stroke
- 8B22.A/I67 Subclavian steal syndrome
- 8B22.B/I67 Moyamoya syndrome
- 8B22.C/I67 Hereditary cerebrovascular diseases
- 8B22.C0/I67 [cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy] syndrome
- 8B22.C1/I67 [cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy] syndrome
- 8B22.CY/I67 Other specified hereditary cerebrovascular diseases
- 8B22.CZ/I67 Hereditary cerebrovascular diseases, unspecified
- 8B22/I67 Certain specified cerebrovascular diseases
- 8B22.Y/I67.8 Other specified cerebrovascular disease
- 8B23/I68 Cerebrovascular abnormalities
- 8B24/G93.1 Hypoxic-ischaemic encephalopathy
- 8B25.0/I69.3 Late effects of cerebral ischemic stroke
- 8B25.1/I69.1 Late effects of intracerebral haemorrhage
- 8B25.2/I69.0 Late effects of subarachnoid haemorrhage
- 8B25.3/I69.2 Late effects of other nontraumatic intracranial haemorrhage
- 8B25.4/I69.4 Late effects of stroke not known if ischaemic or haemorrhagic
- 8B25/I69 Late effects of cerebrovascular disease
- 8B25.Y/I69.8 Late effects of other specified cerebrovascular disease
- 8B25.Z/I69 Late effects of cerebrovascular disease, unspecified
- 8B26.0/G46.3 Brainstem stroke syndrome
- 8B26.1/G46.4 Cerebellar stroke syndrome
- 8B26.2/G46.0 Middle cerebral artery syndrome
- 8B26.3/G46.1 Anterior cerebral artery syndrome
- 8B26.4/G46.2 Posterior cerebral artery syndrome
- 8B26.5/G46 Lacunar syndromes
- 8B26.50/G46.5 Pure motor lacunar syndrome
- 8B26.51/G46.6 Pure sensory lacunar syndrome
- 8B26.5Y/G46 Other specified lacunar syndromes
- 8B26.5Z/G46 Lacunar syndromes, unspecified
- 8B26/G46 Vascular syndromes of brain in cerebrovascular diseases
- 8B26.Y/G46.8 Other specified vascular syndromes of brain in cerebrovascular diseases
- 8B26.Z/G46 Vascular syndromes of brain in cerebrovascular diseases, unspecified
- 8B2Z/I60-I69 Cerebrovascular diseases, unspecified
- 8B40/G83.4 Cauda equina syndrome
- 8B41/G04 Myelitis
- 8B42/G99.2 Myelopathy
- 8B43.0/G95.1 Acute arterial infarction of the spinal cord
- 8B43.1/G95.1 Acute venous infarction of the spinal cord
- 8B43.2/G95.1 Chronic venous infarction of the spinal cord
- 8B43/G95.9 Non-compressive vascular myelopathies
- 8B43.Y/G95.9 Other specified non-compressive vascular myelopathies
- 8B43.Z/G95.9 Non-compressive vascular myelopathies, unspecified
- 8B44.0/G11.4 Hereditary spastic paraplegia
- 8B44.00/G11.4 Autosomal dominant hereditary spastic paraplegia
- 8B44.01/G11.4 Autosomal recessive hereditary spastic paraplegia
- 8B44.02/G11.4 X-linked hereditary spastic paraplegia
- 8B44.0Y/G11.4 Other specified hereditary spastic paraplegia
- 8B44.0Z/G11.4 Hereditary spastic paraplegia, unspecified
- 8B44/G95.9 Degenerative myelopathic disorders
- 8B44.Y/G95.9 Other specified degenerative myelopathic disorders
- 8B44.Z/G95.9 Degenerative myelopathic disorders, unspecified
- 8B4Y/G95.9 Other specified spinal cord disorders excluding trauma
- 8B4Z/G95.9 Spinal cord disorders excluding trauma, unspecified
- 8B60.0/G12.2 Amyotrophic lateral sclerosis
- 8B60.1/G12.2 Progressive bulbar palsy
- 8B60.2/G12.2 Progressive pseudobulbar palsy
- 8B60.3/G12.2 Progressive muscular atrophy
- 8B60.4/G12.2 Primary lateral sclerosis
- 8B60.5/G12.2 Amyotrophic lateral sclerosis-Plus
- 8B60.6/G12.2 Monomelic amyotrophy
- 8B60.7/G12.2 Madras type motor neuron disease
- 8B60/G12.2 Motor neuron disease
- 8B60.Y/G12.2 Other specified motor neuron disease
- 8B60.Z/G12.2 Motor neuron disease, unspecified
- 8B61.0/G12.0 Infantile spinal muscular atrophy, Type I
- 8B61.1/G12 Late infantile spinal muscular atrophy, Type II
- 8B61.2/G12 Juvenile form spinal muscular dystrophy, Type III
- 8B61.3/G12 Adult onset spinal muscular atrophy, Type IV
- 8B61.4/G12 Localised spinal muscular atrophy
- 8B61/G12 Spinal muscular atrophy
- 8B61.Y/G12.8 Other specified spinal muscular atrophy
- 8B61.Z/G12 Spinal muscular atrophy, unspecified
- 8B62/G14 Post polio progressive muscular atrophy
- 8B6Y/VI Other specified motor neuron diseases or related disorders
- 8B6Z/VI Motor neuron diseases or related disorders, unspecified
- 8B80/G52.0 Disorders of olfactory nerve
- 8B81.0/G50-G59 Brainstem lesion
- 8B81/G50-G59 Disorders of vestibulocochlear nerve
- 8B81.Y/G50-G59 Other specified disorders of vestibulocochlear nerve
- 8B81.Z/G50-G59 Disorders of vestibulocochlear nerve, unspecified
- 8B82.0/G50.0 Trigeminal neuralgia
- 8B82.1/G50.1 Atypical facial pain
- 8B82/G50 Disorders of trigeminal nerve
- 8B82.Z/G50 Disorders of trigeminal nerve, unspecified
- 8B83/G50-G59 Disorders of spinal accessory nerve
- 8B84/G52.3 Disorders of hypoglossal nerve
- 8B85/G52.7 Disorders of multiple cranial nerves
- 8B86/G52.2 Disorders of vagus nerve
- 8B87/G52.1 Disorders of glossopharyngeal nerve
- 8B88.0/G51.0 Bell palsy
- 8B88.1/G51.4 Facial myokymia
- 8B88.2/G51.3 Hemifacial spasm
- 8B88.3/G51 Facial neuritis
- 8B88/G51 Disorders of facial nerve
- 8B88.Y/G51.8 Other specified disorders of facial nerve
- 8B88.Z/G51 Disorders of facial nerve, unspecified
- 8B8Y/G50-G59 Other specified disorders of cranial nerves
- 8B8Z/G50-G59 Disorders of cranial nerves, unspecified
- 8B90/G55 Nerve root and plexus compressions
- 8B91.0/G54.5 Neuralgic shoulder amyotrophy
- 8B91.1/G54.0 Thoracic outlet syndrome due to cervical rib
- 8B91/G54.0 Brachial plexus disorders
- 8B91.Y/G54.0 Other specified brachial plexus disorders
- 8B91.Z/G54.0 Brachial plexus disorders, unspecified
- 8B92.0/G54.1 Post radiation lumbosacral plexopathy
- 8B92.1/G54.1 Vasculitic lumbosacral plexopathy
- 8B92.2/G54.1 Diabetic lumbosacral plexopathy
- 8B92.3/G54.1 Lumbosacral radiculoplexopathy
- 8B92/G54.1 Lumbosacral plexus disorders
- 8B92.Y/G54.1 Other specified lumbosacral plexus disorders
- 8B92.Z/G54.1 Lumbosacral plexus disorders, unspecified
- 8B93.0/M54.1 Radiculopathy due to compression
- 8B93.1/M54.1 Radiculopathy due to metabolic disorders
- 8B93.2/M54.1 Radiculopathy due to electric shock or lightning
- 8B93.3/M54.1 Radiculopathy due to radiation injury
- 8B93.4/M54.1 Radiculopathy due to nutritional deficiencies
- 8B93.5/M54.1 Radiculopathy due to toxicity
- 8B93.6/M54.1 Radiculopathy due to intervertebral disc disorders
- 8B93.7/M54.1 Radiculopathy due to neoplastic disease
- 8B93.8/M54.1 Radiculopathy due to spondylosis
- 8B93/M54.1 Radiculopathy
- 8B93.Y/M54.1 Other specified radiculopathy
- 8B93.Z/M54.1 Radiculopathy, unspecified
- 8B94/G54.8 Diabetic radiculoplexoneuropathy
- 8B95/G54 Secondary brachial plexus lesion due to certain specified disorders
- 8B9Y/G54.8 Other specified nerve root or plexus disorders
- 8B9Z/G54 Nerve root or plexus disorders, unspecified
- 8C00/G60.3 Idiopathic progressive neuropathy
- 8C01.0/G61.0 Acute inflammatory demyelinating polyneuropathy
- 8C01.1/G61 Post vaccinal neuropathy
- 8C01.2/G61 Subacute inflammatory demyelinating polyneuropathy
- 8C01.3/G61 Chronic inflammatory demyelinating polyneuropathy
- 8C01/G61 Inflammatory polyneuropathy
- 8C01.Y/G61.8 Other specified inflammatory polyneuropathy
- 8C01.Z/G61 Inflammatory polyneuropathy, unspecified
- 8C03.0/G63.2 Diabetic polyneuropathy
- 8C03.1/G63.0 Polyneuropathy due to infectious diseases
- 8C03.2/G63.1 Polyneuropathy in neoplastic disease
- 8C03.3/G63.4 Polyneuropathy in nutritional deficiency
- 8C03.4/G63.5 Polyneuropathy in systemic connective tissue disorders
- 8C03/G50-G59 Other secondary polyneuropathy
- 8C03.Y/G50-G59 Other specified secondary polyneuropathy
- 8C03.Z/G50-G59 Other secondary polyneuropathy, unspecified
- 8C0Y/G50-G59 Other specified polyneuropathy
- 8C0Z/G50-G59 Polyneuropathy, unspecified
- 8C10.0/G56.0 Carpal tunnel syndrome
- 8C10.1/G56.2 Lesion of ulnar nerve
- 8C10.2/G56.3 Lesion of radial nerve
- 8C10/G56 Mononeuropathies of upper limb
- 8C10.Y/G56.8 Other specified mononeuropathies of upper limb
- 8C10.Z/G56 Mononeuropathies of upper limb, unspecified
- 8C11.0/G57.0 Lesion of sciatic nerve
- 8C11.00/G57.0 Sciatic nerve piriformis syndrome
- 8C11.0Y/G57.0 Other specified lesion of sciatic nerve
- 8C11.0Z/G57.0 Lesion of sciatic nerve, unspecified
- 8C11.1/G57.1 Meralgia paraesthetica
- 8C11.2/G57.2 Lesion of femoral nerve
- 8C11.3/G57.3 Lesion of common peroneal nerve
- 8C11.4/G57.4 Lesion of tibial nerve
- 8C11.5/G57.5 Tarsal tunnel syndrome
- 8C11.6/G57.6 Lesion of plantar nerve
- 8C11/G57 Mononeuropathies of lower limb
- 8C11.Y/G57.8 Other specified mononeuropathies of lower limb
- 8C11.Z/G57 Mononeuropathies of lower limb, unspecified
- 8C12.0/G58.0 Intercostal neuropathy
- 8C12.1/G58.7 Mononeuritis multiplex
- 8C12.2/G58 Lesion of suprascapular nerve
- 8C12.3/G58 Lesion of axillary nerve
- 8C12.4/G58 Lesion of long thoracic nerve
- 8C12.5/G58 Traumatic neuroma, not otherwise specified
- 8C12/G58 Certain specified mononeuropathies
- 8C12.Y/G58.8 Mononeuropathy of other specified nerve
- 8C1Y/G59.8 Mononeuropathy of other specified site
- 8C1Z/G59 Mononeuropathy of unspecified site
- 8C20.0/G60.0 Charcot-Marie-Tooth disease 1 demyelinating
- 8C20.1/G60.0 Charcot-Marie-Tooth disease 2 axonal
- 8C20.2/G60.0 Intermediate Charcot-Marie-Tooth disease
- 8C20/G60.0 Hereditary motor and sensory neuropathy
- 8C20.Y/G60.0 Other specified hereditary motor and sensory neuropathy
- 8C20.Z/G60.0 Hereditary motor and sensory neuropathy, unspecified
- 8C21.0/G60.8 Hereditary sensory and autonomic neuropathy type I
- 8C21.1/G90.1 Hereditary sensory and autonomic neuropathy type III
- 8C21.2/G60 Hereditary sensory and autonomic neuropathy type IV
- 8C21.3/G60.8 Hereditary sensory and autonomic neuropathy type V
- 8C21/G50-G59 Hereditary sensory or autonomic neuropathy
- 8C21.Y/G50-G59 Other specified hereditary sensory or autonomic neuropathy
- 8C21.Z/G50-G59 Hereditary sensory or autonomic neuropathy, unspecified
- 8C2Y/G50-G59 Other specified hereditary neuropathy
- 8C2Z/G50-G59 Hereditary neuropathy, unspecified
- 8C4Y/G50-G59 Other specified disorders of nerve root, plexus or peripheral nerves
- 8C4Z/G50-G59 Disorders of nerve root, plexus or peripheral nerves, unspecified
- 8C60.0/G70.0 Drug-induced myasthenia gravis
- 8C60/G70.0 Myasthenia gravis
- 8C60.Y/G70.0 Other specified myasthenia gravis
- 8C60.Z/G70.0 Myasthenia gravis, unspecified
- 8C61/G70.2 Congenital myasthenic syndromes
- 8C62/G73.1 Lambert-Eaton syndrome
- 8C6Y/G70.8 Other specified myasthenia gravis and neuromuscular junction disorders
- 8C6Z/G70 Unspecified myasthenia gravis or neuromuscular junction disorders
- 8C70.0/G71.0 Becker muscular dystrophy
- 8C70.1/G71.0 Duchenne muscular dystrophy
- 8C70.2/G71.0 Emery-Dreifuss muscular dystrophy
- 8C70.3/G71.0 Facioscapulohumeral muscular dystrophy
- 8C70.4/G71.0 Limb-girdle muscular dystrophy
- 8C70.40/G71.0 Dominant limb-girdle muscular dystrophy
- 8C70.41/G71.0 Recessive limb-girdle muscular dystrophy
- 8C70.4Y/G71.0 Other specified limb-girdle muscular dystrophy
- 8C70.4Z/G71.0 Limb-girdle muscular dystrophy, unspecified
- 8C70.5/G71.0 Scapuloperoneal muscular dystrophy
- 8C70.6/G71.0 Congenital muscular dystrophy
- 8C70/G71.0 Muscular dystrophy
- 8C70.Y/G71.0 Other specified muscular dystrophy
- 8C70.Z/G71.0 Muscular dystrophy, unspecified
- 8C71.0/G71.1 Myotonic dystrophy
- 8C71.1/G71.1 Chondrodystrophic myotonia
- 8C71.2/G71.1 Myotonia congenita
- 8C71.3/G71.1 Drug-induced myotonia
- 8C71.4/G71.1 Neuromyotonia
- 8C71.5/G71.1 Pseudomyotonia
- 8C71/G71.1 Myotonic disorders
- 8C71.Y/G71.1 Other specified myotonic disorders
- 8C71.Z/G71.1 Myotonic disorders, unspecified
- 8C72.0/G71.2 Congenital myopathy with structural abnormalities
- 8C72.00/G71.2 Nemaline myopathy
- 8C72.01/G71.2 Centronuclear myopathy
- 8C72.02/G71.2 Central core disease
- 8C72.0Y/G71.2 Other specified congenital myopathy with structural abnormalities
- 8C72.0Z/G71.2 Congenital myopathy with structural abnormalities, unspecified
- 8C72.1/G71.2 Congenital myopathy with no structural abnormalities
- 8C72/G71.2 Congenital myopathies
- 8C72.Y/G71.2 Other specified congenital myopathies
- 8C72.Z/G71.2 Congenital myopathies, unspecified
- 8C73.0/G71.3 Autosomal recessive cardiomyopathy or ophthalmoplegia
- 8C73.1/G71.3 Neuropathy, ataxia, and retinitis pigmentosa
- 8C73/G71.3 Mitochondrial myopathies
- 8C73.Y/G71.3 Other specified mitochondrial myopathies
- 8C73.Z/G71.3 Mitochondrial myopathies, unspecified
- 8C74.0/G71 Paramyotonia congenita
- 8C74.1/G72.3 Periodic paralysis
- 8C74.10/G72.3 Hypokalaemic periodic paralysis
- 8C74.11/G72.3 Hyperkalaemic periodic paralysis
- 8C74.1Y/G72.3 Other specified periodic paralysis
- 8C74.1Z/G72.3 Periodic paralysis, unspecified
- 8C74/G71 Periodic paralyses or disorders of muscle membrane excitability
- 8C74.Y/G71 Other specified periodic paralyses or disorders of muscle membrane excitability
- 8C74.Z/G71 Periodic paralyses or disorders of muscle membrane excitability, unspecified
- 8C75/G71 Distal myopathies
- 8C76/G71 Myofibrillar myopathy
- 8C77/G71.8 Ocular myopathy
- 8C78/G71.8 Malignant hyperthermia or hyperpyrexia
- 8C7Y/G71.8 Other specified primary disorders of muscles
- 8C7Z/G71 Primary disorders of muscles, unspecified
- 8C80/G72.0 Drug-induced myopathy
- 8C81/G72 Autoimmune myopathy
- 8C82/G72 Myopathy in certain specified infectious or parasitic disease
- 8C83/G72 Myopathy in certain specified endocrine disease
- 8C84/G72 Secondary rhabdomyolysis
- 8C8Y/G72.8 Other specified secondary myopathies
- 8C8Z/G72 Secondary myopathies, unspecified
- 8D0Y/G70-G73 Other specified diseases of neuromuscular junction or muscle
- 8D0Z/G70-G73 Diseases of neuromuscular junction or muscle, unspecified
- 8D20.0/G80.2 Spastic unilateral cerebral palsy
- 8D20.1/G80 Spastic bilateral cerebral palsy
- 8D20.10/G80.0 Spastic quadriplegic cerebral palsy
- 8D20.11/G80.1 Spastic diplegic cerebral palsy
- 8D20.1Z/G80 Spastic bilateral cerebral palsy, unspecified
- 8D20/G80 Spastic cerebral palsy
- 8D20.Y/G80 Other specified spastic cerebral palsy
- 8D20.Z/G80 Spastic cerebral palsy, unspecified
- 8D21/G80.3 Dyskinetic cerebral palsy
- 8D22/G80.4 Ataxic cerebral palsy
- 8D23/G80 Worster-Drought syndrome
- 8D2Y/G80.8 Other specified cerebral palsy
- 8D2Z/G80 Cerebral palsy, unspecified
- 8D40.0/E63.9 Encephalopathy due to nutritional deficiency
- 8D40.1/E63.9 Neuropathy due to nutritional deficiency
- 8D40.2/E63.9 Myopathy due to nutritional deficiency
- 8D40.3/E63.9 Intellectual developmental disorder due to nutritional deficiency
- 8D40/VI Neurological disorders due to nutrient deficiency
- 8D40.Y/VI Other specified neurological disorders due to nutrient deficiency
- 8D40.Z/VI Neurological disorders due to nutrient deficiency, unspecified
- 8D41.0/VI Peripheral neuropathy due to vitamin B6 hyperalimentation
- 8D41.1/VI Myopathy due to hypercalcaemia
- 8D41.2/VI Pseudotumour Cerebri related to Hypervitaminosis A
- 8D41/VI Neurological disorders due to an excess of micro or macro nutrients
- 8D41.Y/VI Other specified neurological disorders due to an excess of micro or macro nutrients
- 8D41.Z/VI Neurological disorders due to an excess of micro or macro nutrients, unspecified
- 8D42/VI Neurological disorders due to overweight or obesity in adults or children
- 8D43.0/G92 Encephalopathy due to toxicity
- 8D43.00/G92 Encephalopathy due to ammonia
- 8D43.0Y/G92 Other specified encephalopathy due to toxicity
- 8D43.0Z/G92 Encephalopathy due to toxicity, unspecified
- 8D43.1/T65.9 Cognitive impairment due to toxicity
- 8D43.2/T65.9 Neuropathy due to toxicity
- 8D43.20/G62.0 Drug-induced polyneuropathy
- 8D43.21/T65.9 Post radiation polyneuropathy
- 8D43.2Y/T65.9 Other specified neuropathy due to toxicity
- 8D43.2Z/T65.9 Neuropathy due to toxicity, unspecified
- 8D43.3/T65.9 Myopathy due to toxicity
- 8D43.4/T65.9 Movement disorders due to toxicity
- 8D43.5/T62.2 Cassava poisoning
- 8D43/VI Neurological disorders due to toxicity
- 8D43.Y/VI Other specified neurological disorders due to toxicity
- 8D43.Z/VI Neurological disorders due to toxicity, unspecified
- 8D44.0/G62.1 Alcoholic polyneuropathy
- 8D44.1/G72.1 Alcoholic myopathy
- 8D44/VI Alcohol-related neurological disorders
- 8D44.Y/VI Other specified alcohol-related neurological disorders
- 8D44.Z/VI Alcohol-related neurological disorders, unspecified
- 8D4Y/VI Other specified nutritional or toxic disorders of the nervous system
- 8D4Z/VI Nutritional or toxic disorders of the nervous system, unspecified
- 8D60.0/G93.2 Brain herniation syndromes
- 8D60.1/G93.6 Cerebral oedema
- 8D60/G93.2 Increased intracranial pressure
- 8D60.Y/G93.2 Other specified increased intracranial pressure
- 8D60.Z/G93.2 Increased intracranial pressure, unspecified
- 8D61.0/VI Spontaneous intracranial hypotension
- 8D61.1/VI Secondary intracranial hypotension
- 8D61/VI Intracranial hypotension
- 8D61.Y/VI Other specified intracranial hypotension
- 8D61.Z/VI Intracranial hypotension, unspecified
- 8D62/G96.0 Cerebrospinal fluid rhinorrhoea
- 8D63/G96.0 Cerebrospinal fluid otorrhoea
- 8D64.0/G91.0 Communicating hydrocephalus
- 8D64.00/G91.0 Increased cerebrospinal fluid production
- 8D64.01/G91.0 Congenital agenesis of arachnoid villi
- 8D64.02/G91.0 Post haemorrhagic hydrocephalus
- 8D64.03/G91.0 Post traumatic hydrocephalus
- 8D64.04/G91.2 Normal-pressure hydrocephalus
- 8D64.0Y/G91.0 Other specified communicating hydrocephalus
- 8D64.0Z/G91.0 Communicating hydrocephalus, unspecified
- 8D64.1/G91.1 Non-communicating hydrocephalus
- 8D64.10/G91.1 Hydrocephalus due to structural malformations
- 8D64.1Y/G91.1 Other specified non-communicating hydrocephalus
- 8D64.1Z/G91.1 Non-communicating hydrocephalus, unspecified
- 8D64.2/G94 Ex-vacuo hydrocephalus
- 8D64/G94 Hydrocephalus
- 8D64.Z/G94 Hydrocephalus, unspecified
- 8D65/G96.0 Cerebrospinal fluid fistula
- 8D66.0/G95.0 Idiopathic syringomyelia
- 8D66.1/G95.0 Syringomyelia due to certain specified cause
- 8D66.2/G95.0 Syringobulbia
- 8D66/G95.0 Syringomyelia or syringobulbia
- 8D66.Y/G95.0 Other specified syringomyelia or syringobulbia
- 8D66.Z/G95.0 Syringomyelia or syringobulbia, unspecified
- 8D67/G93.0 Intracranial arachnoid cyst
- 8D68/G93.0 Porencephalic cyst
- 8D6Y/VI Other specified disorders of cerebrospinal fluid pressure or flow
- 8D6Z/VI Disorders of cerebrospinal fluid pressure or flow, unspecified
- 8D80/G90 Congenital malformations of the autonomic nervous system
- 8D81/G90 Inherited autonomic nervous system disorders
- 8D82/G90 Autoimmune disorders involving the autonomic nervous system
- 8D83/G90 Autonomic nervous system disorder due to infection
- 8D84/G90 Pure autonomic nervous system failure
- 8D85/G90 Autonomic nervous system disorder due to substances
- 8D86/G90 Autonomic nervous system hyperactivity
- 8D87.0/G90 Multiple system atrophy
- 8D87.00/G23.3 Multiple system atrophy, Cerebellar type
- 8D87.01/G23.2 Multiple system atrophy, Parkinsonism
- 8D87.0Y/G90 Other specified multiple system atrophy
- 8D87.0Z/G90 Multiple system atrophy, unspecified
- 8D87/G90 Autonomic nervous system disorder due to certain specified neurodegenerative disorder
- 8D87.Y/G90 Other specified autonomic nervous system disorder due to specified neurodegenerative disorder
- 8D88.0/G99.1 Autonomic neuropathy due to sodium channelopathies
- 8D88.1/G90 Autonomic neuropathy due to diabetes mellitus
- 8D88.2/G99.1 Immune mediated autonomic neuropathy
- 8D88.3/G90 Autonomic disorder due to toxins
- 8D88.4/G99.0 Autonomic neuropathy in endocrine and metabolic diseases
- 8D88/G90 Autonomic neuropathies
- 8D88.Y/G90 Other specified autonomic neuropathies
- 8D88.Z/G90 Autonomic neuropathies, unspecified
- 8D89.0/G90 Reflex syncope
- 8D89.1/G90 Syncope due to autonomic failure
- 8D89.2/G90 Postural orthostatic tachycardia syndrome
- 8D89.3/G90 Baroreflex failure
- 8D89/G90 Disorders of orthostatic tolerance
- 8D89.Y/G90 Other specified disorders of orthostatic tolerance
- 8D89.Z/G90 Disorders of orthostatic tolerance, unspecified
- 8D8A.1/G90 Horner syndrome
- 8D8A.2/G90 Episodic anisocoria
- 8D8A/G90 Focal or segmental autonomic disorders
- 8D8A.Y/G90 Other specified focal or segmental autonomic disorders
- 8D8A.Z/G90 Focal or segmental autonomic disorders, unspecified
- 8D8B/G90 Disorders affecting autonomic synaptic neurotransmission
- 8D8C/G90.4 Autonomic dysreflexia
- 8D8D/G90 Hypoglycaemia unawareness
- 8D8Y/G90.8 Other specified disorders of autonomic nervous system
- 8D8Z/G90 Disorders of autonomic nervous system, unspecified
- 8E00/A81.9 Sporadic Creutzfeldt-Jakob Disease
- 8E01.0/A81.9 Iatrogenically acquired Creutzfeldt-Jakob Disease
- 8E01.1/A81.8 Kuru
- 8E01.2/A81.9 Variant Creutzfeldt-Jakob Disease
- 8E01.3/A81.9 Other acquired Creutzfeldt-Jakob Disease
- 8E01/A81.9 Acquired prion disease
- 8E02.0/A81.0 Genetic Creutzfeldt-Jakob disease
- 8E02.1/A81.9 Gerstmann-Straussler-Scheinker syndrome
- 8E02.2/A81.9 Fatal familial insomnia
- 8E02.3/A81.9 Other genetic prion diseases
- 8E02/A81.9 Genetic prion diseases
- 8E02.Y/A81.9 Other specified Creutzfeldt-Jakob disease
- 8E02.Z/A81.9 Creutzfeldt-Jakob disease, unspecified
- 8E03/A81.9 Variably protease sensitive prionopathy
- 8E0Y/A81.9 Other specified human prion diseases
- 8E0Z/A81.9 Human prion diseases, unspecified
- 8E20/VI Persistent vegetative state
- 8E21/VI Permanent vegetative state
- 8E22.0/R40.1 Minimally conscious state plus
- 8E22.1/R40.1 Minimally conscious state minus
- 8E22/R40.1 Minimally conscious state
- 8E22.Y/R40.1 Other specified minimally conscious state
- 8E22.Z/R40.1 Minimally conscious state, unspecified
- 8E2Y/VI Other specified disorders of consciousness
- 8E2Z/VI Disorders of consciousness, unspecified
- 8E40.0/G03.8 Neoplastic meningitis
- 8E40.1/G03.8 Chemical meningitis
- 8E40.2/G03.8 Inflammatory meningitis
- 8E40.3/G03 Arachnoiditis
- 8E40/G90-G99 Disorders of the meninges excluding infection
- 8E40.Y/G90-G99 Other specified disorders of the meninges excluding infection
- 8E40.Z/G90-G99 Disorders of the meninges excluding infection, unspecified
- 8E41.0/G90-G99 Pachymeningitis due to infection
- 8E41.1/G90-G99 Idiopathic hypertrophic pachymeningitis
- 8E41/G90-G99 Pachymeningitis
- 8E41.Y/G90-G99 Other specified pachymeningitis
- 8E41.Z/G90-G99 Pachymeningitis, unspecified
- 8E42/G90-G99 Superficial siderosis of the nervous system
- 8E43.0/G90-G99 Neuropathic pain
- 8E43.00/G90-G99 Phantom limb syndrome
- 8E43.0Y/G90-G99 Other specified neuropathic pain
- 8E43.0Z/G90-G99 Neuropathic pain, unspecified
- 8E43/G90-G99 Pain disorders
- 8E43.Y/G90-G99 Other specified pain disorders
- 8E43.Z/G90-G99 Pain disorders, unspecified
- 8E44/G90-G99 Post anoxic brain damage
- 8E45/G83.5 Locked-in syndrome
- 8E46/G93.7 Reye syndrome
- 8E47/G93.4 Encephalopathy, not elsewhere classified
- 8E48/G04.8 Encephalitis, not elsewhere classified
- 8E49/G93.3 Postviral fatigue syndrome
- 8E4A.0/G90-G99 Paraneoplastic or autoimmune disorders of the central nervous system, brain or spinal cord
- 8E4A.1/G90-G99 Paraneoplastic or autoimmune disorders of the peripheral or autonomic nervous system
- 8E4A.2/G90-G99 Paraneoplastic or autoimmune neuromuscular transmission disorders
- 8E4A.3/G13 Paraneoplastic or autoimmune disorders of the muscle
- 8E4A/G90-G99 Paraneoplastic or autoimmune disorders of the nervous system
- 8E4A.Y/G90-G99 Other specified paraneoplastic or autoimmune disorders of the nervous system
- 8E4Y/G90-G99 Other specified disorders of the nervous system
- 8E60/G97.2 Post ventricular shunting leak
- 8E61.0/T66 Brain irradiation
- 8E61.1/T66 Spinal cord irradiation
- 8E61/G97 Post radiation injury of the nervous system
- 8E62/G03.8 Postprocedural meningitis
- 8E63/G93.4 Post pump encephalopathy
- 8E64/G97.8 Multifocal cerebral infarctions
- 8E65/G93.1 Anoxic-ischaemic encephalopathy
- 8E66/G97 Intracranial hypotension due to lumbar puncture
- 8E7Y/VII Other specified diseases of the nervous system
- 8E7Z/VII Diseases of the nervous system, unspecified
- 9A00.0/Q15.8 Dystopia canthorum
- 9A00.1/Q15.8 Telecanthus
- 9A00/Q10.3 Congenital malposition of eyelids
- 9A00.Y/Q10.3 Other specified congenital malposition of eyelids
- 9A00.Z/Q10.3 Congenital malposition of eyelids, unspecified
- 9A01.0/H00.0 Preseptal cellulitis
- 9A01.1/H00.0 Abscess of eyelid
- 9A01.2/H00.0 Hordeolum
- 9A01.20/H00.0 Hordeolum externum
- 9A01.21/H00.0 Hordeolum internum
- 9A01.2Z/H00.0 Hordeolum, unspecified
- 9A01.3/H01.0 Infectious blepharitis
- 9A01.4/H03.0 Infestation of eyelid
- 9A01/H01.9 Infectious disorders of eyelid
- 9A01.Y/H01.9 Other specified infectious disorders of eyelid
- 9A02.0/H00.1 Chalazion
- 9A02.00/H00.1 Chalazion externum
- 9A02.01/H00.1 Chalazion internum
- 9A02.0Y/H00.1 Other specified chalazion
- 9A02.0Z/H00.1 Chalazion, unspecified
- 9A02.1/H01.9 Posterior blepharitis
- 9A02.2/H01.9 Ligneous conjunctivitis
- 9A02.4/H01.9 Meibomian gland dysfunction
- 9A02/H01.9 Inflammatory disorders of eyelid
- 9A02.Y/H01.9 Other specified inflammatory disorders of eyelid
- 9A03.0/H02.4 Blepharoptosis
- 9A03.00/H02.4 Marcus-Gunn syndrome
- 9A03.01/H02.4 Mechanical ptosis of eyelid
- 9A03.02/H02.4 Myogenic ptosis of eyelid
- 9A03.03/H02.4 Paralytic ptosis of eyelid
- 9A03.0Y/H02.4 Other specified blepharoptosis
- 9A03.0Z/H02.4 Blepharoptosis, unspecified
- 9A03.1/H02.0 Entropion of eyelid
- 9A03.10/H02.0 Cicatricial entropion of eyelid
- 9A03.11/H02.0 Mechanical entropion of eyelid
- 9A03.12/H02.0 Senile entropion of eyelid
- 9A03.13/H02.0 Spastic entropion of eyelid
- 9A03.1Y/H02.0 Other specified entropion of eyelid
- 9A03.1Z/H02.0 Entropion of eyelid, unspecified
- 9A03.2/H02.1 Ectropion of eyelid
- 9A03.20/H02.1 Cicatricial ectropion of eyelid
- 9A03.21/H02.1 Mechanical ectropion of eyelid
- 9A03.22/H02.1 Senile ectropion of eyelid
- 9A03.23/H02.1 Spastic ectropion of eyelid
- 9A03.24/H02.1 Floppy eyelid syndrome
- 9A03.2Y/H02.1 Other specified ectropion of eyelid
- 9A03.2Z/H02.1 Ectropion of eyelid, unspecified
- 9A03.3/H02.5 Eyelid retraction
- 9A03.4/H02.2 Lagophthalmos
- 9A03.40/H02.2 Cicatricial lagophthalmos
- 9A03.41/H02.2 Mechanical lagophthalmos
- 9A03.42/H02.2 Paralytic lagophthalmos
- 9A03.4Y/H02.2 Other specified lagophthalmos
- 9A03.4Z/H02.2 Lagophthalmos, unspecified
- 9A03.5/H02.7 Dermatochalasis of eyelid
- 9A03/H02.8 Acquired malposition of eyelid
- 9A03.Y/H02.8 Other specified acquired malposition of eyelid
- 9A03.Z/H02.8 Acquired malposition of eyelid, unspecified
- 9A04.0/H02.0 Trichiasis without entropion
- 9A04.1/H02.7 Madarosis of eyelid or periocular area
- 9A04/H02.8 Acquired disorders of eyelashes
- 9A04.Y/H02.8 Other specified acquired disorders of eyelashes
- 9A05.0/G51.4 Myokymia of eyelid
- 9A05.1/H51.8 Eyelid apraxia
- 9A05/H02.8 Movement disorders of eyelid
- 9A05.Y/H02.8 Other specified movement disorders of eyelid
- 9A05.Z/H02.8 Movement disorders of eyelid, unspecified
- 9A06.0/H02 Involvement of eyelid by dermatosis classified elsewhere
- 9A06.1/H02 Vitiligo of eyelid or periocular area
- 9A06.2/H02 Symblepharon, acquired
- 9A06.3/H02 Traumatic scar of eyelid
- 9A06.4/H02.6 Xanthelasma of eyelid
- 9A06.5/H02 Tear Trough Deformity
- 9A06.6/H02 Sunken Sulcus Deformity
- 9A06.7/H02 Dermatitis or eczema of eyelids
- 9A06.70/L20.8 Atopic eczema of eyelids
- 9A06.71/H02 Seborrhoeic dermatitis of eyelids
- 9A06.72/H02 Allergic contact blepharoconjunctivitis
- 9A06.7Y/H02 Other specified dermatitis or eczema of eyelids
- 9A06.7Z/H02 Dermatitis or eczema of eyelids, type unspecified
- 9A06.8/H02.3 Blepharochalasis
- 9A06/H02 Certain specified disorders of eyelid
- 9A06.Y/H02.8 Other specified disorders of eyelid
- 9A0Y/H02.8 Other specified disorders of eyelid or peri-ocular area
- 9A0Z/H02 Disorders of eyelid or peri-ocular area, unspecified
- 9A10.0/H04 Infections of the lacrimal gland
- 9A10.1/H04 Orbital inflammatory syndrome
- 9A10.2/H04 Benign lymphoepithelial lesion of lacrimal gland
- 9A10.3/H04 Hyperlacrimation
- 9A10.4/H04 Underproduction of tears
- 9A10/H04 Disorders of lacrimal gland
- 9A10.Y/H04 Other specified disorders of lacrimal gland
- 9A10.Z/H04 Disorders of lacrimal gland, unspecified
- 9A11.0/H04 Eversion of lacrimal punctum
- 9A11.1/H04.3 Canaliculitis
- 9A11.2/H04.3 Dacryocystitis
- 9A11.3/H04.5 Conjunctivochalasis
- 9A11.4/H04.5 Punctal stenosis
- 9A11.5/H04.5 Nasolacrimal canalicular stenosis
- 9A11.6/H04.5 Dacryolith
- 9A11.7/H04.5 Nasolacrimal sac stenosis
- 9A11.8/H04.5 Nasolacrimal duct obstruction
- 9A11/H04 Disorders of lacrimal drainage system
- 9A11.Y/H04 Other specified disorders of lacrimal drainage system
- 9A11.Z/H04 Disorders of lacrimal drainage system, unspecified
- 9A1Y/H04.8 Other specified disorders of lacrimal apparatus
- 9A1Z/H04 Disorders of lacrimal apparatus, unspecified
- 9A20.0/H05 Axial displacement of eyeball
- 9A20.00/H05 Outward displacement of eyeball
- 9A20.01/H05 Inward displacement of eyeball